Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42296,-0.217054016300847,0.00523249107383878,-0.227309698805571,-0.206798333796123,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.147838374790962,0.00334143424870737,0.141289163663495,0.154387585918428,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,41843,-0.569106064785172,0.012441402653805,-0.59349121398663,-0.544720915583715,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.217152164794466,0.00516004600009012,-0.227265854954642,-0.207038474634289,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42137,-0.241163267171744,0.00441294059630902,-0.24981263074051,-0.232513903602979,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.287487122318985,0.006375817225081,-0.299983724080144,-0.274990520557827,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.158743959576827,0.00395155632341192,-0.166489009970715,-0.15099890918294,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42080,-0.162635100091021,0.00426764801019498,-0.170999690191003,-0.154270509991039,6.94940646381865e-302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.329108986338559,0.0087766772391778,-0.346311273727348,-0.311906698949771,3.10471524610782e-290
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.110051933684934,0.00301255288869852,0.104147330023085,0.115956537346783,8.64048593231425e-279
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,39990,0.211781048794577,0.00591091889979529,0.200195647750978,0.223366449838176,1.72899592134449e-266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.114031559224787,0.00331794156418575,0.107528393758983,0.120534724690592,2.98161807525899e-248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.439100352780112,0.0131181737134039,0.413388732301841,0.464811973258384,3.49821638028724e-236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42145,0.166535608379366,0.00497490004905241,0.156784804283224,0.176286412475509,4.02196134375105e-236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,39575,-0.332199699643397,0.0103567776718494,-0.352498983880222,-0.311900415406572,7.31872837508864e-216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,39979,0.225503912772321,0.00712781711847922,0.211533391220102,0.23947443432454,1.28146445399108e-210
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,39990,0.0841083797415871,0.00269018821072922,0.0788356108485578,0.0893811486346163,6.06726752142728e-206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.273098607024504,0.00882734421616276,-0.290400201688183,-0.255797012360825,3.88937286856703e-203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.280096846445168,0.00914859204946205,-0.298028086862114,-0.262165606028222,4.51062670222049e-199
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.094031947526075,0.00315812518277827,-0.10022187288432,-0.0878420221678296,1.0663919092455e-188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0956501135611385,0.00320752383393117,0.0893633668466334,0.101936860275644,4.62252106914774e-188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.248902881549468,0.00851880674013523,-0.265599742760133,-0.232206020338803,6.00449301777641e-182
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42047,-0.216887485619358,0.00748994295525697,-0.231567773811662,-0.202207197427054,6.64758610691529e-179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.119016539574342,0.00415043739393119,-0.127151396866447,-0.110881682282237,1.29133455994164e-175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.193590459186271,0.0068076280228609,-0.206933410111078,-0.180247508261463,9.76013578500927e-173
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.267453614237492,0.00946920793904664,-0.286013261798023,-0.248893966676961,1.11639009048757e-169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.1417856457698,0.00505392658518067,-0.151691341876754,-0.131879949662846,2.044140187492e-168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,41913,-0.23984127332984,0.00864141790433902,-0.256778452422345,-0.222904094237336,7.16831879293927e-165
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42145,-0.182130186517705,0.00658320000242855,-0.195033258522465,-0.169227114512945,6.20285054853722e-164
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.107674826440815,0.0039579256889098,0.0999172920905515,0.115432360791078,9.26805936820116e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0960504488513293,0.00353497811092793,-0.102979005948748,-0.0891218917539105,2.20477149197024e-158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0917664237021567,0.00338820357057041,-0.0984073027004747,-0.0851255447038387,2.0948901218724e-157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.176781346746551,0.00655057429419885,-0.189620472363181,-0.163942221129922,2.73601502363878e-156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0812819425085285,0.00304453884144733,-0.0872492386377653,-0.0753146463792918,4.56041128695041e-153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.14658580306723,0.00556643739365039,-0.157496020358785,-0.135675585775676,4.37599026724216e-149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,39649,-0.230726438658697,0.00873834758789166,-0.247853599930964,-0.213599277386429,4.89257192399353e-149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.129676644570055,0.00492276046303382,0.120028034062509,0.139325255077602,1.67309864147405e-148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.156409207733721,0.00594574125868607,-0.168062860600746,-0.144755554866696,4.36944700841804e-148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42123,-0.155066703147663,0.00592063611134599,-0.166671149925902,-0.143462256369425,1.56264577282668e-147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.397513686972185,0.0152103375385635,-0.427325948547769,-0.3677014253966,5.9251607808226e-147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0928895162501863,0.00356891311039789,-0.0998845859465662,-0.0858944465538065,8.76903012661939e-146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42089,-0.280911219351034,0.0108006335534398,-0.302080461115776,-0.259741977586292,1.48147964856308e-145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,42181,-0.0886030108591752,0.00347229647730256,-0.0954087119546883,-0.0817973097636622,2.5103131835893e-140
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42296,-0.077284966380531,0.00306535120463083,-0.0832930547416074,-0.0712768780194545,3.83389208755374e-137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.135121789813115,0.00539253943675896,-0.145691167109163,-0.124552412517068,1.59689555733038e-135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.384643212576758,0.0153701308132592,-0.414768668970746,-0.35451775618277,4.17047985472572e-135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.315787231170591,0.0126335543220334,-0.340548997641776,-0.291025464699405,7.15327561303258e-135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.170110471480756,0.00687235337006188,-0.183580284086077,-0.156640658875435,2.85992148274823e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.130210203919461,0.00533069975546855,-0.140658375440179,-0.119762032398743,6.25325096924103e-129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.2174571183345,0.00892781415280849,-0.234955634074004,-0.199958602594995,2.76895325295295e-128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41225,-0.106102087688629,0.00435960873573521,-0.11464692081067,-0.0975572545665875,6.78073899071153e-128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.221031075491126,0.00912506044581765,-0.238916193964928,-0.203145957017323,2.07372856159378e-126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,39468,0.107232075382888,0.00444788760723042,0.0985142156727165,0.11594993509306,3.79161623036181e-125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.136540393173138,0.00574869893986407,-0.147807843095271,-0.125272943251004,3.63827912991369e-122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.136272702766352,0.00575846965422971,-0.147559303288643,-0.124986102244062,2.61452820367675e-121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0874805052791353,0.00370300162428651,-0.0947383884627368,-0.0802226220955337,5.88642721375499e-121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0802356949970626,0.00339970960576325,-0.0868991258243586,-0.0735722641697667,1.01090397506155e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0785469370102696,0.0033472614046672,-0.0851075693634173,-0.0719863046571219,2.07530152489995e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0915592149283752,0.003935223144272,0.0838461775656021,0.0992722522911483,1.91963956255426e-117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42199,0.0692988481045256,0.00299276185034602,0.0634330348778473,0.0751646613312038,2.25061520225773e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42070,-0.1898205819436,0.00821917680723681,-0.205930168485784,-0.173710995401416,9.12276244296266e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.137161807489243,0.00594185015336344,-0.148807833789835,-0.12551578118865,1.16055982405877e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.145923169729055,0.00633300734333392,-0.158335864121989,-0.13351047533612,3.23953079695949e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.10858326286303,0.00471792324502316,0.0993361333027849,0.117830392423276,5.2681373871293e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0568970087999987,0.00249639000062004,-0.0617899332012139,-0.0520040843987834,7.13641813068432e-113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0772076113837541,0.00342025581545437,-0.0839113127820446,-0.0705039099854635,2.62249754003488e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,41839,-0.124966203160407,0.00556928045491297,-0.135881992852036,-0.114050413468777,1.80049672432982e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.162014460500273,0.00725795085690652,-0.17624004417981,-0.147788876820737,2.05053782370777e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0730970668016849,0.00328039878558355,-0.0795266484214286,-0.0666674851819411,4.6745155264524e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.119088504170027,0.00535868890922649,-0.129591534432111,-0.108585473907944,4.4545738920626e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0656464043612366,0.00299103377065354,-0.0715088305517175,-0.0597839781707556,5.8683760155334e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0757632051552987,0.00346887541567477,-0.0825622009700213,-0.0689642093405762,5.98499631565056e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42193,-0.0760919095901761,0.00349336061587775,-0.0829388963972965,-0.0692449227830557,2.0052591764224e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42137,-0.0651745140486062,0.00299553723888617,-0.0710457670368231,-0.0593032610603893,3.42806945798856e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.177508664281676,0.00816869650221532,-0.193519309426018,-0.161498019137334,6.58611816778234e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.196124133587157,0.00903251536048491,-0.213827863693708,-0.178420403480607,8.84003429020435e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.182865005240592,0.00846365058449235,-0.199453760386197,-0.166276250094987,8.37461672307922e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.192032377040816,0.00889762493999288,-0.209471721923202,-0.17459303215843,1.4626663261674e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.110666938795353,0.00515319866718565,-0.120767208183037,-0.100566669407669,1.22292842437965e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.192704281218921,0.00898807978577779,-0.210320917599045,-0.175087644838797,2.66519831457882e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,39736,-0.0643488439391371,0.00299936684632899,-0.0702276029579419,-0.0584700849203323,4.36569183015462e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.119254186985676,0.00557488511689966,-0.130180961814799,-0.108327412156552,7.27242289868373e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42137,0.0611530161976335,0.00286149780813268,0.0555444804936934,0.0667615519015736,1.09507176676778e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0822032389486524,0.00384662672892588,-0.0897426273373472,-0.0746638505599577,1.15036285222347e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.17335487235545,0.00815974097597923,-0.189347964668369,-0.157361780042531,2.97517459044591e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,39958,-0.0770237484775073,0.00368435669073483,-0.0842450875913475,-0.069802409363667,2.92527097455662e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.108228798716329,0.00518802059008784,-0.118397319072901,-0.0980602783597565,3.92081284373009e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,39979,-0.044600171955738,0.00214215590304497,-0.0487987975257062,-0.0404015463857699,1.62118784679588e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42296,-0.0575289210094906,0.00277392979989886,-0.0629658234172924,-0.0520920186016889,4.26349903354859e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0742950973985384,0.00358624449656555,-0.0813241366118068,-0.0672660581852699,7.17118692102046e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.117979945385831,0.00572123758618358,0.106766319716911,0.12919357105475,4.95557520127308e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0729912221852953,0.00354600252989048,0.06604105722671,0.0799413871438806,9.56735529917938e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0614578178792456,0.00298910945097335,-0.0673164724031533,-0.0555991633553378,2.92830502278653e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0798812172990502,0.00389212900137044,0.0722526444563641,0.0875097901417362,3.22831293535668e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.165651325358382,0.00807631210463721,-0.181480897083471,-0.149821753633293,7.9432426169297e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.10513595818625,0.00515750874259884,-0.115244675321743,-0.0950272410507561,1.01896457019897e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.141980605788447,0.00700995204292885,-0.155720111792587,-0.128241099784306,1.2377761755631e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,39638,-0.135544408510555,0.00669724760610894,-0.148671013818528,-0.122417803202581,1.85162445197785e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.107427950590658,0.00530878034379067,-0.117833160064487,-0.0970227411168279,1.89881488753709e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42199,-0.0391516853986282,0.00194336835005791,-0.0429606873647417,-0.0353426834325147,5.73293779068092e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42129,0.378219729291283,0.0188469683734553,0.34127967127931,0.415159787303255,2.69814388392878e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0729090758169215,0.00366053660174404,-0.0800837275563399,-0.0657344240775032,4.86684906068836e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42194,-0.0654946208909019,0.00328946920706366,-0.0719419805367467,-0.0590472612450571,5.71431146189065e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.169246331337319,0.00852633886423628,-0.185957955511222,-0.152534707163416,1.8942511408314e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.12096469706691,0.00611679040394507,-0.132953606258643,-0.108975787875178,7.98634102863144e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0444775724458801,0.00225078643827071,0.0400660310268695,0.0488891138648907,1.01607925570539e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42239,-0.0421888104049801,0.00213980265472848,-0.0463828236082479,-0.0379947972017123,2.40534002694113e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42310,-0.10544721947861,0.00535267122845798,-0.115938455086388,-0.0949559838708323,3.24404394924248e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0574769606919919,0.00293423742945322,-0.0632280660537202,-0.0517258553302636,5.0010675751007e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0816003184615108,0.00416966603686948,-0.089772863893775,-0.0734277730292466,7.13648034697775e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,39862,-0.0515672398658846,0.00263709504587278,-0.0567359461557952,-0.0463985335759739,9.16948614217979e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0874708981612606,0.00448292592171026,-0.0962574329678127,-0.0786843633547085,1.20712900571402e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.220803658809007,0.0113334715118507,-0.243017262972234,-0.198590054645779,2.16523035835033e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.102278109847682,0.00526630178189018,0.0919561583551775,0.112600061340187,1.11458410057511e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0540800681471493,0.00278508296924299,-0.0595388307668656,-0.0486213055274331,1.23247860688603e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.188287213950905,0.00972604894254912,-0.207350269878301,-0.169224158023509,2.31431400245009e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.105031068258835,0.00542858654188602,-0.115671097880931,-0.094391038636738,2.67175504516291e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0460708450214606,0.00238771274169123,-0.0507507619951754,-0.0413909280477457,7.35216825165649e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.252805490999908,0.0131268727777481,-0.278534161644295,-0.227076820355522,1.4357170262315e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0673968261612939,0.00350602404361367,-0.0742686332867767,-0.0605250190358111,2.77860971970771e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.106639075302474,0.00558680291763358,-0.117589209021036,-0.0956889415839119,3.61245620722892e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.116995722108997,0.00612178757074277,-0.128994425747652,-0.104997018470341,3.9690703219968e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.122220744906316,0.00641584381438281,0.109645691030125,0.134795798782506,7.10055712278176e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0750147652203857,0.00395591284354655,-0.0827683543937369,-0.0672611760470344,3.64492515250001e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.115640346530225,0.00610139486770364,-0.127599080470924,-0.103681612589526,4.30393138037131e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.133245049121946,0.00706287099618773,-0.147088276274474,-0.119401821969418,2.18518130600398e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.109832974719632,0.00582210539926791,-0.121244301302197,-0.0984216481370667,2.3815595064264e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42296,-0.0901706822731052,0.00482801322044794,-0.0996335881851832,-0.0807077763610272,6.90788053629755e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0686981595529891,0.00369121340703883,-0.0759329378307852,-0.061463381275193,3.51119228904499e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.105785097497104,0.00569273577641942,-0.116942859618886,-0.094627335375322,6.37531325518765e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,42145,-0.136920284285533,0.00739702556009695,-0.151418454383323,-0.122422114187743,1.45761777456859e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.141567165200039,0.00766740691225677,-0.156595282748062,-0.126539047652015,3.46967955344637e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,39966,0.112928802427428,0.00611243440261631,0.1009484309983,0.124909173856556,4.08959460574265e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.162939245621528,0.00889242534058645,-0.180368399289078,-0.145510091953979,4.37801811679857e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.133693555352656,0.00731318687041771,-0.148027401618674,-0.119359709086637,8.91605038351144e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42296,-0.0593224339431848,0.00325244677515108,-0.0656972296224809,-0.0529476382638887,1.85866944933522e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42152,-0.0634155197450814,0.00348344404746607,-0.0702430700781149,-0.0565879694120479,3.51163102858826e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.103478659001279,0.00567810135671292,-0.114607737660436,-0.0923495803421217,3.67348032073846e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0619100358890795,0.00340393268329445,0.0552383278298224,0.0685817439483366,4.71249416945792e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.107611888101393,0.00592070228303743,-0.119216464576146,-0.0960073116266392,6.14214011964914e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.132553181246355,0.00730737236184935,-0.146875631075579,-0.11823073141713,1.76583156217862e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0559750111122557,0.00309365163592303,0.0499114539058465,0.0620385683186648,2.52265068396489e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.10874822408696,0.0060052949459186,-0.120518602180961,-0.0969778459929598,2.83616607625137e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42145,-0.120939696144801,0.00671259995135147,-0.13409639204945,-0.107783000240152,9.86692114108518e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0743508845135274,0.00412751991352086,-0.0824408235440283,-0.0662609454830266,1.02543100309245e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,39736,-0.123822404748729,0.00687698870350706,-0.137301302607603,-0.110343506889856,1.81696834894763e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.139295436991646,0.00773854696622425,-0.154462989045446,-0.124127884937847,1.9009280545918e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0753720938698487,0.00420339675626091,0.0671334362275774,0.0836107515121201,4.46940671794931e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,39802,-0.0447786680424195,0.0024942248139373,-0.0496673486777366,-0.0398899874071024,4.49027185650486e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.055342060048871,0.00310470254612674,-0.0614272770392794,-0.0492568430584626,4.0432724843767e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0675624554514829,0.00379502582596537,0.0601242048325908,0.0750007060703751,4.22811794412729e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.113379530387266,0.00639112617456851,-0.12590613768942,-0.100852923085111,1.24550743078976e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42184,-0.0539859237110645,0.00304810263454992,-0.0599602048747823,-0.0480116425473466,2.06421792150378e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0819285449200846,0.00462894358096899,-0.0910012743387838,-0.0728558155013854,2.50721297063251e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.209770260862166,0.0118988200812965,-0.233091948221507,-0.186448573502825,1.20239690851939e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42185,-0.0668507824771662,0.00381324100974772,-0.0743247348562718,-0.0593768300980607,4.63937939941787e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0623548841774813,0.00355731986754305,-0.0693272311178657,-0.055382537237097,4.80623167302385e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,39736,0.0443188498481786,0.00253798343806093,0.0393444023095792,0.0492932973867781,2.1879110073932e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0642298094657389,0.00368834554780305,-0.0714589667394329,-0.0570006521920449,3.41952281444259e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0792782862088848,0.00455498422591134,-0.088206055291671,-0.0703505171260985,4.03961367201405e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0959424378886212,0.0055127826145645,-0.106747491813168,-0.0851373839640748,4.16884524862245e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.139200579237622,0.00803287393063304,-0.154945012141663,-0.123456146333581,1.4586770312539e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,39736,-0.0709015400074734,0.00409241926108062,-0.0789226817591914,-0.0628803982557554,2.24841141300177e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0622087011919355,0.003603834707981,0.0551451851642927,0.0692722172195782,4.65073697412306e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.102279660224103,0.0059278839254564,-0.113898312717997,-0.0906610077302084,5.29790712309058e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0758103317895019,0.00440774404402806,-0.0844495101157969,-0.0671711534632069,1.34551586218976e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.151004969785714,0.0087887157240025,-0.168230852604759,-0.133779086966669,1.86262883991653e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.139649681815539,0.00815003012882759,-0.155623740868041,-0.123675622763037,5.5332914739491e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.068418868246431,0.00400018601391374,-0.0762592328337019,-0.0605785036591601,9.28789186702412e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0823028365396112,0.00485599403330078,-0.0918205848448808,-0.0727850882343417,9.14286195433698e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0714817894638895,0.00422998025179615,-0.0797725507574099,-0.063191028170369,2.01244582265158e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0391913492431456,0.00231762573209547,-0.0437338956780527,-0.0346488028082385,2.24141322105454e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0343101570956023,0.00204504601084929,0.0303018669143377,0.0383184472768669,1.52941334273812e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0661699275960699,0.00394392482805943,-0.0739000202590664,-0.0584398349330735,1.5316270631179e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,39806,-0.0480138253825877,0.00287516837686495,-0.053649155401243,-0.0423784953639325,7.3758069024497e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,39966,0.067179003004361,0.00403865152563722,0.059263246014112,0.07509475999461,2.09734137267481e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0640014072440632,0.00386313042212747,-0.0715731428714331,-0.0564296716166934,4.85823527476066e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.0806426558992957,0.00487384322458546,-0.0901953886194832,-0.0710899231791082,6.65634453292716e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0430653642013527,0.00260486810435524,-0.0481709056858889,-0.0379598227168164,8.3180376108309e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,39934,-0.0740220345753327,0.00450570593637491,-0.0828532182106275,-0.0651908509400379,5.88316606109544e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,39638,-0.110374902349193,0.00672468426047721,-0.123555283499728,-0.0971945211986578,7.82489373606576e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42145,-0.0614899154343009,0.00376183373961241,-0.0688631095639412,-0.0541167213046606,1.72958489065926e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0986297524558172,0.00604474423347239,0.0867820537582113,0.110477451153423,3.69426878855251e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.10567240467446,0.0064994303516846,-0.118411288163762,-0.0929335211851581,6.94565164738452e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,42145,-0.140607133419139,0.00865785823935001,-0.157576535568266,-0.123637731270013,9.36729245449787e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0475420837555055,0.00292674222441587,0.0418056689956504,0.0532784985153606,1.12338621423722e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0469234050206965,0.0029005330586196,0.041238360225802,0.0526084498155909,3.23124261864458e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0459436780786303,0.0028431653417762,-0.0515162821485117,-0.040371074008749,3.4136926306175e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42171,0.0671252846813552,0.00415427509952684,0.0589829054862826,0.0752676638764278,3.47231296444026e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.117626238157557,0.00728596604815533,-0.131906731611942,-0.103345744703173,4.46559943004906e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.125265625258441,0.0077822981974228,-0.14051892972539,-0.110012320791492,9.4125621797738e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.171694531670802,0.0107047285581016,-0.192675799644681,-0.150713263696923,2.38317934649043e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0765481025346849,0.00476955929725842,-0.0858964387573114,-0.0671997663120583,2.56178256504707e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.190425042490914,0.0119153895918646,-0.213779206090969,-0.167070878890859,5.86189027991207e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0282903074885498,0.0017729880796999,0.024815250852338,0.0317653641247616,8.3907374526027e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0746396342697627,0.00468227320913328,-0.0838168897596639,-0.0654623787798614,1.10175941969116e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0977084276356981,0.00612604176845731,-0.109715469501874,-0.0857013857695218,1.17824019428979e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0903334579063678,0.0056732794786033,-0.10145308568443,-0.0792138301283053,1.43931519149166e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.111603877466166,0.00702123168282952,-0.125365491564512,-0.09784226336782,2.22508598743022e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.046215222671674,0.00291809293801769,-0.0519346848301886,-0.0404957605131593,5.46255211028634e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0469534145186107,0.00297380406519512,-0.0527820704863931,-0.0411247585508282,1.49738891107195e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.102484201352531,0.00650634313361465,-0.115236633894416,-0.0897317688106464,2.70283778590472e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.211127932373396,0.0134593902379274,-0.237508337239733,-0.184747527507058,5.74846726611656e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.103697151833548,0.00661256343909112,-0.116657776174167,-0.0907365274929295,6.04042045284089e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42217,-0.0955448667321549,0.00609355987983768,-0.107488244096637,-0.0836014893676731,6.29516524603599e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0676421729604426,0.00431692005136813,-0.0761033362611241,-0.0591810096597611,7.47080007866046e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0594896979915302,0.00379777065631407,-0.0669333284779057,-0.0520460675051546,7.95737218529326e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.0842100864080182,0.00539242674356742,-0.0947792428254103,-0.073640929990626,1.6675094130817e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,39657,-0.140103238721512,0.00898091206687656,-0.15770582637259,-0.122500651070434,2.74927694646709e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0864747189898155,0.0055534563655655,-0.0973594934663239,-0.0755899445133072,3.33376232081173e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0584563103661735,0.00375397477841046,-0.0658141009318581,-0.051098519800489,3.35463417873857e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42119,-0.147742509780304,0.00952688979995269,-0.166415213788211,-0.129069805772396,8.8992957566456e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0978503663942214,0.00632207310561484,-0.110241629681226,-0.0854591031072163,1.44875423023421e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0804482112584605,0.00522275117086518,-0.0906848035533562,-0.0702116189635647,4.38210402743063e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,41697,-0.0661556764202052,0.00429448199584159,-0.0745728611320547,-0.0577384917083557,4.43445486615454e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0456621738728056,0.00296805256667514,-0.0514795569034889,-0.0398447908421223,5.8359879663914e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.107570978685679,0.00701458095827554,-0.121319557363899,-0.093822400007459,1.23071633548283e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0917799775157316,0.00599140081122494,-0.103523123105732,-0.0800368319257307,1.99894577438133e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.186266027495538,0.0121802816377708,-0.210139379505568,-0.162392675485507,2.36304641832717e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0462544890927503,0.00302422626864395,-0.0521819725792924,-0.0403270056062082,2.75932182134686e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,41839,-0.0834280995472842,0.00547526720327869,-0.0941596232657105,-0.072696575828858,5.51982029621147e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.10505994460846,0.00690285637919545,0.0915303461052366,0.118589543111683,7.04285849421928e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42119,0.0719921027626386,0.00474240243577749,0.0626969939885147,0.0812872115367624,1.26773671363474e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,39966,0.0657748794511606,0.00432945529017171,0.057289147082424,0.0742606118198971,1.27430797043444e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.109194390906892,0.00719900932464756,-0.123304449183201,-0.0950843326305824,1.8374941293458e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.0430928085763619,0.00285835517916173,-0.0486951847275189,-0.037490432425205,5.97673282780886e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.134704050038954,0.00895322109748484,-0.152252363390024,-0.117155736687884,1.1390047489282e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.114313406769483,0.00761366747919401,-0.129236195028704,-0.0993906185102632,1.81116678854435e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,39979,-0.0310577278523326,0.00207566799608913,-0.0351260371246673,-0.0269894185799979,3.85000506533076e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0370956715677491,0.00248212939454467,-0.0419606451810566,-0.0322306979544415,4.20437852633725e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0480701645207447,0.00321976751873363,-0.0543809088574626,-0.0417594201840268,6.35105696930528e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42181,-0.0862259954768118,0.00578968824409833,-0.0975737844352446,-0.0748782065183791,9.03316669210632e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42185,0.0652025353195003,0.00438010401341103,0.0566175314532146,0.0737875391857859,1.00046319257599e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42262,-0.0866934616266901,0.00582487508426691,-0.0981102167918532,-0.0752767064615269,1.03659416395912e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,39966,-0.181017075473727,0.0121552004986557,-0.204841268451092,-0.157192882496362,1.08884716380095e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0537321892090328,0.00362244552132702,-0.0608321824308337,-0.0466321959872318,2.1829726306288e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,39736,-0.0736054901606465,0.00495966581898353,-0.0833264351658542,-0.0638845451554388,2.36020112249009e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0613259275372873,0.00414480382963673,-0.0694497430433753,-0.0532021120311993,3.73431983420031e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.076378466813831,0.00516167102182693,-0.0864953420166118,-0.0662615916110502,4.37932588664689e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.166044078521789,0.0112654145549308,-0.188124291049453,-0.143963865994124,8.65531169293949e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0425205485001286,0.00288626162499675,0.036863475715135,0.0481776212851222,9.56203667015118e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.14340813523863,0.00976614130031915,-0.162549772187255,-0.124266498290004,2.25652559633468e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0798614772700045,0.00544391739247546,-0.0905315553592564,-0.0691913991807526,2.36165768072473e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0409259158096198,0.00279498986595784,-0.0464040959468971,-0.0354477356723424,3.48045285374561e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.136001748894833,0.00929914917128614,-0.154228081270554,-0.117775416519112,5.44014976744418e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0659737187460309,0.00451523371526467,-0.0748235768279496,-0.0571238606641121,5.45778113420321e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42070,-0.0610725863526607,0.00418312446408847,-0.0692715103022741,-0.0528736624030473,6.54391558883391e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0759303827444961,0.00521452926185145,-0.086150860097725,-0.0657099053912673,1.15541854023514e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.104834754049115,0.00720562200865091,-0.118957773186071,-0.0907117349121595,1.35967631105729e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42274,0.0831593500362062,0.00574464039727805,0.0718998548575412,0.0944188452148712,3.83322832160197e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.057283467769065,0.00395880466378228,-0.0650427249100782,-0.0495242106280517,4.25481421654569e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,39934,-0.0687093533233432,0.00474707735117585,-0.0780136249316478,-0.0594050817150385,4.64262340762493e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,39638,-0.0922743143003386,0.00637586357930797,-0.104771006915782,-0.0797776216848949,4.87223937499453e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0459968213745742,0.00318122014834803,-0.0522320128653364,-0.0397616298838121,4.92386650553762e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.170377580326389,0.0117828808757,-0.193472026842761,-0.147283133810017,5.70095392447997e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0301266227177615,0.00208913379279607,0.0260319204838812,0.0342213249516418,8.56020965244934e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,39958,-0.0431113720731792,0.00298949946206447,-0.0489707910188256,-0.0372519531275328,9.87642357126284e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0508684204752553,0.0035390416305311,-0.0578049420710963,-0.0439318988794143,1.95972195368595e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,39929,-0.200910877225712,0.0140117246373094,-0.228373857514839,-0.173447896936586,3.17675482064985e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0581210794018507,0.00405981022685975,-0.0660783074464958,-0.0501638513572056,3.76810462178466e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.117355203059789,0.00820403812480355,-0.133435117784403,-0.101275288335174,4.43702654804989e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0654044440896057,0.00457328323044969,-0.0743680792212871,-0.0564408089579243,4.62040832995499e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0896463079742967,0.00627949663985264,-0.101954121388408,-0.0773384945601855,6.65296576873259e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.139414794648161,0.00977460569139561,-0.158573021803297,-0.120256567493026,7.97500429054928e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0971774417303116,0.00681375706669024,-0.110532405581024,-0.0838224778795987,9.39132793302385e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0695135032434351,0.00489260417051841,-0.0791030074176512,-0.059923999069219,1.72706567128476e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,41830,-0.0750224060815149,0.00528455979346665,-0.0853801432767095,-0.0646646688863203,2.07364836764023e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.133224425402906,0.00939026180716354,-0.151629338544946,-0.114819512260865,2.32916783694631e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0302379297471293,0.00213780014674465,-0.0344280180347488,-0.0260478414595098,4.24343870190067e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.147430605719344,0.0104407803529721,-0.16789453521117,-0.126966676227519,5.9273854417696e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0475539378438142,0.00337060955263592,-0.0541603325669806,-0.0409475431206478,7.00559870830674e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0581968059018434,0.00412553112147272,0.0501107649037568,0.0662828468999299,7.16706238401904e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0391507006458589,0.00277983733148946,-0.0445991818155783,-0.0337022194761396,9.92779285248274e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0610641380120193,0.00433831150271532,-0.0695672285573413,-0.0525610474666972,1.11577273205346e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0664981099771643,0.0047327222605025,-0.0757742456077492,-0.0572219743465794,1.57253624983763e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0484292550385034,0.00344809323062199,-0.0551875177705225,-0.0416709923064843,1.70428401718621e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.095680321771402,0.00682778157123563,-0.109062773651024,-0.0822978698917802,2.6157315803873e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,39954,0.0532733329365405,0.00380415847772785,0.0458171823201939,0.0607294835528871,3.43387536078406e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.0788001594488916,0.00564049279551359,-0.0898555253280982,-0.067744793569685,4.85010737445103e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0702979741449861,0.00503795852010977,-0.0801723728444012,-0.0604235754455709,5.98367305571187e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.120144743265646,0.00862917365921105,-0.1370579236377,-0.103231562893592,1.07150391459464e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42249,-0.0359950854482127,0.0025965388252664,-0.0410843015457348,-0.0309058693506905,2.09737709892662e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0450398159471012,0.00325015483414882,-0.0514101194220329,-0.0386695124721695,2.25907019980164e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.148444364160076,0.0107866721908602,-0.169586241654163,-0.12730248666599,9.54489655230432e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.139596653444049,0.0101593747274398,-0.159509027909831,-0.119684278978267,1.12075427169295e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0459749945057273,0.00335049055093787,-0.0525419559855656,-0.0394080330258891,1.45065917689214e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0417639004592811,0.00305175282258211,-0.0477453359915421,-0.0357824649270202,2.36823031202869e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0871600183102431,0.00639141827517429,-0.0996871981295847,-0.0746328384909015,4.58661858890125e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.158993318760592,0.0116609795089559,-0.181848838598146,-0.136137798923039,5.34168195197379e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42296,-0.0493945227314058,0.00362553094026572,-0.0565005633743266,-0.042288482088485,5.40773851020893e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0434907981295753,0.00319087580463924,-0.0497449147066682,-0.0372366815524823,5.69656900323664e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.111255837240799,0.00816955534550945,-0.127268165717998,-0.0952435087636009,6.6416789966286e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42119,-0.10602428055623,0.00779304115022261,-0.121298641210666,-0.0907499199017936,7.05472762915766e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42129,-0.045002478194121,0.00330792799685615,-0.0514860170679591,-0.038518939320283,7.10524910485186e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42134,0.056847940394352,0.00418096847701179,0.0486532421794089,0.0650426386092951,7.87000117403205e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.081158311561434,0.00597299363230551,-0.0928653790807528,-0.0694512440421152,8.92641018137578e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0938330784905815,0.00691082443971403,-0.107378294392421,-0.080287862588742,1.01044324287655e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.134186444678748,0.00988263300687705,-0.153556405372227,-0.114816483985269,1.01522489823299e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0984727309706683,0.00725519153195989,-0.11269290637331,-0.0842525555680269,1.25875934810338e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.129943109775927,0.00960345464454511,-0.148765880879235,-0.111120338672618,1.92411357817689e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.067017422832916,0.00496293011380323,-0.0767447658559704,-0.0572900798098617,3.15823836646853e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.178817098112713,0.0132545121957043,-0.204795942016294,-0.152838254209133,3.26122701354839e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.113113998863552,0.00840608483115613,-0.129589925132618,-0.0966380725944859,5.84532040846119e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.101697386680117,0.00756707103859709,-0.116528845915768,-0.0868659274444669,6.55865582740079e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0571722028489002,0.00425508133923986,0.0488322434239901,0.0655121622738104,6.78018532758692e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,41839,-0.0959688316224895,0.00714280509859372,-0.109968729615733,-0.0819689336292458,6.91653082043058e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0436558616057228,0.00326099812883093,-0.0500474179382314,-0.0372643052732142,1.29537096295638e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.121679271120321,0.00910515884843094,-0.139525382463245,-0.103833159777396,2.02793829963351e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.031646600839244,0.00236836069870756,-0.0362885878087108,-0.0270046138697772,2.05651236169636e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.113996688385828,0.00853538248184033,-0.130726038050235,-0.0972673387214209,2.21437521615284e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0523633032884878,0.00393121778623578,-0.06006849014951,-0.0446581164274657,3.16087669774554e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0737231370241949,0.00553533003179378,-0.0845723838865107,-0.0628738901618791,3.6748100907578e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.109442259672947,0.00823395587220215,-0.125580813182463,-0.0933037061634308,4.63036750786098e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42249,-0.0530533734498536,0.00399759949430157,-0.0608886684586847,-0.0452180784410225,6.00351844329668e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0713390919511378,0.00537626558351756,-0.0818765724948322,-0.0608016114074434,6.15182917491657e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.121047676757508,0.00914243903055641,-0.138966857257398,-0.103128496257617,9.1700263909886e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0291846007364548,0.00220923133075389,-0.0335146941447324,-0.0248545073281772,1.36834021142977e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0981842246484846,0.00743139322950925,-0.112749755378323,-0.0836186939186464,1.48914334139877e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42296,-0.0526452903327325,0.00399533248948559,-0.0604761420121243,-0.0448144386533408,2.07539497283128e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0593986755273092,0.00451276974749057,-0.0682437042323907,-0.0505536468222277,2.51972992958013e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.117688649134676,0.00895246641261189,-0.135235483303395,-0.100141814965957,3.130527074428e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.14099613755929,0.0107213800160514,-0.162010042390751,-0.119982232727829,3.25437603216937e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.103016560200901,0.00784030286186407,-0.118383553810155,-0.0876495665916476,3.44387516227033e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42181,-0.0785422936618309,0.0059908391980029,-0.0902843384899166,-0.0668002488337453,4.95386474737817e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.106217813210639,0.00810303214989421,-0.122099756224432,-0.0903358701968462,5.06125844545913e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,39736,-0.165808151709305,0.012664468732163,-0.190630510424345,-0.140985792994266,7.04594958449054e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42070,-0.0993998317564379,0.00759947872235143,-0.114294810052247,-0.0845048534606292,7.40591781997508e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0499754898658183,0.00382378486911357,-0.0574701082092809,-0.0424808715223557,8.53130610578093e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.09102904321037,0.00697071215666093,-0.104691639037425,-0.0773664473833146,9.82109627176203e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0459899307064774,0.00352431384550131,-0.0528975858436599,-0.0390822755692948,1.11324059657246e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.148312772685738,0.0113724012417597,-0.170602679119587,-0.126022866251888,1.2157143660989e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0513235386583001,0.00393651249755342,-0.0590391031535048,-0.0436079741630954,1.27696579377947e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0973893823798139,0.00749138293153027,-0.112072492925613,-0.0827062718340146,2.29490764969381e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0761277248621941,0.00586053511360381,-0.0876143736848576,-0.0646410760395306,2.35222583021729e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0548416638070819,0.00422635038566108,-0.0631253105629776,-0.0465580170511862,2.82602766341983e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0519591525237687,0.00400883729819737,-0.0598164736282355,-0.0441018314193018,3.41563415546956e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42153,0.0702035305207807,0.00542611466145226,0.0595683457843342,0.0808387152572271,4.60959571451482e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0683184465676138,0.00528458316328972,-0.0786762295676617,-0.057960663567566,5.26242928299216e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0415546968012351,0.00322556062904602,-0.0478767956341653,-0.0352325979683049,1.03268812127562e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,39966,-0.103799659299274,0.00807433053493693,-0.11962534714775,-0.0879739714507974,1.46257569341807e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42129,-0.0523906736251913,0.00407993424980637,-0.0603873447548118,-0.0443940024955708,1.59882857712231e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42129,-0.0430587005252688,0.00335887628137887,-0.0496420980367714,-0.0364753030137663,2.10803435413596e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0482053677757143,0.00376645008654452,-0.0555876099453416,-0.0408231256060871,2.76335288807932e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0401791560457688,0.00314275659462064,-0.0463389589712252,-0.0340193531203123,3.31338010699933e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.0900618932357423,0.0070471305164231,-0.103874269047932,-0.076249517423553,3.47466587356012e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.102699779226501,0.008036031241814,-0.118450400460457,-0.0869491579925458,3.90363175304955e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0928169916197111,0.00727750662627936,-0.107080904607219,-0.0785530786322036,4.82111613426931e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42230,-0.0939486315667802,0.00739550962059625,-0.108443830423149,-0.0794534327104116,9.13958780951209e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39418,-0.0320202206101054,0.00252214823224305,-0.0369636311453018,-0.027076810074909,1.14159454530557e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.110542231269286,0.00871588207254833,-0.127625360131481,-0.0934591024070917,1.18444312379662e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0785139037435901,0.0061884475053938,-0.0906432608541619,-0.0663845466330182,1.23703038398836e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.03758327587821,0.00297425228847378,-0.0434128103636187,-0.0317537413928014,2.13910976027776e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.10149598818369,0.00805343224528639,-0.117280715384452,-0.085711260982929,3.28699828900168e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.100747820663213,0.00802229954349771,-0.116471527768468,-0.0850241135579573,5.67033736908468e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,39943,0.0255376857157874,0.00203535762472284,0.0215483847713307,0.0295269866602442,7.13989145620482e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,41843,-0.0642312571487223,0.00512622597846746,-0.0742786600665185,-0.0541838542309261,8.17305488606839e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0757392552613836,0.00605856104587744,-0.0876140349113034,-0.0638644756114638,1.15272279381814e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42145,0.0420390203377317,0.0033660371485196,0.0354415875266333,0.0486364531488302,1.34330434146089e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.133463480748366,0.0107011047477814,-0.154437646054018,-0.112489315442715,1.66534796130144e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0904543950302475,0.00725494301430874,-0.104674083338293,-0.0762347067222024,1.75080867370966e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0708608776968633,0.00568436010054057,-0.0820022234939228,-0.0597195318998038,1.80012018725928e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.0515470709498905,0.00413336769206517,0.0434456702734427,0.0596484716263382,1.83460803354463e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0863853558653836,0.00693543419290087,-0.0999788068834693,-0.0727919048472979,2.03000926403447e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,41900,-0.0711794904035079,0.00572292297725365,-0.0823964194389251,-0.0599625613680908,2.56674225224058e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0411452857442956,0.00331665589780118,-0.0476459313039859,-0.0346446401846053,3.78020333957812e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0357344385089734,0.00288190580314907,0.0300859031348013,0.0413829738831456,4.074187167286e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0523682525707317,0.00422490459109316,-0.0606490655692743,-0.0440874395721891,4.67666142507374e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0879742274753006,0.00711671215130419,-0.101922983291857,-0.0740254716587443,6.56505243979658e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,39966,-0.0372900871142856,0.00301555793396265,-0.0432005806648524,-0.0313795935637188,6.69918739161264e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0397887404506715,0.00322778233568701,-0.046115193828618,-0.0334622870727249,9.9571050877037e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,39657,-0.126331666643253,0.0102429217376447,-0.146407793249036,-0.106255540037469,1.01028503982262e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.151360307736742,0.0122728502571575,-0.175415094240771,-0.127305521232713,1.01323682217861e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.1146206468861,0.00930119400293713,-0.132850987131857,-0.0963903066403431,1.04220163331048e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0838735336172805,0.00682810527021781,-0.0972566199469074,-0.0704904472876536,1.7098808592899e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0756708200791702,0.00616800240598118,-0.0877601047948934,-0.0635815353634471,2.03703688717372e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42119,-0.0517501605970499,0.00422581214123809,-0.0600327523938765,-0.0434675688002232,2.67492249048082e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0414229336466426,0.00338744571366465,-0.0480623272454253,-0.0347835400478599,3.3278425984994e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0468679477701372,0.00383307440077293,-0.0543807735956522,-0.0393551219446223,3.35053396430952e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.161637452841268,0.0132382382869531,-0.187584399883696,-0.13569050579884,4.5613248059417e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0866716755824343,0.0071037829335091,-0.100595090132112,-0.0727482610327565,4.62304746305547e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.110633078581019,0.00906812181357506,-0.128406597335627,-0.0928595598264123,4.67446781838463e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0684724866201867,0.00561699946090766,-0.0794818055635657,-0.0574631676768077,5.30169754329513e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.119150572263577,0.00977867053733474,-0.138316766516753,-0.0999843780104009,5.64877112241066e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0765873119288948,0.00629990780680157,-0.0889351312302259,-0.0642394926275638,7.91629495284039e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0672115194481973,0.00552894866835676,-0.0780482588381766,-0.0563747800582181,8.61954533372203e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.064232329766157,0.00528772407091669,-0.0745962689451538,-0.0538683905871603,8.95012704221141e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.037393900786542,0.00307964800706025,-0.0434300108803801,-0.0313577906927039,9.47372817234602e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0796218632885804,0.0065662950583153,-0.0924918016028784,-0.0667519249742824,1.16208593103684e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0776180083868091,0.00640419274940609,-0.090170226175645,-0.0650657905979732,1.23841936657793e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39358,-0.0316227821801491,0.00260888997234112,-0.0367362065259377,-0.0265093578343605,1.35045000968034e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0561916773803928,0.00464088634539622,-0.0652878146173694,-0.0470955401434162,1.42871931604703e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.182628889203136,0.0150762018588702,-0.212178244846522,-0.153079533559751,1.44030852772628e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0504187304973858,0.004162344292601,-0.0585769253108838,-0.0422605356838879,1.45184220727567e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0911911908072667,0.00753414062926687,-0.10595810644063,-0.0764242751739037,1.51932288799585e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.107631207901091,0.00889427723016149,-0.125063991272207,-0.0901984245299741,1.54891267483807e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0550497736592385,0.00455734769125791,-0.063982175134104,-0.046117372184373,2.00802973598815e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0602534931473838,0.00498751999486552,-0.0700290323373202,-0.0504779539574474,2.13589962541276e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0790147865189417,0.00654712984397297,-0.0918471610131287,-0.0661824120247547,2.29953250698881e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.119164717633319,0.00988193572499516,-0.13853331165431,-0.0997961236123289,2.58232117502717e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0809169689688346,0.00672445742247379,-0.0940969055168832,-0.067737032420786,3.77960034480687e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0799031659356862,0.00664618988109994,-0.0929296981026421,-0.0668766337687303,4.30714311814789e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0506580299670598,0.00422524510117037,-0.0589395103653537,-0.0423765495687659,5.92382557067621e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0825257970597233,0.00689251334499768,-0.0960351232159188,-0.0690164709035278,7.25120363883232e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42070,-0.130972561628154,0.0109711055323626,-0.152475928471584,-0.109469194784723,1.09690552042243e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0250619832013145,0.00210001439849492,-0.0291780114223646,-0.0209459549802645,1.14069141392738e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.120849926757153,0.0101425434496368,-0.140729311918442,-0.100970541595865,1.42950121842422e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.110651793921694,0.00928895460714505,-0.128858144951699,-0.0924454428916899,1.48777509749782e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0878991873240908,0.00738059888631642,-0.102365161141271,-0.0734332135069106,1.66995512591252e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42070,-0.0685009644693005,0.00575964677900122,-0.0797898721561429,-0.0572120567824581,1.86486600205696e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.064283673888312,0.00540883420744248,-0.0748849889348992,-0.0536823588417247,2.05466647014278e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0369813940677453,0.00311136010458319,-0.0430796598727284,-0.0308831282627623,2.19812157127449e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0440732055780887,0.00371451941325065,0.0367927475281174,0.05135366362806,2.59838484334016e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42119,-0.122545336619285,0.0103311341916215,-0.142794359634863,-0.102296313603707,2.70417193984556e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.047038369718521,0.0039662367402546,-0.05481219372942,-0.039264545707622,2.76864148380661e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.131745785364767,0.011137574354826,-0.153575431100226,-0.109916139629308,3.98312739087092e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0467450141178385,0.00395867733006394,0.0389860065509132,0.0545040216847639,5.44911387883395e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42199,-0.0406073182041038,0.00344230836756342,-0.0473542426045281,-0.0338603938036795,5.82165740102128e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0542971421904134,0.00460327624113884,0.0452747207577813,0.0633195636230456,5.90240400801211e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0501679093327924,0.00425577126881842,-0.0585092210196765,-0.0418265976459083,6.48440071537341e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0721950235345937,0.0061292569457308,-0.0842083671482261,-0.0601816799209614,7.16518490110267e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0412441086522676,0.00350255917997624,-0.048109124645021,-0.0343790926595141,7.48355627440229e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,39757,-0.163379384029578,0.0138680204607589,-0.190560704132665,-0.136198063926491,7.54917386928624e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0558730471450772,0.0047509756959386,0.0465611347810375,0.0651849595091168,8.9245938090577e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.104922644470557,0.00892068594212909,-0.12240718891713,-0.0874381000239844,9.4703087942071e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,42119,-0.0369128995350172,0.00314145709838296,-0.0430701554478478,-0.0307556436221866,1.00440439577572e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0836452869998024,0.00712166334659974,-0.0976037471591379,-0.0696868268404669,1.07367175226163e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0782126593701707,0.00667063475354115,-0.0912871034871114,-0.0651382152532301,1.44584292936116e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.0793382785678595,0.00677318858957654,-0.0926137282034295,-0.0660628289322895,1.55375759562112e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0452954029002809,0.00387165180869706,-0.0528838404453272,-0.0377069653552347,1.97562049819746e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0783285175424473,0.00670042456380779,0.065195685397384,0.0914613496875106,2.02965628905965e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42262,-0.0489410222824374,0.00418997437558958,-0.057153372058593,-0.0407286725062819,2.26015445537071e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0763006804645621,0.0065318195462154,-0.0891030467751442,-0.0634983141539799,2.26148689157796e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,41992,-0.0629452911177724,0.00539202945154452,-0.0735136688427997,-0.0523769133927452,2.46153254021567e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.064205313152985,0.00550561935373935,-0.0749963270863141,-0.0534142992196558,3.05037903588069e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.112323653539483,0.00964120408759656,-0.131220413551172,-0.0934268935277937,3.43975569514049e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0508918702420952,0.00436867064166942,-0.0594544646997673,-0.0423292757844232,3.47912776964056e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0241388858810338,0.00207369550742941,-0.0282033290755955,-0.0200744426864722,3.61442804035204e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.10445689598017,0.00897200906609726,-0.12204203374972,-0.0868717582106189,3.76722998400831e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.137855973783433,0.0118418115534965,-0.161065924428286,-0.11464602313858,3.81743573586863e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0493673672377301,0.00424633117648627,-0.0576901763436432,-0.041044558131817,4.2787982134849e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.105952088866828,0.00911346178218188,-0.123814473959904,-0.0880897037737513,4.279170562713e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0543117704966145,0.0046708186664385,-0.063466575082834,-0.045156965910395,4.49460948931991e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0799070621513819,0.00687592990802256,-0.0933838847711061,-0.0664302395316577,4.81853322386733e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0492824600338445,0.00425543677638825,-0.0576231161155655,-0.0409418039521235,7.15595551199304e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,39958,-0.0404078447185399,0.0034876053135054,-0.0472435511330105,-0.0335721383040693,7.2241001534693e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42230,0.0338185628693995,0.00292352302483378,0.0280884577407253,0.0395486679980737,8.36126460699692e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0817360422910894,0.00706531900096426,-0.0955840675329794,-0.0678880170491995,8.84774605473066e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0957297270330191,0.00828415685434801,-0.111966674467541,-0.079492779598497,1.02500612881702e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0905710253805152,0.00784889622456602,-0.105954861980665,-0.0751871887803658,1.24044842059795e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0280513770515038,0.00243504342504416,-0.0328240621645903,-0.0232786919384172,1.45054249156707e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.104977212459051,0.0091142443255386,-0.122841131337107,-0.0871132935809954,1.49813880431819e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0640913771339852,0.00556171289165438,-0.0749923344016278,-0.0531904198663427,1.49870121480266e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.117275588744666,0.0101864212597395,-0.137240974413756,-0.0973102030755769,1.58418667988769e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.104372639386344,0.00908986939634756,-0.122188783403185,-0.0865564953695027,2.24171687777116e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.120095258706561,0.0104664962236179,-0.140609591304852,-0.0995809261082699,2.44508754265388e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0770723747962442,0.0067245639419196,-0.0902525201224067,-0.0638922294700818,2.84523840962637e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.0299113294254227,0.00261456985320455,-0.0350358863377036,-0.0247867725131417,3.61670774282782e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.167987475194299,0.0146838877901982,-0.196767895263087,-0.139207055125511,3.62572605553573e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0307403145975403,0.00269149094664844,0.0254649923421094,0.0360156368529713,4.4763492122055e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0483461394380836,0.00423332199384069,-0.0566434505460114,-0.0400488283301559,4.87245545882303e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0283787196923831,0.00248622195323664,-0.0332517147207269,-0.0235057246640393,5.2021849926338e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0492739130274157,0.00432581842315235,-0.0577525171367943,-0.0407953089180371,6.34465822379681e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0673152941225203,0.00591171465429056,-0.0789022548449298,-0.0557283334001108,6.70470423983894e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0395413838092593,0.00347296680914434,-0.0463483987551822,-0.0327343688633364,7.17585294807818e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0514612479674001,0.00452365337506505,-0.0603276085825276,-0.0425948873522726,7.50181276595882e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.052126797634568,0.0045868308914642,-0.0611169861818378,-0.0431366090872981,8.58126671491626e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.024376404060867,0.00214599748597913,-0.0285825591333861,-0.020170248988348,9.13448461430796e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0581238014895642,0.00511688013527946,-0.0681528865547119,-0.0480947164244164,9.13793136274546e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.054508085495038,0.00479757061748594,-0.0639113239053104,-0.0451048470847656,9.41059507832291e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0342514878361934,0.00301676480892787,-0.040164346861692,-0.0283386288106947,9.70246581232136e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0748042324964243,0.00659881293977731,-0.0877379058583878,-0.0618705591344608,1.18989109041883e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.104764685799702,0.0092735340214599,-0.122940812481763,-0.0865885591176406,1.94688265293764e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.129792348953599,0.0114912836294253,-0.152315264867273,-0.107269433039926,1.99808345292109e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.055868247226429,0.00495468534151648,-0.0655794304958013,-0.0461570639570567,2.33460708593472e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0884159546352494,0.00784597301252994,-0.103794061739808,-0.0730378475306907,2.6988819902356e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0954609167363599,0.00847819629567861,-0.11207818147589,-0.0788436519968298,2.82215026267659e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.131796389127396,0.011704035009163,-0.154736297745356,-0.108856480509437,2.9313075628063e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42145,-0.0823059170373412,0.00731384992774388,-0.0966410628957192,-0.0679707711789632,3.00324800602831e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,39736,-0.0844390219515939,0.00750378512545458,-0.0991464407974849,-0.0697316031057029,3.22297041269549e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0469832539129886,0.00418174522656921,-0.0551794745570642,-0.0387870332689129,3.67721678745959e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0706197996717603,0.00628267728381231,-0.0829338471480325,-0.0583057521954882,3.68272981480043e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0332736418335565,0.00296664807057703,-0.0390882720518875,-0.0274590116152255,4.8553251593914e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0711619171225174,0.00635518053990222,-0.0836180709807257,-0.058705763264309,5.62701253926521e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0351302963838308,0.00313668963877974,-0.0412782080758391,-0.0289823846918225,5.811976781052e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0705481426885565,0.00631195031420677,-0.0829195653044018,-0.0581767200727113,7.05961611910017e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0334511259065666,0.00299588588542356,-0.0393230622419968,-0.0275791895711364,8.0722916417469e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.137218938023808,0.012286066073053,-0.161299627526992,-0.113138248520624,8.20957434058003e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,42145,-0.130294501339749,0.011672633864364,-0.153172863713903,-0.107416138965596,8.31972916784011e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0540407381210184,0.0048466479413611,-0.0635401680860862,-0.0445413081559507,9.54321112140802e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0787658434528843,0.00706584259150674,-0.0926148949322375,-0.064916791973531,9.83630302907154e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0305223087146149,0.0027369502042571,-0.0358867311149588,-0.025157886314271,9.87667958205879e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.069696805205941,0.00625396525604305,-0.0819545771077854,-0.0574390333040967,1.01655092396534e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0688734054003897,0.00619229249883923,-0.0810102986981146,-0.0567365121026648,1.2933402174389e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0452101055079772,0.00406501818091285,-0.0531775411425664,-0.037242669873388,1.39464884657226e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42262,0.0551324463705586,0.0049646577886074,0.0454017171048881,0.0648631756362291,1.57147020794496e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0922637304988333,0.00831007354071042,-0.108551474638626,-0.0759759863590408,1.6193524269011e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.113520371716456,0.010226905762203,-0.133565107010374,-0.093475636422538,1.65813766186756e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0869705872519775,0.00784708148454244,0.0715903075422743,0.102350866961681,2.11756572676526e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,39736,-0.0632709729700353,0.00571032096434995,-0.0744632020601611,-0.0520787438799094,2.20431754100465e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,39930,-0.12500665965089,0.0112837422808829,-0.147122794521421,-0.10289052478036,2.23145494719097e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0392883313616944,0.00354804296460112,-0.0462424955723126,-0.0323341671510762,2.2360567635855e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42119,-0.095374254434124,0.00861749672487406,-0.112264548014877,-0.0784839608533709,2.38676690578183e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0903006434736876,0.00818318602404397,-0.106339688080814,-0.0742615988665615,3.42051735107537e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0261093416112838,0.00236689193120318,0.0214702334261255,0.030748449796442,3.5851067232265e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0786831099658801,0.00714742658694564,-0.0926920660762936,-0.0646741538554667,4.58041819383032e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0464027499174092,0.00422056076785739,-0.0546750490224096,-0.0381304508124087,5.36987528895009e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,39929,-0.045822949565187,0.00416646121795352,-0.0539892135523759,-0.0376566855779981,5.40910452226919e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0379756679951513,0.00345549713213126,-0.0447484423741286,-0.0312028936161741,5.60602214165057e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0764673665486659,0.00695994895622877,-0.0901088665028743,-0.0628258665944575,5.80185063694079e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0409476842931601,0.00372761171428181,-0.0482538032531525,-0.0336415653331678,5.92286099910674e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42296,-0.0559749937379938,0.00509973517988508,-0.0659704746905686,-0.045979512785419,6.5113979506353e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0883521539244455,0.00805819368123045,-0.104146213539657,-0.0725580943092339,7.82543029907183e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0609955852876845,0.00558212932627863,0.0500546118081784,0.0719365587671906,1.11816007687024e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.048438617858823,0.00443663957454691,-0.057134431424935,-0.0397428042927111,1.29966574069126e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0624205242574487,0.00572001531761062,-0.0736317542799655,-0.0512092942349319,1.31462820828348e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0280438690765748,0.00257068168198007,-0.0330824051732557,-0.0230053329798938,1.35818401319349e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,41881,-0.060593839134804,0.005555228045853,-0.0714820861046759,-0.0497055921649322,1.38885273292088e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,39929,-0.0716141229934336,0.00656342444173003,-0.0844784348992244,-0.0587498110876427,1.39911424834891e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,39736,-0.0364023657456261,0.00333761008779893,-0.0429440815177121,-0.0298606499735402,1.47533870686103e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,41913,-0.0550136439811509,0.00505387230584556,-0.0649192337006082,-0.0451080542616936,1.76541783028153e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0368275989420033,0.00338180378203551,-0.0434559343547929,-0.0301992635292137,1.77576448557131e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0268541178702572,0.00247013898892465,-0.0316955902885496,-0.0220126454519649,2.04781560857728e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0901425835155314,0.00829441257511873,-0.106399632162764,-0.0738855348682987,2.23776099842296e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0772270230539516,0.00711144340863947,-0.091165452134885,-0.0632885939730182,2.46237478320242e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0324081091620544,0.00298712167478285,-0.0382628676446288,-0.02655335067948,2.60122959647699e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0378262762590149,0.003486669713077,-0.0446601488966458,-0.030992403621384,2.77147583005953e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0439540091895282,0.00405441076516023,-0.0519006542892422,-0.0360073640898141,2.84791220153541e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,39978,-0.0651000275183029,0.00600387082860532,-0.0768676143423693,-0.0533324406942364,2.92557561373165e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.119400118966421,0.0110194606826722,-0.140998261904458,-0.0978019760283834,3.18114348246906e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0846485580393276,0.00781896978789192,-0.0999737388235958,-0.0693233772550595,3.34313859393463e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.053513768469448,0.00494537831217038,-0.063206709961302,-0.043820826977594,3.73705170482875e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0840162948032009,0.00777291096111377,-0.0992512002869839,-0.0687813893194179,4.23793292788319e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0487995038083724,0.00451844683481618,-0.0576556596046121,-0.0399433480121327,4.43949423593993e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0769674806129519,0.00713151562926606,-0.0909452512463133,-0.0629897099795904,4.80044860772882e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0389207273870698,0.00360785129184234,0.0318493388550588,0.0459921159190808,5.05142086044128e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0420203516065667,0.00389567916184936,-0.0496558827637914,-0.0343848204493419,5.16440231270205e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0974626415042855,0.00903413575536751,-0.115169547584806,-0.0797557354237652,5.29125453949493e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,39990,-0.0336758932964319,0.00312160532586758,-0.0397942397351323,-0.0275575468577314,5.29612355270108e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0918486113802897,0.00851457428184151,-0.108537176972699,-0.0751600457878803,5.39358407022779e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0483246426069066,0.00448061700699009,-0.0571066519406072,-0.039542633273206,5.46344542438721e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0453234149190713,0.00420390846186262,-0.053563075504322,-0.0370837543338206,5.74951797144154e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0646997362832795,0.0060094613588723,-0.0764782805466692,-0.0529211920198898,6.39566597300001e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0713558807341968,0.00663087921961572,-0.0843524040046436,-0.05835935746375,6.74815426003816e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0574914367275009,0.00534571609090435,-0.0679690402656735,-0.0470138331893284,7.23252169972555e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0929459776706096,0.00864725127424241,-0.109894590168125,-0.0759973651730945,7.72191265055435e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42185,-0.0546430834237653,0.00508402909388199,-0.064607780447774,-0.0446783863997566,7.76478927328996e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42025,-0.0832651422035361,0.00774980281657646,-0.0984547557240259,-0.0680755286830462,8.11444781448774e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0535229501450436,0.00499227711749797,0.0437380869947476,0.0633078132953396,1.03456293574029e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,39958,-0.0529503009746465,0.00493901268603528,-0.0626307658392756,-0.0432698361100173,1.09033519660628e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,41994,0.0314219100321754,0.00293332264526118,0.0256725976474635,0.0371712224168873,1.14578379154984e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0332418857467901,0.0031215677640617,-0.039360158564351,-0.0271236129292291,2.23891798662052e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.108217007648254,0.0101723249704162,-0.12815476459027,-0.0882792507062385,2.50779805187355e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.0291861734855197,0.00274937602011917,-0.0345749504849533,-0.0237973964860862,3.19508166520398e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0697635981391892,0.00657345290465108,-0.0826475658323053,-0.0568796304460731,3.29021781448471e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0442456061686171,0.00418557350272228,-0.0524493302339528,-0.0360418821032815,5.15803054246014e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.118226077224216,0.0111952394092579,-0.140168746466361,-0.0962834079820703,6.00235850146489e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0485796867575212,0.00460389299490027,-0.0576033170275257,-0.0395560564875167,6.29145227945555e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0711744489295907,0.00674725537182707,-0.0843990694583718,-0.0579498284008097,6.84256041860784e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.058537590437921,0.00555725509321899,-0.0694298104206302,-0.0476453704552118,7.63658953635058e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0287968071328818,0.00273479037716527,0.0234366179936379,0.0341569962721257,7.90276107579567e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42217,-0.0628867765489091,0.00597660607871099,-0.0746009244631826,-0.0511726286346355,8.57709289883322e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.12461988874365,0.011856093511963,-0.147857832027098,-0.101381945460203,1.01188253741392e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0464327655297682,0.00441969902553815,-0.055095375619823,-0.0377701554397135,1.07040110205691e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42123,-0.0307418161593847,0.002933425288978,-0.0364913297257816,-0.0249923025929879,1.34018947657111e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0837480843194556,0.00799257828770214,-0.0994135377633518,-0.0680826308755594,1.43349535088375e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.110705602489881,0.0105753950220027,-0.131433376733007,-0.0899778282467559,1.52084637738069e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0969856722896481,0.00928580098678761,-0.115185842223752,-0.0787855023555444,1.94012431848853e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0568742966804848,0.00545229758629194,0.0461877934113526,0.067560799949617,2.22747298726562e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0820932051136011,0.00786804644657551,-0.0975145761488891,-0.0666718340783131,2.26545175910847e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0865192981908814,0.00829628258509103,-0.10278001205766,-0.070258584324103,2.39943707866976e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0990799479740858,0.00950351407017314,-0.117706835551625,-0.0804530603965464,2.46622579406664e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0437644431571741,0.00421422626277665,-0.0520243266322164,-0.0355045596821319,3.61683515484583e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.139449880733656,0.0134311848276147,-0.16577500299578,-0.113124758471531,3.69755731654765e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0865292502209503,0.00833060540709362,-0.102857236818854,-0.0702012636230468,3.71940284391383e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0652995191958116,0.00629801668368516,-0.0776436318958345,-0.0529554064957887,4.31280651362339e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0177304071166773,0.00171030101908633,0.0143782171192681,0.0210825971140865,4.3444872493534e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42016,0.0382013262414986,0.00369567807892131,0.0309577972068128,0.0454448552761843,5.96122659284125e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0652957002568847,0.00633390771738502,-0.0777101593829593,-0.0528812411308101,7.973610124398e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42129,-0.042791839158029,0.0041534231576169,-0.0509325485469582,-0.0346511297690999,8.45285400644424e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0614953299348383,0.00597666144321757,-0.0732095863635447,-0.0497810735061319,9.70211214164331e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0691087168194762,0.0067370134468913,-0.0823132631753832,-0.0559041704635693,1.33717634836927e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,39948,-0.0486879173044804,0.00475266515917086,-0.0580031410164553,-0.0393726935925055,1.60431569696549e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.106882944285149,0.0104367842083303,-0.127339041333476,-0.0864268472368216,1.67183133551593e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.103755918066515,0.0101578392779692,-0.123665283051334,-0.0838465530816948,2.10029691082323e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0251819648335143,0.00246701018552818,-0.0300173047971495,-0.0203466248698791,2.25419591024399e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0343325592251153,0.00336399595885052,-0.0409259913044623,-0.0277391271457683,2.28375659644705e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0797515850307935,0.00782812286173663,-0.0950947058397973,-0.0644084642217897,2.85740908754809e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0288327556976158,0.00283212079795556,-0.0343837124616087,-0.0232817989336229,2.95934573335886e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.13740642956164,0.0134935493362023,-0.163853786260596,-0.110959072862683,3.017393488651e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0679575816244867,0.00667783396607446,-0.0810461361979926,-0.0548690270509807,3.20594001911601e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0299674621678289,0.00294703101305259,-0.0357436429534119,-0.0241912813822458,3.33977439598699e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0440345653462232,0.00433266695177445,-0.0525265925717011,-0.0355425381207453,3.52687451080714e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42249,-0.0662552460538311,0.00652237923644711,-0.0790391093572674,-0.0534713827503948,3.71506562016327e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0506062050332049,0.0049828803040233,-0.0603726504290906,-0.0408397596373192,3.80194987086875e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0614249049845882,0.00605206954833049,-0.073286961299316,-0.0495628486698605,4.08130173056984e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0464562329161745,0.00458182125220219,0.0374758632618582,0.0554366025704908,4.51353948654007e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,41839,-0.0369024718127393,0.00364021060391753,-0.0440372845964176,-0.0297676590290609,4.61249037833815e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0257076322299379,0.00253553722514999,-0.0306772851912319,-0.0207379792686439,4.69711566458025e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0675711001128299,0.00666890652486492,-0.0806421569015651,-0.0545000433240946,4.84005104001861e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0269776510336215,0.00266313894779959,-0.0321974033713087,-0.0217578986959343,5.13865708607241e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.033599736035525,0.00331868559813208,-0.0401043598078639,-0.0270951122631861,5.49811895105762e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0520096595153356,0.00514563545695583,-0.062095105010969,-0.0419242140197022,6.46065197979598e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0882150558361493,0.00873923880833029,-0.105343963900477,-0.0710861477718219,7.3966093306075e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0355205849986178,0.00352997056631183,0.0286018426886466,0.0424393273085889,9.79740426390036e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,39492,-0.0763603112052222,0.00759153926969117,-0.0912397281738169,-0.0614808942366275,1.06812927830253e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0575401743458788,0.00572984743660701,-0.0687706753216285,-0.046309673370129,1.25935652183715e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0358044442302445,0.00356940825788968,-0.0428004844157083,-0.0288084040447808,1.34750080699554e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0560805496457729,0.0055953134767498,-0.0670473640602025,-0.0451137352313433,1.46204889504174e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0370684155576897,0.00370502120318744,-0.044330257115937,-0.0298065739994423,1.75022375711238e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0606963908740898,0.00607004574114657,-0.072593680526737,-0.0487991012214425,1.85820547033678e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0401022711158631,0.00401495260572619,-0.0479715782230864,-0.0322329640086397,2.06869284601181e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.040954477963116,0.00410304573561955,-0.0489964476049304,-0.0329125083213017,2.21125293726013e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42145,0.0408793665892362,0.00409569555425198,0.0328518033029023,0.0489069298755701,2.2219138646649e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0531251932783392,0.00532289854703803,0.0426923121261447,0.0635580744305338,2.31380002113075e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0580220408778287,0.00581808782132709,-0.0694254930076298,-0.0466185887480276,2.51275540780693e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.093015476953335,0.00934615477938478,-0.111333940320929,-0.0746970135857408,3.0701252155692e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0832757835938509,0.00837349738856862,-0.0996878384754454,-0.0668637287122564,3.29513668711635e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0554973739308897,0.00558417983976422,-0.0664423664168275,-0.0445523814449518,3.39813533376788e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0972404703578356,0.00978239249578147,-0.116413959649567,-0.0780669810661039,3.47542743668738e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0407844948317898,0.00410921558363785,-0.04883855737572,-0.0327304322878596,3.89863373972992e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0431426689048563,0.00435054739326869,-0.051669741795663,-0.0346155960140497,4.2193061306794e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0854822667798528,0.00862922371228578,-0.102395545255933,-0.0685689883037727,4.69113213145483e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0890805186940456,0.00898941340288338,-0.106699768963697,-0.0714612684243942,4.69767492335322e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0363459735707224,0.00367387014620852,-0.0435467590572911,-0.0291451880841537,5.33445918383462e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.055919709523235,0.0056537983367255,-0.067001154263217,-0.044838264783253,5.47809866693829e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0734004927148025,0.00743751934665811,-0.0879780306342524,-0.0588229547953526,6.78247230394314e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0575719889255555,0.00583404685964029,-0.0690067207704504,-0.0461372570806605,7.06547965194217e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0398014546224797,0.00404024986220037,-0.0477203443523924,-0.0318825648925669,8.10281118391003e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.115030270591264,0.0116730971811174,-0.137909541066254,-0.0921510001162736,8.11079350039453e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0515891707975525,0.00523868470203841,-0.0618569928135478,-0.0413213487815572,8.70019487748224e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.063825243419185,0.0064938218298633,-0.076553134205717,-0.0510973526326529,1.01159828286193e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0442789175547036,0.00450677000900296,-0.0531121867723494,-0.0354456483370578,1.05007010804007e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0349972171012783,0.00356340833335138,-0.041981497434647,-0.0280129367679096,1.08384829793065e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0406616407454366,0.00414045970385354,-0.0487769417649895,-0.0325463397258836,1.09337459081165e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.055296943545372,0.00563166256967784,0.0442588849088035,0.0663350021819406,1.1112637081802e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0484598439092883,0.0049417972425739,-0.0581457665047332,-0.0387739213138435,1.26278321326016e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0405542144070181,0.00414132857189352,-0.0486712184079294,-0.0324372104061068,1.44008019177298e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42146,-0.0592821273736008,0.00605458064572592,-0.0711491054392236,-0.047415149307978,1.45807623683031e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0360383015768,0.00368643851386689,-0.0432637210639791,-0.0288128820896209,1.75207676431071e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0335679938757008,0.00343729483421746,0.0268308960006345,0.040305091750767,1.86808858796555e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0660037856680088,0.00675776425830091,-0.0792490036142786,-0.052758567721739,1.92339678101883e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0325992788940824,0.00334032614405687,0.0260522396517309,0.0391463181364339,1.99492084638191e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0385840565284601,0.00395821428698454,-0.0463421565309498,-0.0308259565259704,2.23220227326925e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.118037618842266,0.0121191091675191,-0.141791072810603,-0.0942841648739286,2.41552586217543e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.113478774483916,0.0116620615447567,-0.136336415111639,-0.0906211338561927,2.72959678519467e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0520735911247184,0.00535385739367687,-0.062567151616325,-0.0415800306331117,2.87174916470879e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42181,-0.0420310847135115,0.00432351412344738,-0.0505051723954684,-0.0335569970315546,2.88537888497639e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0354627465730692,0.00364924364131974,-0.0426152641100559,-0.0283102290360825,2.99066990375187e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0733431112188372,0.00755007363657599,-0.0881412555465261,-0.0585449668911483,3.21767516818418e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0155121545696926,0.001598207623093,0.0123796676284303,0.0186446415109549,3.46796821259011e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0511710759155977,0.00527219065062992,-0.0615045695908323,-0.0408375822403631,3.47404278632257e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0882633983150955,0.00909423674258994,-0.106088102330572,-0.0704386942996192,3.48754537821422e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42069,-0.0460528757843857,0.00474905555344408,-0.0553610246691361,-0.0367447268996353,3.65897033518944e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0627116987467054,0.00646822025622036,-0.0753894104488973,-0.0500339870445135,3.84601644308874e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0869642502572136,0.00898876373773494,-0.104582227183174,-0.0693462733312531,4.57041298327745e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.05872120329986,0.00607972075032415,-0.0706374559704954,-0.0468049506292247,5.34489101214713e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0722950149838592,0.00748966803849859,-0.0869747643393164,-0.057615265628402,5.65458761825433e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0555547637793719,0.00575603408352641,-0.0668365905830837,-0.0442729369756601,5.70214371079044e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,39930,-0.070507524232152,0.00731952266518504,-0.0848537886559146,-0.0561612598083893,7.04956272240803e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.104102738054494,0.0108120537624048,-0.125294363428808,-0.0829111126801811,7.12277692200935e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.109984309506612,0.0114550135231612,-0.132436136012008,-0.0875324830012161,9.24512955289401e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42145,-0.0385764378914769,0.00402141356017111,-0.0464584084694123,-0.0306944673135416,1.00538957522633e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0283616802798772,0.00296141569543899,-0.0341660550429377,-0.0225573055168168,1.16865529661562e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,41997,-0.0711632754807793,0.00743644196177248,-0.0857387017258533,-0.0565878492357052,1.25918902747258e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0418293688270012,0.00437359867894386,-0.0504016222377311,-0.0332571154162712,1.37392234365503e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.084926222476746,0.00888519050366809,-0.102341195863935,-0.0675112490895566,1.44452878678123e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0502998531508551,0.00526696415518351,-0.0606231028950148,-0.0399766034066955,1.51264252441709e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,41959,-0.0444413318814041,0.00465538382750995,-0.0535658841833236,-0.0353167795794846,1.5754959014823e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42051,-0.0705673460883051,0.00741062095391265,-0.0850921631579739,-0.0560425290186363,1.97576272299963e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0454819621090691,0.0047860917447754,-0.0548627019288289,-0.0361012222893093,2.46181062421961e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0500571138102885,0.00527768504637553,-0.0604013765011845,-0.0397128511193924,2.915341689927e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42084,-0.081689183753476,0.00862640862957826,-0.0985969446674494,-0.0647814228395026,3.26748023439031e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0785365763248281,0.00830446358620052,-0.0948133249537811,-0.0622598276958751,3.69010054824872e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0316576167456072,0.00335319433344742,-0.0382298776391641,-0.0250853558520502,4.2861791575691e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0380814196497,0.00403387626070379,-0.0459878171206795,-0.0301750221787206,4.32223659155156e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.072618613863716,0.00769364342168395,-0.0876981549702166,-0.0575390727572155,4.50672214718057e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0737916436746907,0.00782123134807415,-0.089121257116916,-0.0584620302324653,4.5592719266059e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0589495043454364,0.00624862237632995,-0.0711968042030431,-0.0467022044878297,4.59632814699998e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0845498113136094,0.00897566873470842,-0.102142122033638,-0.0669575005935809,5.38852865255933e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0644856662874922,0.00684811030297891,-0.0779079624813309,-0.0510633700936536,5.4053352680893e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42119,-0.0348427206005789,0.0037014335625512,-0.0420975303831792,-0.0275879108179785,5.57368383114607e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0557180940444293,0.00592731280031296,-0.0673356271330427,-0.0441005609558159,6.29476413466732e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0563037690687877,0.00599908905375566,-0.0680619836141488,-0.0445455545234266,7.46085364041759e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42145,-0.123608003778317,0.0131859382294094,-0.149452442707959,-0.0977635648486743,8.05671894977449e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0500611354725274,0.00534156697200094,-0.0605306067376492,-0.0395916642074055,8.25554369051926e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.063558980496599,0.0067864645899409,-0.0768604510928832,-0.0502575099003149,8.77123068838266e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0595407154048199,0.00637271392734318,-0.0720312347024126,-0.0470501961072273,1.08260510640597e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0676125085077869,0.00724613690472191,-0.0818149368410418,-0.053410080174532,1.24899151752375e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.111595916912749,0.0119683251048168,-0.13505383411819,-0.0881379997073085,1.29013184635781e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0305116828873408,0.00327278808615485,-0.0369263475362043,-0.0240970182384773,1.30409411186698e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0428450012104069,0.00459714628717778,-0.0518554079332754,-0.0338345944875385,1.34362729532386e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0635633199798977,0.0068182770397328,-0.076927142977774,-0.0501994969820214,1.34639885267276e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.029913724341162,0.00321399385599251,0.0236142963834166,0.0362131522989073,1.50870135573923e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0842045320733477,0.00904371189006301,-0.101930207377871,-0.0664788567688241,1.50938438972087e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0971992926786911,0.0104521912496629,-0.11768558752803,-0.0767129978293518,1.67735471812435e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.01663244679346,0.00179148206533906,-0.0201437516415246,-0.0131211419453955,1.92410096673323e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.0954099155984324,0.0102776350017536,-0.115554080201869,-0.0752657509949953,1.94217809773018e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0537080122896671,0.00578865229870336,-0.0650537707951257,-0.0423622537842085,1.98730105735331e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0400242946764847,0.00431341144306468,-0.0484785811048914,-0.0315700082480779,2.02590987255676e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.103403737005227,0.0111499191510925,-0.125257578541368,-0.0815498954690857,2.06072663363219e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0221446046982076,0.00239004515219869,-0.0268290931965171,-0.0174601161998982,2.2948278142275e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0522860979605106,0.00564885686992337,-0.0633578574255604,-0.0412143384954608,2.50882199646614e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.0246483924058896,0.00266600109709606,-0.0298737545561979,-0.0194230302555814,2.68770863459231e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0364945395041791,0.00394842147043637,-0.0442334455862344,-0.0287556334221238,2.82913454256292e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,39906,-0.0324138501248103,0.00350769700513142,-0.0392889362548678,-0.0255387639947527,2.88371382139211e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0356401044090985,0.00386862799152863,-0.0432226152724946,-0.0280575935457024,3.64534717433005e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,39979,-0.0203263922803872,0.00220613609523821,-0.0246504190270541,-0.0160023655337203,3.70643510917823e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,39966,-0.0257161066450549,0.00279295082703196,-0.0311902902660375,-0.0202419230240723,3.92105266229914e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42070,-0.0307090434698138,0.00334213238469704,-0.03725962294382,-0.0241584639958076,4.56044488188168e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0612582373272413,0.00666950486564532,-0.0743304668639061,-0.0481860077905764,4.85731472538502e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0268073283999757,0.00291999882249486,-0.0325305260920657,-0.0210841307078858,4.89827284984439e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0547979706212266,0.00596887924867579,-0.0664969739486312,-0.0430989672938221,5.04823050801494e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0818026397561653,0.0089153617543634,-0.0992767487947175,-0.064328530717613,5.13991288442237e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0618841896526438,0.00674624915474141,-0.075106837995937,-0.0486615413093507,5.25752484184098e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.101423110469398,0.0110631946456159,-0.123106971974805,-0.0797392489639907,5.66810701641687e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,39979,-0.0688162735787028,0.00750754707294571,-0.0835310658416765,-0.0541014813157292,5.73433334823749e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,39958,0.0274558145545568,0.00299677351619742,0.0215821384628098,0.0333294906463037,5.97784903110347e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,39919,-0.061513777345441,0.00671495959129366,-0.0746750981443766,-0.0483524565465054,6.04106830221389e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0772491538663446,0.00843905089793756,-0.0937896936263022,-0.0607086141063869,6.43749422219753e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0573546416762207,0.00626777470835774,-0.0696394801046018,-0.0450698032478395,6.45202040041115e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0739326212220781,0.00812296968068935,-0.0898536417962292,-0.0580116006479269,1.01310844432231e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.055593344050244,0.00611706775739714,-0.0675827968547424,-0.0436038912457456,1.14279073701306e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0926404061472517,0.0101963465876266,-0.112625245459,-0.0726555668355036,1.17469574274814e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0473629213841249,0.00521386614516577,-0.0575820990286498,-0.0371437437396,1.19216777030213e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,41839,-0.0695147940820146,0.00765563358057702,-0.0845198358999456,-0.0545097522640837,1.23519425074905e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0243766862371274,0.00269087867563795,-0.0296508084413777,-0.019102564032877,1.49392683829812e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0307247782422095,0.00339607543792385,-0.0373810861005403,-0.0240684703838788,1.6696878366055e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0755316384815947,0.00835083592989799,-0.0918992769041947,-0.0591640000589946,1.74992238585906e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0840006903220112,0.00929763703236321,-0.102224058905443,-0.0657773217385793,1.91197553763436e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0328189344113323,0.00363706694005445,-0.039947585613839,-0.0256902832088256,2.1155254450567e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0659154654772808,0.00731038106979392,-0.0802438123740769,-0.0515871185804847,2.25513706416593e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0299621883784533,0.00332460372599888,-0.0364784116814111,-0.0234459650754955,2.34155831571656e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0558373366509217,0.00620599549890515,-0.0680010878287758,-0.0436735854730676,2.68724873522316e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0858436936801798,0.00955390527340173,-0.104569348016047,-0.0671180393443124,2.922171625168e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0410912215388308,0.004573528248976,-0.0500553369068238,-0.0321271061708379,2.93670321437108e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0733596614635412,0.00816794408286334,-0.0893688318659534,-0.0573504910611291,3.09470113922867e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0454269268364083,0.00506074252786392,-0.0553459821910215,-0.035507871481795,3.15926591077234e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0473892887617633,0.00527840682536573,-0.0577349661394801,-0.0370436113840465,3.20510223441245e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.067482991998222,0.00752120630628115,-0.082224556358533,-0.0527414276379109,3.35790649441532e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0661215220473654,0.00737902442490095,-0.0805844099201713,-0.0516586341745596,3.63822460186683e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0525387426516041,0.0058619992088463,-0.0640282611009429,-0.0410492242022654,3.67605369285366e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42262,-0.106356629068168,0.0118970191343417,-0.129674786571477,-0.0830384715648578,4.39400436210029e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.075152494639672,0.00842753805805237,0.0586345200458893,0.0916704692334546,5.3723936693488e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.05463739290734,0.00613188246084443,-0.0666558825305951,-0.0426189032840849,5.74288435614984e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0306855812984112,0.00344548402619585,-0.0374387299897551,-0.0239324326070673,5.95905807249871e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0634382371211634,0.00712334684376708,-0.0773999969349469,-0.0494764773073799,6.11299862393435e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0272657931757057,0.00306267078940172,-0.0332686279229331,-0.0212629584284784,6.13318217395111e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0315393557413487,0.00355073279307604,0.0245799194669196,0.0384987920157777,7.51833703671812e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,39638,-0.0708764531354645,0.0079845577002386,-0.0865261862279322,-0.0552267200429968,7.95065431415958e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.035777860977892,0.00403577751642795,-0.0436879849100907,-0.0278677370456932,8.60025435987015e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0512405890923412,0.00578799635384612,-0.0625850619458796,-0.0398961162388028,9.79156438244987e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0689458759168581,0.00779433040468248,-0.0842227635100358,-0.0536689883236805,1.02249113233019e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0631486500319081,0.00714014536085777,-0.0771433349391893,-0.0491539651246269,1.05831421974858e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,39934,-0.0525864175705896,0.00594717720044251,-0.064242884883457,-0.0409299502577223,1.07654154641414e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.055500931187971,0.00629343009479065,-0.0678360541737606,-0.0431658082021813,1.29506201127952e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0457809280547304,0.00519100744170181,-0.0559553026404659,-0.0356065534689948,1.32015617579551e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0631246710072033,0.0071657184018222,-0.0771694790747749,-0.0490798629396318,1.44177927993185e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0245302340331439,0.00278813922199991,0.0190654811580241,0.0299949869082638,1.55918751523215e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0745157825883493,0.00847661149464305,-0.0911299411178497,-0.057901624058849,1.70522881003672e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,39929,-0.0211994938385403,0.00241436812098928,-0.0259316553556793,-0.0164673323214013,1.85985077389645e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0268125281546291,0.0030553010335643,-0.0328009181804151,-0.020824138128843,1.90046565357104e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0257077753547477,0.00292911895104595,0.0199667022106976,0.0314488484987977,1.92471841286639e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0360621457503567,0.00411427133343723,-0.0441261175638937,-0.0279981739368197,2.08289112358253e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0383011330729058,0.00437709552053191,-0.0468802402931484,-0.0297220258526633,2.42717799292049e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0499939777151492,0.00571358995123884,-0.0611926140195773,-0.0387953414107211,2.44309325252364e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0657956134915341,0.00753596298070793,-0.0805661009337216,-0.0510251260493466,2.81932938773524e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0483239856377692,0.0055490750491907,-0.0592001727341829,-0.0374477985413554,3.44155338045926e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0622539435061047,0.00715951563827692,-0.0762865941571274,-0.0482212928550819,3.93573652451249e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,42129,-0.047709464460321,0.00549231158328133,-0.0584743951635524,-0.0369445337570896,4.15900745847507e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0954285705658067,0.0109864112246296,-0.116961936566081,-0.0738952045655327,4.17583470250282e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0291738554127694,0.0033589911520738,-0.035757478070834,-0.0225902327547047,4.29209419279326e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0962809577855295,0.0110878843206221,-0.118013211053949,-0.0745487045171102,4.37976637310881e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0267507939897927,0.00308556062608169,-0.0327984928169128,-0.0207030951626726,4.82141089406738e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0295762789904146,0.00341049178549991,-0.0362608428899944,-0.0228917150908348,4.83360154728797e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0851945700041546,0.00982977844406749,0.0659282042537824,0.104460935754527,4.9517779150462e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42137,0.0261330058782017,0.00301682950144904,0.0202200200553616,0.0320459917010418,5.13735337227432e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0413372064343509,0.00477361306899147,-0.0506934880495741,-0.0319809248191276,5.3780420202645e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0837255548795376,0.00967591792045795,-0.102690354003635,-0.06476075575544,5.59745882967285e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42249,0.0347209863017479,0.00402100564143927,0.026839815244527,0.0426021573589689,6.5230766667381e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42137,0.0460172640684937,0.00533046593910453,0.0355695508278488,0.0564649773091386,6.64457656332438e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0529859485887497,0.0061405793186525,-0.0650214840533086,-0.0409504131241907,6.89611873516255e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0365618527139003,0.00424080959588787,-0.0448738395218405,-0.0282498659059601,7.51989510951328e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42181,-0.039494036918861,0.00458410639569415,-0.0484788854544216,-0.0305091883833005,7.72994442956516e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0253125486800976,0.00294205589889842,-0.0310789782419385,-0.0195461191182567,8.55824975817922e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0736500451596866,0.00855800363029958,-0.0904237322750738,-0.0568763580442994,8.59007103935278e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,39958,-0.0500794117703521,0.00582437215592348,-0.0614951811959621,-0.0386636423447421,9.15349413502748e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0669554515403473,0.00779891623879369,-0.0822413273683829,-0.0516695757123116,1.00474362354886e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0667457754311712,0.00778440634466617,-0.0820032118667169,-0.0514883389956255,1.12868481213323e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,39736,-0.0613893126917615,0.00716734270795578,-0.0754373043993548,-0.0473413209841682,1.22138170926751e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0294656971081012,0.00344174667612449,0.0227198736228972,0.0362115205933052,1.2350863940714e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0634540088056837,0.00741818263240101,-0.0779936467651897,-0.0489143708461777,1.34341774671158e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0933428761557183,0.0109208294654759,-0.114747701908051,-0.0719380504033856,1.39475761712817e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0626728427530186,0.0073411594915017,-0.077061515356362,-0.0482841701496753,1.55050644818036e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,41839,-0.062401846613331,0.00731143321716295,-0.0767322557189704,-0.0480714375076916,1.55519912409973e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0354718460490976,0.00415730384938797,-0.0436201615938981,-0.0273235305042972,1.58417992955805e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0288565852652206,0.00338492636799783,-0.0354910409464964,-0.0222221295839449,1.72661988242456e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0524602932915566,0.00615561365943106,-0.0645252960640414,-0.0403952905190717,1.7644389500629e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.024960294601675,0.00293258105203876,0.0192124357396791,0.030708153463671,1.89770395094514e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0896368455376121,0.0105353719576031,-0.110286174574514,-0.06898751650071,1.95112529285353e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0265693774076768,0.00312399002506421,-0.0326923978568026,-0.020446356958551,2.00583601933061e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0371186316064938,0.00436500331175427,-0.0456740380975322,-0.0285632251154554,2.06695959606702e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0372697299640077,0.00438492298283383,-0.045864179010362,-0.0286752809176534,2.14187195253908e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0693598039276945,0.00816211722918594,-0.085357553696899,-0.0533620541584901,2.18088064145917e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42016,0.0237626972865793,0.00279980072569459,0.0182750878642179,0.0292503067089407,2.33541403477286e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0471471396771623,0.00555607144069337,-0.0580370397009213,-0.0362572396534033,2.4162166797227e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.058942803448337,0.00695039745369942,-0.0725655824575878,-0.0453200244390861,2.47085438337495e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42145,-0.0497749352060703,0.00587157206808574,-0.0612832164595183,-0.0382666539526223,2.54165882755944e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0773089783742884,0.00911971781179689,-0.0951836252854103,-0.0594343314631665,2.59377957622852e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0412276732193752,0.00486823398178518,-0.0507694118236742,-0.0316859346150763,2.73603574798939e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0692911547324585,0.00818269752187645,-0.0853292418753364,-0.0532530675895807,2.80361533590027e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.030210890042575,0.0035685916216714,-0.0372053296210509,-0.0232164504640991,2.85785249127156e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0523446728594697,0.00618694867766029,-0.0644710922676839,-0.0402182534512556,2.93584619349558e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0597882579966705,0.00709654949083354,-0.0736974949987042,-0.0458790209946368,4.04302024402684e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0281625726131215,0.00334361142993993,0.0216090942104392,0.0347160510158038,4.09556106412703e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0428607646569855,0.00509356192758965,-0.0528441460350612,-0.0328773832789098,4.34029877682566e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0241739070697845,0.00287313082653441,0.0185425706497771,0.029805243489792,4.36676079369109e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.132107170877884,0.0157465324230375,-0.162970374427038,-0.101243967328731,5.45558397942657e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.071403688767421,0.0085223042433231,-0.0881074050843343,-0.0546999724505077,5.89963039939199e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0413426855063226,0.00493817025382437,-0.0510214992038184,-0.0316638718088268,6.34429291772255e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0427970398644308,0.00511726571248671,-0.0528268806609047,-0.0327671990679568,6.70741448106627e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0445571288457517,0.00532881592927832,-0.0550016080671372,-0.0341126496243662,6.91333471742162e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0410729061627503,0.00491459149944765,-0.0507055055016677,-0.0314403068238329,7.16443282201992e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0261657520831105,0.00313117613892196,-0.0323028573153975,-0.0200286468508234,7.21264123361508e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,39866,-0.085891567210298,0.0102825100475929,-0.10604528690358,-0.065737847517016,7.42304205407988e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.02418398816051,0.00289781150644051,-0.0298636987131334,-0.0185042776078867,7.7665050107128e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42070,-0.0268451785025605,0.00321780321651704,-0.0331520728069339,-0.0205382841981871,7.962088315341e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0485001295980593,0.00582100543790997,-0.0599093002563628,-0.0370909589397557,8.88672528845414e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0342847620569255,0.00411695913152392,-0.0423540019547123,-0.0262155221591386,9.03187222056443e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0376624083394512,0.004523328583374,0.0287966843160381,0.0465281323628642,9.1358368589459e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0456714294565351,0.00548674880969596,-0.0564254571235392,-0.034917401789531,9.50107293435296e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0245599992101458,0.00295376785530259,-0.0303493842065389,-0.0187706142137528,1.00504835534021e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.03859792670771,0.0046426726287219,-0.047697565060005,-0.0294982883554151,1.01536453190118e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0383516572176053,0.00461373885595233,-0.0473945853752719,-0.0293087290599387,1.04760428648419e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0846850839592953,0.0101885699107548,-0.104654680984375,-0.064715486934216,1.0502133677935e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0963960791625774,0.0116066808361878,-0.119145173601505,-0.0736469847236493,1.10917754459412e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0252185153702613,0.00304248206958004,0.0192552505138844,0.0311817802266382,1.25097591081187e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0268658803757408,0.00324310469778469,-0.0332223655833988,-0.0205093951680828,1.30216504796468e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0345019948325954,0.00416779252638712,-0.0426708681843142,-0.0263331214808767,1.36904688793808e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.043831554211716,0.00529356084051685,-0.054206933459129,-0.033456174964303,1.37159222927952e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0815407590667469,0.00984883645863579,-0.100844478525673,-0.0622370396078208,1.37839060013746e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0760883846035564,0.00919420385857419,-0.0941090241663618,-0.0580677450407509,1.39534946696801e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0969529358902861,0.0117259936775983,-0.119935883498379,-0.0739699882821935,1.48530104813163e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,39958,-0.0270925641345892,0.0032770134900806,-0.0335155105751471,-0.0206696176940312,1.52059439563189e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,41997,-0.0710376310183475,0.00859547939292119,-0.0878847706284731,-0.054190491408222,1.53339617841329e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0394964433060537,0.0047867903737769,-0.0488785524386565,-0.030114334173451,1.74692705074838e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0559641992292309,0.00678563370053463,-0.0692640412822787,-0.042664357176183,1.79658989194581e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0853057878984707,0.0103578104620055,-0.105607096404002,-0.0650044793929398,1.94613120716428e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0215769052884292,0.00262097169660842,-0.0267140098137817,-0.0164398007630767,2.00219702586048e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0848496065856413,0.0103267978819847,-0.105090130434331,-0.0646090827369512,2.28962490894928e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0257689595015117,0.00313756126981183,-0.0319185795903428,-0.0196193394126805,2.34884326154465e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0614982429269381,0.00748946153432503,-0.0761775875342152,-0.0468188983196611,2.43162823104369e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0444264009336689,0.00541247678134595,-0.0550348554251069,-0.0338179464422308,2.4892733236351e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00810105480745596,0.000987332259012003,0.00616588357979244,0.0100362260351195,2.51035262340869e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0414132325667979,0.00504628258568059,-0.0513039464347318,-0.0315225186988639,2.51966318718105e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0240411989022188,0.0029325751215231,-0.0297890461404041,-0.0182933516640335,2.66116049280777e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0322917489885532,0.00394605256858726,-0.0400260120229842,-0.0245574859541222,3.0079128612283e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0676296474055882,0.00826732423150541,-0.0838336028993388,-0.0514256919118376,3.13183467794355e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,42284,-0.0183108646448649,0.00224185420188198,-0.0227048988805536,-0.0139168304091762,3.41592684642897e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0233865107064793,0.00286356025614643,0.0177739326044323,0.0289990888085263,3.49682722356077e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0392639803164398,0.00480869320565819,-0.0486890189995298,-0.0298389416333497,3.49742777787907e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0872882742460026,0.0107263762179845,-0.108311971633252,-0.066264576858753,4.44716563892174e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0325874286224047,0.00401010352021533,-0.0404472315220268,-0.0247276257227827,4.80262613309503e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0834754202179354,0.0102791261048942,-0.103622507383528,-0.0633283330523427,5.02711191507442e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0210868189844237,0.00259850654330949,0.0159937461595371,0.0261798918093103,5.27742132521312e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0221809295214646,0.00273284690298909,-0.0275373094513233,-0.016824549591606,5.29496778869835e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.059135708201742,0.00728871064127341,-0.0734215810586378,-0.0448498353448461,5.34834906462121e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0326998629181294,0.00402963515512746,-0.0405979478221792,-0.0248017780140796,5.37888651127498e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0291464690211865,0.00360068447985526,-0.0362038106017028,-0.0220891274406702,6.22285827037236e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0301994563792418,0.00373486991190561,-0.0375198014065768,-0.0228791113519068,6.81910081307746e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0298892057755436,0.00369776324668991,-0.0371368217390558,-0.0226415898120314,6.85217212681226e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.114648015120597,0.0141860126551736,-0.142452599924738,-0.086843430316457,7.04846166648156e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0630139598958867,0.0078102562475467,-0.0783220621410783,-0.0477058576506952,7.73828344629826e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0491109574526226,0.00608979524426426,-0.0610469561313806,-0.0371749587738647,7.97045156534565e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42143,-0.0912220324119911,0.0113172123935701,-0.113403768703388,-0.0690402961205938,8.233694926406e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0579248442223257,0.00719012192994415,-0.0720174832050162,-0.0438322052396352,8.66016439413327e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0412065971933024,0.0051260175159189,-0.0512535915245035,-0.0311596028621014,9.82927261815308e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.029869423854477,0.00371677284161607,-0.0371542986240444,-0.0225845490849095,1.00186761984728e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0472084229654385,0.00587442373422333,-0.0587222934845162,-0.0356945524463608,1.00380008745789e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0575611547451636,0.00716916565401956,-0.0716127194270419,-0.0435095900632853,1.06246259952079e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0661468009636348,0.00824772613800581,-0.0823123441941262,-0.0499812577331434,1.16130671185967e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0343969235984403,0.00429273144035743,-0.0428106772215408,-0.0259831699753397,1.23072882194178e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0445300543626099,0.00555895223841193,-0.0554256007498972,-0.0336345079753225,1.23621474316995e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0569258251659746,0.00711716346569937,-0.0708754655587454,-0.0429761847732038,1.3627027426229e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0245950992460712,0.00307536545669728,-0.0306228155411979,-0.0185673829509445,1.37296048222766e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.046942115838802,0.00587202735374194,-0.0584512894521362,-0.0354329422254678,1.40932659493597e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0402466482869851,0.00503363407395308,-0.0501125710719332,-0.0303807255020371,1.41868720674265e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0894451390963088,0.0111930059872012,-0.111383430831223,-0.0675068473613944,1.44444913877252e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0553113838266955,0.00692340635813206,-0.0688812602886344,-0.0417415073647567,1.49146659426975e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,39934,-0.044563724643462,0.00558989402998872,-0.0555199169422399,-0.0336075323446841,1.70824011866299e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0798710500893637,0.010041798926388,-0.0995529759850842,-0.0601891241936432,1.97965965413172e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0263653495062532,0.00332233933988578,0.019853564400077,0.0328771346124293,2.25329671350332e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42145,-0.0365167393649921,0.00460313631448882,-0.0455388865413902,-0.0274945921885941,2.3059154567739e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0474484332576241,0.0059846914041411,-0.0591784284097407,-0.0357184381055075,2.39478383880464e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0141053427501465,0.00177917062685193,-0.0175925171787762,-0.0106181683215167,2.43398480596477e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.045132767517241,0.00569301454702084,-0.0562910760294018,-0.0339744590050802,2.44652301169186e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0388481306569457,0.00490656623917056,-0.04846500048572,-0.0292312608281715,2.64817517544575e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.101385012472501,0.0128150483366778,-0.12650250721239,-0.076267517732613,2.78145825153144e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42217,0.041002417616065,0.00518411426036594,0.0308415536657478,0.0511632815663823,2.78821793091333e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0563981728543334,0.00712995643490298,-0.0703728874667433,-0.0424234582419236,2.82027313826316e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0566824352969951,0.00716793690563506,-0.0707315916320398,-0.0426332789619503,2.87152397779942e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0662043597009704,0.00838035518812284,-0.0826298558696911,-0.0497788635322496,3.00269779392187e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0614145978192916,0.00777380994275525,-0.0766512653070919,-0.0461779303314913,3.04201975481946e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0474162615562032,0.00600516258985866,-0.0591863802323262,-0.0356461428800803,3.10482993088865e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0707140646479777,0.00895576087805916,-0.0882673559689737,-0.0531607733269818,3.10932913828968e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0379852834641028,0.00481217361460812,0.0285534231794709,0.0474171437487347,3.20661531134297e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,41913,-0.0459369306931625,0.00582698215975464,-0.0573578157262816,-0.0345160456600434,3.43038480250403e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0308938334055817,0.00391895968607461,0.0232126724208754,0.0385749943902879,3.43700776999211e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,41913,-0.0375243664335034,0.00476293818198705,-0.046859725270198,-0.0281890075968088,3.57202410109782e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0648506604410611,0.00825021171152734,-0.0810210753956546,-0.0486802454864675,4.11974988480747e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0202306214527102,0.00257444552060273,0.0151847082323289,0.0252765346730916,4.18670027361974e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0574177310766604,0.00731043494587189,-0.0717461835705693,-0.0430892785827514,4.32140196824132e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0677045194021607,0.00862153467619518,-0.0846027273675032,-0.0508063114368181,4.37090737355553e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0299725898749733,0.00381867257728951,-0.0374571881264607,-0.0224879916234859,4.57292364663689e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0486597974931043,0.00620360948116195,-0.0608188720761818,-0.0365007229100269,4.69746073860917e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0230987698348737,0.00294650409179817,-0.0288739178547981,-0.0173236218149493,4.93191468936347e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0332002112064503,0.00423529359253496,-0.0415013866478188,-0.0248990357650818,4.94950025002463e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0503627433366006,0.00643636249614527,0.0377474728441559,0.0629780138290453,5.46894439642957e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42170,0.0310656467853746,0.00397483259386292,0.0232749749014033,0.0388563186693459,5.87193868759355e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0492985748924773,0.00630871325269003,-0.0616636528677498,-0.0369334969172048,6.01198705360992e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0725333664569838,0.00928891275539673,-0.0907396354575614,-0.0543270974564062,6.20134201304428e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0419413195577161,0.00536988341498382,-0.0524662910510844,-0.0314163480643479,6.21302191372715e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0717766521400987,0.00919126983154537,-0.0897915410099276,-0.0537617632702697,6.27513090415606e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,39929,-0.0241044000123224,0.00308979834655166,-0.0301604047715636,-0.0180483952530811,6.66563189276011e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0509842388178026,0.00654803296288793,-0.0638183834250629,-0.0381500942105422,7.40654832150386e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0372742215276863,0.00478810455617463,0.027889536597584,0.0466589064577886,7.48899124391893e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0233520267747813,0.00300091144251385,-0.0292338132021084,-0.0174702403474542,7.66962195389008e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0542057968404241,0.00696508277842514,-0.0678573590861374,-0.0405542345947109,7.72894896975644e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.061168761562248,0.00786283819725029,-0.0765799244288586,-0.0457575986956374,7.93089015080765e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0639922597703641,0.00823355403677061,-0.0801300256824345,-0.0478544938582937,8.27277794444545e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,39649,-0.0361593177952441,0.0046566126545795,-0.04528627859822,-0.0270323569922683,8.8750683399162e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0375629631753451,0.00484187116003576,-0.0470530306490152,-0.028072895701675,9.24745690065117e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42249,-0.0306715339510222,0.0039547479450365,-0.0384228399232937,-0.0229202279787507,9.41208873415239e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,39657,-0.0410538787971766,0.00529357393385838,-0.0514292837075391,-0.0306784738868142,9.57872515665251e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0278998616432648,0.00359970044929218,-0.0349552745238775,-0.0208444487626522,9.78917631512492e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0403214394557425,0.00521412578477112,-0.0505411259938939,-0.0301017529175911,1.13805167541844e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.046175257954081,0.00597327945991197,-0.0578828856955085,-0.0344676302126536,1.1488025881405e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42196,-0.0245388081726632,0.00317726402998412,-0.0307662456714321,-0.0183113706738943,1.21306548391553e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.02916800833216,0.00377998397310105,-0.0365767769194381,-0.021759239744882,1.27970396254486e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,39657,-0.037720673568016,0.00490129918939626,-0.0473272199792326,-0.0281141271567993,1.52274704558982e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0727415853314679,0.00945183176399925,-0.0912671755889065,-0.0542159950740294,1.52326414346352e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0552319244613152,0.00717740415376212,-0.069299636602689,-0.0411642123199415,1.53325006939034e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42116,-0.0334126040806199,0.00435133772508873,-0.0419412260217939,-0.024883982139446,1.71727662693245e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42137,0.0215137581644452,0.00280600486785857,0.0160139886234424,0.027013527705448,1.8797512488436e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0662142531287339,0.00865553613251445,-0.0831791039484622,-0.0492494023090056,2.14628402301782e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0373691725836593,0.00488526599047838,-0.0469442939249969,-0.0277940512423217,2.18746662486348e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0299498352925586,0.00392216375401134,-0.0376372762504209,-0.0222623943346964,2.41986287568989e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0265013074301183,0.00347303511295021,0.0196941586087359,0.0333084562515007,2.52748016631254e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0258599061659892,0.00338983592437589,0.0192158277542125,0.032503984577766,2.53009463149379e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0191090610790882,0.00250529457545921,-0.0240194384469883,-0.0141986837111882,2.55136831607149e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,39979,-0.0338755355546071,0.00444127354623391,-0.0425804317052255,-0.0251706394039886,2.58540456824014e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0793529304451288,0.0104242759527215,-0.0997845113124629,-0.0589213495777946,2.87189886414369e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0365837404446238,0.00480583139595543,-0.0460031699806964,-0.0271643109085511,2.91032324136791e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0393049228173046,0.00516523152332107,-0.0494287766030139,-0.0291810690315953,2.93315819327434e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0363806270315557,0.00478212420274504,-0.045753590468936,-0.0270076635941755,2.97982302642642e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0634975658409277,0.00835137925070853,-0.0798662691723164,-0.047128862509539,3.07857893630621e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0470981564730194,0.00619541090911807,-0.0592411618548908,-0.034955151091148,3.10930943584587e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0410844043882207,0.00540599783234518,-0.0516801601396172,-0.0304886486368241,3.20832542609973e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0279822726571892,0.0036831922821593,-0.0352013295302215,-0.020763215784157,3.22260730107188e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42119,-0.0390030289279928,0.00513644788449986,-0.0490704667816125,-0.0289355910743731,3.32058179365849e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0293907038299021,0.00387172368074292,-0.0369792822441582,-0.021802125415646,3.37873413053218e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42296,-0.0394743011240947,0.00520175842122573,-0.0496697476296971,-0.0292788546184923,3.44097378475109e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0499780187555517,0.00658607294518305,-0.0628867217281105,-0.037069315782993,3.49844757574011e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0414324832161399,0.00546148033089537,-0.0521369846646948,-0.030727981767585,3.55563321528821e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0679842694603464,0.00896861155577475,-0.0855627481096649,-0.0504057908110279,3.67385825465494e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0532442003240801,0.00702542126795802,-0.0670140260092778,-0.0394743746388824,3.76558001142648e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0444508547774435,0.00586581681522156,-0.0559478557352777,-0.0329538538196092,3.79005066709796e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,39736,0.0383460675987232,0.00506192118074086,0.0284247020844711,0.0482674331129752,3.86387743433134e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0703588430710547,0.00929784936503003,-0.0885826278265135,-0.0521350583155958,4.11439676874738e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0406872571632527,0.00538280754049085,-0.0512375599426147,-0.0301369543838906,4.38871054359033e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.03986150633438,0.0052737569438327,-0.0501980699442921,-0.0295249427244679,4.40353177281525e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0723643158416901,0.00957591496734652,-0.0911331091776893,-0.053595522505691,4.44558740244686e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0483435084787054,0.00640382459561957,-0.0608950046861198,-0.0357920122712911,4.71674461850282e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0474336885492997,0.00629675106978535,-0.059775320646079,-0.0350920564525204,5.34379824720327e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0267090388411263,0.00354707735032931,-0.0336613104477717,-0.0197567672344808,5.46288443386021e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0228853040132104,0.00304067885713933,-0.0288450345732035,-0.0169255734532174,5.62517293313328e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0410190768294604,0.00545462504918173,-0.0517101419258566,-0.0303280117330642,5.81663682518335e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.027788461049023,0.00369657998143731,-0.0350337578126401,-0.0205431642854059,6.01916626593383e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0343752674140174,0.00457469316663059,-0.0433416660206134,-0.0254088688074215,6.16772931210281e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0360634556862614,0.0048030715070105,0.0266494355325208,0.045477475840002,6.35859986128645e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0532848110354171,0.00711106612361416,-0.0672225006377009,-0.0393471214331334,7.13715813316584e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.044793054460556,0.00598046749008861,-0.0565147707411297,-0.0330713381799823,7.41821244480516e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0245325885451715,0.00327662695673403,-0.0309547773803702,-0.0181103997099728,7.558490843985e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0265613238346497,0.0035497361169348,-0.0335188066238419,-0.0196038410454575,7.73669721917469e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0190020633767518,0.00254434732717798,-0.0239889841380207,-0.014015142615483,8.61323979691092e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0309285123490553,0.00414497881744484,-0.0390526708312472,-0.0228043538668634,9.06538246674913e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0674063318974301,0.00903371752324351,-0.0851124182429874,-0.0497002455518728,9.06653126616732e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0260415047741251,0.00349255784378914,-0.0328869181479518,-0.0191960914002984,9.43315224105026e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0215877345044437,0.00289565870008433,-0.027263225556609,-0.0159122434522784,9.64458846254001e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0187162357442391,0.00251646192171027,0.013783970377687,0.0236485011107912,1.0874025128342e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42016,-0.0343598723490961,0.00462337796141733,-0.0434216931534741,-0.0252980515447181,1.13636958893158e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.053894668649166,0.00725941522633763,-0.0681231224927877,-0.0396662148055442,1.21954338266164e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42167,0.0167812887093768,0.00226472800535852,0.0123424218188741,0.0212201555998795,1.33915884295476e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,39657,-0.0340544825186232,0.0045956283890658,-0.0430619141611921,-0.0250470508760542,1.35317569237342e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0427861820092741,0.00577583665171441,-0.0541068218466343,-0.0314655421719138,1.35993194610553e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0241520896121224,0.00326181474975348,-0.0305452465216393,-0.0177589327026056,1.39373509333418e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.042685356074568,0.00577522819315833,-0.0540048033331583,-0.0313659088159776,1.55856630091351e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0506173482254622,0.0068508331468022,-0.0640449811931945,-0.0371897152577299,1.5722624447731e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0734952787591369,0.00995077334435096,-0.0929987945140648,-0.053991763004209,1.60260970297836e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0894801517978313,0.0121253535803164,-0.113245844815251,-0.0657144587804112,1.67947050374061e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0366513222236239,0.00497390782593641,-0.0464001815624593,-0.0269024628847886,1.82168565948214e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0515176687800378,0.00699558530497487,-0.0652290159777886,-0.0378063215822871,1.90382832948555e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0623261140926054,0.00846909393405179,-0.0789255382033469,-0.0457266899818639,1.95709758080405e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0491974575549598,0.00668643409120375,-0.0623028683737191,-0.0360920467362005,1.97633826888875e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0846187358251011,0.0115029699998269,-0.107164557024762,-0.0620729146254404,2.02203557844397e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0479935626720844,0.00653348373349637,-0.0607991907897373,-0.0351879345544315,2.16213438925111e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0360007092447097,0.00490257907306527,-0.0456097642279177,-0.0263916542615018,2.20282150790209e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0316788530104225,0.00431997283666121,-0.0401459997702785,-0.0232117062505666,2.37514293844616e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.031900058529491,0.00435002651327405,-0.0404261104955081,-0.0233740065634738,2.39876053181062e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0579580111402641,0.00791027922368196,-0.0734621584186808,-0.0424538638618475,2.48814581795476e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42299,-0.0267140426449858,0.00364627264331994,-0.0338607370258928,-0.0195673482640787,2.49634939042239e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0391009675692751,0.00533815457857264,-0.0495637505432775,-0.0286381845952728,2.52734594776376e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.025483801656583,0.00348195196008985,-0.0323084274983591,-0.0186591758148069,2.64822976749302e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0404962255988223,0.00553556795334392,-0.0513459387873763,-0.0296465124102682,2.70443376992846e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0339854818539818,0.00465065647973703,-0.0431007685542664,-0.0248701951536973,2.87287641042169e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,41900,0.0182346689603352,0.0024959147358655,0.0133426760780388,0.0231266618426316,2.91307251599505e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0647446663956133,0.00886247791537655,-0.0821151231097514,-0.0473742096814753,2.95311856761733e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0491907366429863,0.00673912822839118,-0.062399427970633,-0.0359820453153396,3.08678874301983e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0865901766903608,0.0118688760736775,0.063327179585953,0.109853173794769,3.17452848879233e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.044000993147579,0.00603353391534987,-0.0558267196216648,-0.0321752666734933,3.20603244477293e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0541507692854135,0.00743335392529459,-0.0687201429789909,-0.0395813955918361,3.43821012131055e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0685794481962485,0.00941721081007936,-0.087037181384004,-0.050121715008493,3.46237378760389e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0555715366892773,0.0076319992113906,-0.0705302551436029,-0.0406128182349517,3.48579285252063e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0376075312998286,0.00516494987549432,-0.0477308330557975,-0.0274842295438597,3.52411201448023e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0284355812393756,0.00390867570740113,-0.0360965856258818,-0.0207745768528694,3.65519966566868e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0560873357963905,0.00771071618382602,-0.0712003395166895,-0.0409743320760915,3.68074529510808e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0432640637211534,0.00594867402754041,-0.0549234648151326,-0.0316046626271742,3.71134405613854e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0492278127352495,0.00677386309896192,-0.0625045844092149,-0.0359510410612842,3.90928274916273e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,39930,-0.04529295265096,0.00623553575066393,-0.0575146027222613,-0.0330713025796587,4.01402110599645e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0680240107322565,0.0093687529245306,-0.0863867664643364,-0.0496612550001765,4.05957490293928e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0327301084737937,0.0045097371284878,-0.0415691932456298,-0.0238910237019576,4.1652705027583e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0484717297975817,0.00668322907964069,-0.0615708587936775,-0.035372600801486,4.31115712246886e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,39827,-0.0409592931520065,0.00564802160444243,-0.0520294154967137,-0.0298891708072993,4.3776978914769e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0676179217638656,0.00935388462437399,-0.0859515356276386,-0.0492843079000926,5.13304622059553e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,42199,-0.017515358789127,0.00242600224002086,-0.0222703231795679,-0.0127603943986861,5.48098178160042e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0683911446970758,0.00947604684479736,-0.0869641965128786,-0.049818092881273,5.64441309277246e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0392942998174811,0.00544464117483114,-0.0499657965201501,-0.028622803114812,5.65189824387269e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,39757,-0.0420089490505799,0.00582453711388284,-0.0534250417937903,-0.0305928563073696,5.8530248642383e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0405843710355657,0.00562729072173182,-0.0516138608501601,-0.0295548812209714,5.86267015261573e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42145,-0.0189644489102036,0.00263055488435228,-0.0241203364835341,-0.0138085613368731,5.92218727967839e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0998841622436617,0.0138744443315493,-0.127078073133498,-0.072690251353825,6.37827363330972e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0272416013464239,0.00378414992829558,-0.0346585352058832,-0.0198246674869645,6.38871819905007e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,42105,-0.033141420545168,0.00460489449508196,-0.0421670137555286,-0.0241158273348074,6.48011353392516e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,41997,-0.0275953648475027,0.00383785759224128,-0.0351175657282956,-0.0200731639667098,6.807447666918e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,39914,-0.0754826423355218,0.0105007220667614,-0.0960640575863742,-0.0549012270846693,6.97201080574428e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0208227331160553,0.00289921526140382,-0.0265051950284068,-0.0151402712037039,7.21697096501929e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0360903107472607,0.00502446104877812,-0.0459382544028658,-0.0262423670916556,7.26241978934808e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0259990650616313,0.00362055979921514,-0.033095362268093,-0.0189027678551696,7.28737257756866e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0266018125636043,0.00370445162196438,-0.0338625377426545,-0.0193410873845541,7.34974773042333e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0365340869505467,0.00508953038166693,-0.0465095664986139,-0.0265586074024796,7.43454579813411e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0615981614854608,0.00859720411179211,0.0447476414263483,0.0784486815445733,8.18629816386074e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0159951697746174,0.00223339767999671,-0.0203726292274109,-0.0116177103218238,8.37501167219724e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0410790109839287,0.00574766702075952,-0.0523444383446173,-0.02981358362324,9.32750313133076e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0280135012146444,0.00392729780272187,-0.0357110049079793,-0.0203159975213095,1.03222706929613e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.041089845878929,0.00576291994192328,-0.0523851689650986,-0.0297945227927593,1.05454623260525e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0238514613834747,0.0033457468911491,-0.0304091252901269,-0.0172937974768224,1.06266798333381e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0280170731549196,0.0039344661421042,-0.0357286267934439,-0.0203055195163954,1.13852936510566e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0449809291539307,0.00632459765685671,-0.0573771405613699,-0.0325847177464916,1.21331938172987e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0227466937409185,0.00320261846929511,-0.0290238259407369,-0.0164695615411001,1.28748491049084e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0209471904984513,0.00295014564907552,-0.0267294759706393,-0.0151649050262633,1.32033935040532e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0488412738564466,0.0068795427561548,-0.06232517765851,-0.0353573700543832,1.32704143953336e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0323620925061418,0.00455997311828341,-0.0412996398179773,-0.0234245451943063,1.33766023938149e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0360763225631541,0.00508405845394183,-0.04604107713288,-0.0261115679934281,1.34876617601432e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0973081463220534,0.013714748815312,-0.124189054000065,-0.0704272386440418,1.35616655800111e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42137,-0.0485040324756744,0.00684076362884387,-0.0619119291882084,-0.0350961357631404,1.40314597793956e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0802217506026051,0.0113123361990398,-0.102393929552723,-0.058049571652487,1.4067773595738e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0497304974444669,0.00701472948705219,-0.0634793672390892,-0.0359816276498446,1.41482035764907e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42137,-0.0342087538484002,0.00482952542838454,-0.0436746236880339,-0.0247428840087665,1.47762947680027e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0577423017350294,0.00815055525544088,-0.0737173900356935,-0.0417672134343653,1.47862791981098e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0261773180541029,0.00369591417096523,0.0189333262790111,0.0334213098291948,1.4824830411171e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0435176072253788,0.00614349500673294,-0.0555588574385754,-0.0314763570121823,1.49096244670078e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42070,-0.0448055285468534,0.00633885306596519,-0.0572296805561452,-0.0323813765375616,1.64448847536312e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42119,-0.0249798641379131,0.00353750705763352,-0.0319133779708748,-0.0180463503049514,1.7284570915861e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0223600396221199,0.00316963173145111,-0.0285725178157641,-0.0161475614284758,1.81708707308121e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,39850,-0.0749605542631036,0.0106292837677606,-0.0957939504479144,-0.0541271580782929,1.86348582561975e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0177719780605705,0.00252058406117918,0.0128316333006593,0.0227123228204817,1.8648900845332e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0596142793497421,0.0084548497458332,-0.0761857848515752,-0.043042773847909,1.88105597003677e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0377547089094324,0.00535679717936449,-0.0482540313809868,-0.027255386437878,1.90315049534278e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0383039348503289,0.00543486505546337,-0.0489562703590371,-0.0276515993416207,1.90543704076138e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0694930640036864,0.00985815795622585,-0.0888150535978891,-0.0501710744094837,1.90562457302065e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0392183656062927,0.00556366222262603,-0.0501231435626397,-0.0283135876499456,1.90937930400754e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0426418911910716,0.00606200979037839,-0.0545234303802133,-0.03076035200193,2.10091637753548e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,39930,-0.066399728381382,0.00944262926387055,-0.0849072817385683,-0.0478921750241957,2.15447770368711e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0459121828310205,0.00653573982293169,-0.0587222328839666,-0.0331021327780744,2.24866958431937e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,41900,-0.0375489928561608,0.00534580134584273,-0.0480267634940125,-0.027071222218309,2.26062340257127e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,39934,0.0370351855553273,0.00528317801746572,0.0266801566410945,0.0473902144695601,2.51820252568315e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0383643902893135,0.00547680952320192,-0.0490989369547893,-0.0276298436238378,2.58776748080963e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.057163166128355,0.00817553992751097,-0.0731872243862765,-0.0411391078704335,2.83724463095462e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0844777621431112,0.0120966941991624,-0.108187282773469,-0.0607682415127529,3.01297389394162e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42137,-0.032420616834986,0.0046437241595006,-0.0415223161876071,-0.0233189174823648,3.05442261502928e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0679578457957202,0.00975105128098251,-0.0870699063064459,-0.0488457852849945,3.33634415775025e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0328430821990647,0.00471325505164779,-0.0420810621002943,-0.023605102297835,3.35824726924429e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0201056653742548,0.00288839840655506,-0.0257669262511028,-0.0144444044974069,3.53916142549558e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0185839342053532,0.0026712643851903,-0.0238196124003262,-0.0133482560103802,3.63560308352616e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0322236540185565,0.00463491919546049,0.0231392123954539,0.041308095641659,3.79492393677368e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0248841610370446,0.00358001984072142,0.0178673221492306,0.0319009999248586,3.79852445467459e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0327069286627353,0.00470877665410879,-0.0419361309047885,-0.023477726420682,3.97046406123035e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0673853036813205,0.00976398037800417,-0.0865227052222087,-0.0482479021404323,5.42340978246055e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.022685197539446,0.00329033548645504,-0.0291342550928978,-0.0162361399859941,5.69306806840637e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,39966,-0.0632740249839911,0.00918267810490292,-0.0812720740696009,-0.0452759758983814,5.85006479604942e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0318913051090508,0.0046406441687753,-0.0409869676798504,-0.0227956425382513,6.59814611800736e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0385410464076019,0.0056107451617061,-0.0495381069245459,-0.0275439858906579,6.74703921126313e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,39929,-0.101590969710674,0.0148013040044389,-0.130601525559374,-0.0725804138619737,7.06276435401209e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0583991730908703,0.00851251650744745,-0.0750837054454673,-0.0417146407362733,7.16847247826899e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0175664233735117,0.00256096247809711,-0.022585909830582,-0.0125469369164413,7.22064209083521e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0805681815852441,0.0117566598886626,-0.103611234967023,-0.0575251282034653,7.61454188978751e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0168153901436798,0.00245884065984707,-0.02163471783698,-0.0119960624503795,8.32722141037675e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0407786984383625,0.00596709255713321,-0.0524741998503436,-0.0290831970263814,8.61715547532339e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0905019674450965,0.0132927210173412,-0.116555700639085,-0.0644482342511078,1.02992394573576e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0545147484400549,0.00800800107943888,-0.0702104305557551,-0.0388190663243547,1.04389915055807e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0490574125774585,0.00721956126077237,-0.0632077526485723,-0.0349070725063447,1.12786002742192e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.052271670924465,0.00769349310636424,-0.0673509174129389,-0.0371924244359911,1.13383174965763e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0838478470726666,0.0123455206631285,-0.108045067572398,-0.0596506265729347,1.16313564024983e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,39930,-0.0576645834348002,0.00849170314073992,-0.0743083215906505,-0.04102084527895,1.17174576069183e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0852469625276362,0.0125556835924751,-0.109856102368887,-0.060637822686385,1.17227410490278e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0370256688295948,0.00546715345881836,-0.0477412896088788,-0.0263100480503108,1.31998671391632e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.032952971707023,0.00486685689211616,-0.0424920112155707,-0.0234139321984753,1.3338538179637e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0557806945594415,0.00824739292278934,-0.0719455846881086,-0.0396158044307744,1.40290823439512e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0371787503985287,0.00551440307459944,-0.0479869804247436,-0.0263705203723138,1.6241030150345e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0375999194210142,0.00557795061959845,-0.0485327026354271,-0.0266671362066012,1.63813018168165e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.054993357328627,0.00816008015404725,-0.0709871144305596,-0.0389996002266944,1.65573936149896e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0303180512858255,0.00450197965350525,0.0214941711649552,0.0391419314066958,1.7263961133887e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0177152935485536,0.00263154169575194,0.0125574718248798,0.0228731152722274,1.74114002197652e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,39876,-0.0343237675716115,0.00509943770582243,-0.0443186654750235,-0.0243288696681996,1.76805612532248e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0856812777921869,0.0127535625621396,-0.110678260413981,-0.0606842951703933,1.93005804565513e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0747082373891654,0.0111758961855258,-0.0966129939127959,-0.0528034808655348,2.40395514152568e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0635119778606732,0.00950205907573224,-0.0821360136491084,-0.044887942072238,2.43658999661188e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0428840729552535,0.00641943689923356,-0.0554661692777513,-0.0303019766327557,2.49536963189045e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0376092168440603,0.0056348934296133,-0.0486536079661024,-0.0265648257220182,2.60114618813234e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0572067818720833,0.00857859306042691,-0.0740208242705201,-0.0403927394736466,2.685370199484e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0171183447863962,0.00256723571116992,0.0120865627925031,0.0221501267802892,2.69353168711121e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,39990,-0.0502376370580564,0.00753578122851442,-0.0650077682659447,-0.0354675058501682,2.73993191973017e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0602023022729241,0.00905393926013946,-0.0779480232227974,-0.0424565813230507,3.08055954898137e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,39736,-0.0556389048584638,0.00840183718478395,-0.0721065057406403,-0.0391713039762873,3.70106418067129e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42217,-0.0331791232741583,0.00501197765115514,-0.0430025994704224,-0.0233556470778942,3.72739408766544e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0249961307411643,0.00377809321837898,-0.0324011934491871,-0.0175910680331415,3.82577593751109e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0511658541377153,0.00773452499669796,-0.0663255231312433,-0.0360061851441873,3.87635350066973e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0191644973765977,0.00289802538131215,-0.0248446271239695,-0.0134843676292258,3.90837911230261e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.0109806913005529,0.00166037172263947,0.00772636272417954,0.0142350198769262,3.92433640835703e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42296,-0.0414950061277637,0.00627893511725074,-0.0538017189575752,-0.0291882932979522,4.02305862319564e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0231781623110063,0.0035075999905399,0.0163032663295481,0.0300530582924645,4.07501525068896e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,41839,-0.058102328930449,0.0087962378201231,-0.0753429550578903,-0.0408617028030078,4.11701148117907e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0639368736468214,0.00967985980892459,-0.0829093988723136,-0.0449643484213292,4.12037437581838e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42077,-0.0177980610688098,0.00269614365265322,-0.0230825026280101,-0.0125136195096095,4.22815670110317e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0492923264983983,0.00746818732540815,-0.0639299736561982,-0.0346546793405983,4.29227328112596e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0550171060647835,0.00834360142271113,-0.0713705648532973,-0.0386636472762697,4.44173505443939e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,39908,-0.0608611892569668,0.00923185947231393,-0.0789556338227021,-0.0427667446912315,4.51681708057775e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0655972597063972,0.00996282099654427,-0.085124388859624,-0.0460701305531704,4.74479644307789e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42035,-0.0479190124861061,0.007291874261502,-0.06221108603865,-0.0336269389335622,5.16261147495922e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0290799558214722,0.00442669897141803,-0.0377562858054515,-0.0204036258374928,5.24308836161956e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.0239891463404814,0.00365198248395856,0.0168312606719227,0.0311470320090402,5.30031294008223e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0340805683122516,0.00519510788184378,-0.0442629797606654,-0.0238981568638378,5.61061896605152e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0336108828611822,0.00512797170162656,-0.0436617073963703,-0.0235600583259942,5.82784183828652e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42145,-0.0246596772595092,0.00376378428359055,-0.0320366944553467,-0.0172826600636717,5.8890200534445e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,41973,-0.0287570489158147,0.00438919627488779,-0.0373598736145947,-0.0201542242170346,5.89369241229424e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0316355215299022,0.00483054928088571,-0.0411033981204382,-0.0221676449393662,6.04482169374032e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,41820,0.0831732922639308,0.0127047075616152,0.058272065443165,0.108074519084697,6.10144614125441e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0851506176049712,0.0130249153188946,-0.110679451630004,-0.0596217835799378,6.53241619481243e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,39979,-0.0150882916185143,0.00230883985829048,-0.0196136177407637,-0.010562965496265,6.63219701617424e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0320948997805979,0.00491121690174801,-0.041720884908024,-0.0224689146531718,6.63382268152489e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,39946,-0.0335840785450364,0.00514099492148474,-0.0436604285911465,-0.0235077284989263,6.74011799342095e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0242509006841158,0.00371313490411299,-0.0315286450961773,-0.0169731562720544,6.81211825062193e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42181,-0.0489665776102829,0.00751000204115,-0.0636861816109369,-0.0342469736096289,7.27052290471538e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0654352964846848,0.0100422701359579,-0.0851181459511622,-0.0457524470182074,7.47921050219234e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0335347263066878,0.00515081908045005,-0.0436303317043699,-0.0234391209090057,7.80333438362331e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0584028804510463,0.0089776070409433,-0.0759989902512952,-0.0408067706507974,8.08897532484268e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,41751,-0.0756394294743615,0.0116557653963747,-0.098484729651256,-0.052794129297467,8.92429307640359e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0300442718322453,0.0046330564593312,-0.0391250624925344,-0.0209634811719561,9.26341296100651e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42166,-0.0214014436752149,0.00330295090947535,-0.0278752274577865,-0.0149276598926432,9.52096943126675e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0196689842061768,0.00303725679891713,-0.0256220075320544,-0.0137159608802992,9.74734580873167e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0380998523769893,0.00588907462609021,-0.0496424386441261,-0.0265572661098524,1.02453562995981e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0262751318898004,0.00406230014193684,-0.0342372401679966,-0.0183130236116042,1.03502655704451e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0395135061553156,0.00611130572002291,-0.0514916653665605,-0.0275353469440707,1.05121915328745e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0447583118227655,0.00692421240339811,-0.0583297681334258,-0.0311868555121052,1.0552548062679e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,39930,-0.0243237299363584,0.00376689493727403,-0.0317068440134155,-0.0169406158593013,1.10993772535354e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.045853001919265,0.00710272494146262,-0.0597743428045317,-0.0319316610339982,1.11406224543263e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,41839,-0.0736747119584212,0.0114158385906655,-0.0960497555961256,-0.0512996683207168,1.12933882171035e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0463713520077685,0.00718793624370111,-0.0604597070454227,-0.0322829969701143,1.14694218410691e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,41751,-0.0520895858883016,0.00807513288389286,-0.0679168463407316,-0.0362623254358716,1.1529572427955e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0616847450204877,0.0095681664809495,-0.0804383513231487,-0.0429311387178267,1.1881075096527e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42296,-0.024581227233802,0.00381451832499748,-0.0320576831507971,-0.017104771316807,1.20160795860529e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0479074822763723,0.00744104729728938,-0.0624919349790595,-0.0333230295736851,1.24939172930324e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0438989739249585,0.0068203612064199,-0.0572668818895415,-0.0305310659603755,1.26365663701756e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0195612769299587,0.00304767630792024,0.013587831366435,0.0255347224934824,1.42222882093669e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0393806700437923,0.00613812185274409,-0.0514113888751707,-0.0273499512124138,1.45715606602665e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42189,-0.0248111606442263,0.00386947497282108,-0.0323953315909556,-0.017226989697497,1.48349872951116e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,41992,0.022665348151314,0.00354049137623113,0.0157259850539009,0.029604711248727,1.58725996964253e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.0185232055190986,0.00289393256077026,-0.0241953133382083,-0.0128510976999889,1.60754966927643e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0463074926648606,0.00723676301695385,-0.0604915481780902,-0.0321234371516311,1.62808844034907e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0266082281141441,0.00415917342447852,-0.034760208026122,-0.0184562482021662,1.63275785795397e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,39990,-0.0505904514226133,0.00790741358027915,-0.0660889820399604,-0.0350919208052661,1.63758209919886e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42185,0.0457269959533545,0.00715370300304067,0.0317057380673948,0.0597482538393142,1.68997406371322e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0636127351528467,0.00996801774906265,-0.0831500499410095,-0.0440754203646839,1.80960356987296e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0565250742753393,0.00886967311675723,-0.0739096335841835,-0.0391405149664951,1.91558002898161e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,39657,-0.0395007324439019,0.0062083543687637,-0.0516691070066788,-0.0273323578811251,2.06326163628759e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.068252103715024,0.0107338865151105,-0.0892905212846405,-0.0472136861454074,2.10247547512569e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0576881919349357,0.00907713022214159,-0.0754793671703332,-0.0398970166995382,2.16100366040074e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0441771913447541,0.00695378458718145,-0.0578066091356298,-0.0305477735538785,2.19291655072612e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0254015122890867,0.00400426387138138,-0.0332498694769942,-0.0175531551011792,2.31734193966845e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0356439294332991,0.00562253701906411,-0.0466641019906647,-0.0246237568759334,2.38030222213302e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0407374420965922,0.00642672506895735,-0.0533338232317486,-0.0281410609614358,2.38980422791996e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42124,0.0392412127593592,0.00619069029606184,0.027107459779078,0.0513749657396404,2.38996586269413e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0319856841052199,0.00505056970188851,-0.0418848007209214,-0.0220865674895184,2.47979996771989e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0456674549572828,0.00721392688095086,-0.0598067516439465,-0.0315281582706191,2.53820469125705e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0420373245216114,0.00664176853097306,-0.0550551908423186,-0.0290194582009042,2.55658925046319e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0395006010971113,0.00626037288924801,-0.0517709319600374,-0.0272302702341852,2.90158619648814e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0393903184909678,0.0062459703479201,-0.0516324203728912,-0.0271482166090444,2.94335564777614e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42174,0.0177338415570998,0.00281210229638349,0.0122221210561881,0.0232455620580114,2.94721874957313e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0193405594111096,0.00306752296504714,0.0133282143996172,0.025352904422602,2.97250434249283e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0288666655984377,0.00458170997641032,-0.037846817152202,-0.0198865140446735,3.05936333463996e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0247249653741428,0.00392416908585593,-0.0324163367824204,-0.0170335939658652,3.07696853559743e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0842920633593221,0.0133796675917613,-0.110516211839174,-0.0580679148794699,3.09267579388777e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,41975,0.0185240017081146,0.00294737611105938,0.0127471445304383,0.024300858885791,3.38219277270088e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0445158449489759,0.00708793650528426,-0.058408200499333,-0.0306234893986187,3.50233958858444e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0281998409474139,0.00449048268707718,-0.0370011870140852,-0.0193984948807426,3.51548037856461e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,39929,-0.057189454882143,0.00911946589940487,-0.0750636080449766,-0.0393153017193095,3.71463043330696e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0402468622850287,0.0064216311012997,-0.0528332592435762,-0.0276604653264813,3.80454043986796e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.0327038167571979,0.00522653189988532,-0.0429478192809731,-0.0224598142334227,4.03794508807695e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0281068754058626,0.00449243023550145,-0.0369120386674454,-0.0193017121442797,4.05494658389275e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0160529610927263,0.00256987077666139,-0.0210899078149826,-0.01101601437047,4.32145543537367e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0566644223229818,0.00907822637633415,-0.0744577460205967,-0.0388710986253668,4.45719052267705e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0316810539095611,0.00508294281189713,-0.0416436218208795,-0.0217184859982427,4.74819825552433e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0291257520731741,0.00467483606781671,-0.0382884307660949,-0.0199630733802534,4.81926638363623e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0262198846493515,0.00421362693419716,-0.0344785934403779,-0.017961175858325,5.03699885293632e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0267289990877419,0.00430116096225568,-0.0351592745737631,-0.0182987236017208,5.30713479017347e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42137,-0.0253331662690579,0.00407753032958054,-0.0333251257150358,-0.0173412068230801,5.35494458442718e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0609316988506195,0.00980791525039335,-0.0801552127413905,-0.0417081849598485,5.40256337334755e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0588352888546796,0.00948070724051826,-0.0774174750460954,-0.0402531026632638,5.63742922198234e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0197363057175492,0.00318570518386797,-0.0259802878779304,-0.0134923235571679,5.98488467176084e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,41997,0.0305217942935547,0.00492738331486977,0.02086412299641,0.0401794655906995,6.02492922236577e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0370624845462515,0.00598582213653624,-0.0487946959338625,-0.0253302731586405,6.15764120108141e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0407679029644921,0.00658695323518788,-0.0536783313054603,-0.0278574746235238,6.22134818397292e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,39586,-0.0429561487719233,0.00694238930991821,-0.056563231819363,-0.0293490657244836,6.3296406389255e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,39979,-0.0181446674198955,0.00293643676129997,-0.0239000834720434,-0.0123892513677475,6.66531261841809e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0190159509725017,0.00308410184276915,-0.0250607905843293,-0.0129711113606742,7.2114559758817e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0695487024629397,0.0112823798482733,-0.0916621669655553,-0.0474352379603241,7.27947997379245e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0702828155855201,0.011404559361548,-0.0926357519341542,-0.047929879236886,7.39854460713024e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0240481178875657,0.00390795403023571,-0.0317077077868277,-0.0163885279883037,7.8369323656455e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0272594390520703,0.0044322416134731,-0.0359466326144776,-0.018572245489663,8.00092766686711e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0224676017998236,0.003655718888602,-0.0296328108214836,-0.0153023927781637,8.21951599016101e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0371910025381612,0.00605234617749524,-0.0490536010460519,-0.0253284040302705,8.27364637373688e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0599434866123525,0.00976362630320789,-0.07908019416664,-0.040806779058065,8.56382064091951e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0260751238287682,0.00425090262198893,-0.0344068929678665,-0.0177433546896699,8.85436160100648e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0448009072790326,0.00730853112363102,-0.0591256282813494,-0.0304761862767158,9.03488690412917e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0479282772434061,0.00782367031937649,-0.063262671069384,-0.0325938834174282,9.26226059023043e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,39979,0.019955276026372,0.00325733202629799,0.013570905254828,0.0263396467979161,9.29391059602197e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0238574988087451,0.00389481499260906,-0.0314913361942589,-0.0162236614232313,9.29886766080397e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0253973187822464,0.00414674759130205,0.0172696935032944,0.0335249440611984,9.3381684675252e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0601479046263345,0.00982636036144255,-0.0794075709347619,-0.0408882383179071,9.55180363953215e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,39966,0.0328410651161452,0.00536500404761707,0.0223256571828158,0.0433564730494747,9.58457227303299e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42310,0.0175463249139251,0.002868288487139,0.0119244794791327,0.0231681703487175,9.77322016416446e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,42166,0.03190726774644,0.00523548531935962,0.0216457165204951,0.0421688189723848,1.12807343141444e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0442559600837887,0.00726931548115435,-0.0585038184268512,-0.0300081017407261,1.17381916694542e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0380119344282117,0.00625099925593852,-0.0502638929698511,-0.0257599758865722,1.22713566200353e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42310,0.0198305895786355,0.00326254077674289,0.0134360096562194,0.0262251695010516,1.24711424074145e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,39930,-0.0676839058320846,0.0111594679393133,-0.0895564629931387,-0.0458113486710305,1.3603088970568e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0185242224801635,0.0030544251032137,0.0125375492778647,0.0245108956824624,1.36475956385885e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0432554415882584,0.00713605730830255,-0.0572421139125314,-0.0292687692639854,1.39231807752104e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0585867219883819,0.00966820141005928,-0.0775363967520981,-0.0396370472246657,1.40670115207941e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.019804846012378,0.00327979855291508,0.0133764408486645,0.0262332511760916,1.60494930478861e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0647742575629472,0.010753557783813,-0.0858512308192207,-0.0436972843066737,1.75962903492019e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0441631917364844,0.00734490022843863,-0.0585591961842241,-0.0297671872887447,1.87181669527602e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0224381663203121,0.0037330166620005,-0.029754878977833,-0.0151214536627911,1.89431415483287e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0361856001815421,0.00602156327450747,-0.0479878641995768,-0.0243833361635075,1.92198013372862e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,39979,-0.0153281510646332,0.00255148580578791,-0.0203290632439775,-0.0103272388852889,1.94120327711848e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0631496446723885,0.0105188848363139,-0.0837666589515637,-0.0425326303932132,1.98215787159902e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0150222334755115,0.00250229335121531,-0.0199267284438935,-0.0101177385071295,1.99144313390115e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0278137870192888,0.00463451082590649,-0.0368974282380656,-0.0187301458005121,2.00672900631069e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0757030362144206,0.01261658850931,-0.100431549692668,-0.050974522736173,2.02075292700182e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0464184473309021,0.00774348892951957,-0.0615956856327604,-0.0312412090290437,2.09374905917061e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0283054827013872,0.00472354615987491,-0.037563633174742,-0.0190473322280324,2.13231355490694e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0671409793856434,0.0112137073302641,-0.089119845752961,-0.0451621130183258,2.19809037300769e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0432551266018196,0.00722858156581166,-0.0574231464708105,-0.0290871067328288,2.23479564342737e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0386287883607249,0.00645601449418941,0.0259749999521136,0.0512825767693361,2.24020941242634e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0561848116673079,0.00939675058262241,-0.0746024428092478,-0.037767180525368,2.31151184841597e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,41846,-0.0360719828186952,0.0060370843654275,-0.0479046681749331,-0.0242392974624573,2.35899190899475e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,39870,-0.0209606520310919,0.00351039443819928,-0.0278410251299625,-0.0140802789322213,2.42875176847101e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0453125326445845,0.00759088265944485,0.0304344026320726,0.0601906626570964,2.44175901436374e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0258542258913302,0.004337234069778,-0.0343552046680951,-0.0173532471145653,2.58156950554969e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0236342082368193,0.00396566794926458,-0.0314069174173779,-0.0158614990562607,2.59088970676241e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0287981210404516,0.00483513339735169,-0.0382749824992609,-0.0193212595816423,2.64905588849883e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0195044421298007,0.00327910727055375,-0.0259314923800861,-0.0130773918795154,2.79292073250867e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0255807764231305,0.00430217010860366,-0.0340130298359937,-0.0171485230102674,2.81522360492197e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0448427073619458,0.00754383737996967,-0.0596286286266863,-0.0300567860972052,2.84560743079332e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0533388999635278,0.0089814656137484,-0.0709425725664746,-0.0357352273605809,2.9573683315934e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0517219852438248,0.00872928582403503,-0.0688313854589335,-0.0346125850287161,3.21390428008687e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0370971774587008,0.00626175708390067,-0.0493702213431461,-0.0248241335742555,3.2254376451652e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0341514429304684,0.00576976448676796,-0.0454601813245336,-0.0228427045364032,3.33191044628285e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0534993692453396,0.00906791151934671,-0.0712724758232592,-0.0357262626674201,3.72705404942734e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0377797984797536,0.00640466003028553,0.025226664820394,0.0503329321391132,3.74817948079111e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0565847173526957,0.00961460196752702,-0.0754293372090487,-0.0377400974963428,4.0678848629395e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0140034478651702,0.00237945896442282,-0.018667187435439,-0.00933970829490152,4.07095304430625e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0542025699542217,0.0092093594550258,-0.0722529144860723,-0.0361522254223712,4.07852406039884e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0299015028285223,0.00508193363923909,-0.0398620927614309,-0.0199409128956137,4.10144148981691e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42016,0.0210970541422156,0.00358726688921191,0.0140660110393603,0.0281280972450709,4.17265392251772e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0197200438674923,0.00335299590625223,-0.0262919158437467,-0.013148171891238,4.18506775119353e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0344612390545696,0.00586815723649314,-0.0459628272380961,-0.0229596508710431,4.41075001740189e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0337717179795456,0.00576502312947948,-0.0450711633133253,-0.0224722726457658,4.79149648550118e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0299014481644857,0.00511386964828753,-0.0399246326751293,-0.0198782636538422,5.11673253327758e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0468880524465919,0.00802389465964384,-0.0626148859794939,-0.03116121891369,5.25282321724436e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0559214291286089,0.00957224402359829,-0.0746830274148615,-0.0371598308423562,5.30194415382842e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0429918094023761,0.00737552188950756,-0.057447832305811,-0.0285357864989413,5.70373434807273e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.013609201796849,0.00233463440045336,0.00903331837196044,0.0181850852217376,5.72310762223083e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0271900299557115,0.00466541749957925,-0.0363342482548868,-0.0180458116565362,5.76667340912703e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0167968766774426,0.00288515754550441,-0.0224517854666313,-0.011141967888254,5.95309567244119e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0153685866933093,0.00263983340862978,0.0101945132123949,0.0205426601742237,5.97893956140013e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0332361333777557,0.00571665684172342,-0.0444407807875336,-0.0220314859679778,6.24060083595375e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0261722966179712,0.00450560175851088,-0.0350032760646525,-0.0173413171712898,6.43110939655312e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0619875321660691,0.010677342527579,-0.0829151235201241,-0.0410599408120142,6.58884922176246e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0323952955872667,0.00558490984183004,-0.0433417188772536,-0.0214488722972798,6.76260469146896e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0211714785104336,0.00365361819976129,-0.0283325701819658,-0.0140103868389015,7.03286587290324e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0395088109019098,0.00682931870362418,0.0261233462428065,0.0528942755610132,7.44166379894382e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0203826055528327,0.00352471226275817,-0.0272910415878387,-0.0134741695178266,7.51102058270424e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42144,-0.0202625723642941,0.00350545828817615,-0.0271332706091193,-0.0133918741194688,7.62137730522885e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0379547686122601,0.00656938949415337,-0.0508307720208007,-0.0250787652037195,7.74585982518343e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0355653094736878,0.00615812890883824,-0.0476352421350108,-0.0234953768123649,7.84795215490501e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42119,-0.0535920082942897,0.00928971350138896,-0.0717998467570121,-0.0353841698315674,8.15078407632667e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0347877462559229,0.00603039567408052,-0.0466073217771207,-0.022968170734725,8.16014916258292e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42286,0.0272495605985607,0.00472462008095245,0.0179893052398939,0.0365098159572275,8.216229473184e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0546128169048163,0.00947160152148496,-0.0731771558869269,-0.0360484779227058,8.33213469385575e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0444987030157174,0.00772355289119816,-0.0596368666824658,-0.029360539348969,8.52134944199074e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.015663948831683,0.00272451390853993,-0.0210039960924213,-0.0103239015709448,9.15424853338605e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0614845546778121,0.0106975059109534,-0.0824516662632808,-0.0405174430923433,9.29502951722573e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0230444064576757,0.00401535032793063,-0.0309144931004197,-0.0151743198149316,9.76376441399576e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0231649505208025,0.00403898122296946,-0.0310813537178227,-0.0152485473237824,9.98657940162919e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0432275958481023,0.00754165358235118,-0.0580092368695106,-0.028445954826694,1.01491962383777e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0372856821083404,0.00651828248872906,-0.0500615157862493,-0.0245098484304314,1.09138881465765e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0608116700322056,0.0106353237496541,-0.0816569045815277,-0.0399664354828835,1.10570896960375e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,41647,-0.0377353877764331,0.00661379568474214,-0.0506984273185277,-0.0247723482343385,1.1848382883686e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,39990,-0.0462044387009462,0.00810086132500172,-0.0620821268979496,-0.0303267505039429,1.20191900203022e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,39934,-0.0473231730908448,0.00831272666750852,-0.0636161173591615,-0.0310302288225281,1.28033103170248e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0476909484628573,0.00837934570497499,0.0312674308811063,0.0641144660446082,1.28561793794884e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0338609240628933,0.00595905279212345,-0.0455406675354553,-0.0221811805903314,1.36189534449231e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0420265113108663,0.00740186214901547,-0.0565341611229366,-0.027518861498796,1.3982142014096e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0207300509511137,0.00365288391200279,-0.0278897034186392,-0.0135703984835882,1.41591152013517e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0396564312003781,0.00699192806148853,-0.0533606102008957,-0.0259522521998606,1.44900475968351e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0418674045073855,0.00740258863805546,0.0273583307767967,0.0563764782379742,1.58296027004326e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0186694798383012,0.00330382292011411,-0.0251449727617248,-0.0121939869148775,1.63556481048541e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.0235632241581749,0.00417155486851111,-0.0317394717004567,-0.0153869766158931,1.65708590451057e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0223582032399703,0.00395927074203449,-0.0301183738943579,-0.0145980325855827,1.67152259464955e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.0266612953845744,0.00472168940983762,-0.0359158066278561,-0.0174067841412927,1.67728365269612e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0133928870427252,0.00238012751649201,-0.0180579369750495,-0.00872783711040084,1.87015219802245e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0657891388436255,0.0116925206906531,-0.0887064793973056,-0.0428717982899453,1.87525155858114e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0728099802783777,0.0129421004161711,-0.098176497094073,-0.0474434634626823,1.89080052480108e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0319922556039156,0.00569380763180114,0.0208323926455854,0.0431521185622459,1.96102938905061e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.0286773858014927,0.00510904230137329,-0.0386911087121844,-0.018663662890801,2.03446798838884e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0342174382060517,0.00609797518099364,-0.0461694695607992,-0.0222654068513042,2.04865146054458e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0311765413773369,0.00556896744374744,-0.0420917175670818,-0.0202613651875919,2.2079536836789e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42070,0.0273093480553526,0.00488072736773302,0.0177431224145959,0.0368755736961093,2.24477947649214e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,39445,-0.0278299319191485,0.00497586305958427,-0.0375826235159337,-0.0180772403223634,2.28604272970061e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0395697823752269,0.00708882683912098,-0.053463882979904,-0.0256756817705498,2.42345101701393e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0280592658276775,0.00502691840604538,-0.0379120259035265,-0.0182065057518285,2.42695132223431e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0437599821199966,0.00784131020611009,-0.0591289501239724,-0.0283910141160209,2.45046536413764e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0521752869314233,0.00935005309514222,-0.0705013909979021,-0.0338491828649446,2.4574047734432e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0310307800499096,0.00557037351610099,-0.0419487121414676,-0.0201128479583517,2.59688290005656e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0547093599882992,0.00982359497104014,-0.0739636061315379,-0.0354551138450606,2.60779122729218e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0394053098777552,0.00707727310346437,-0.0532767651605454,-0.025533854594965,2.62868274749623e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0219097183253878,0.00393480521639778,-0.0296219365495274,-0.0141975001012481,2.63271850606092e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0169389567722468,0.00304914919188819,-0.0229152891883477,-0.010962624356146,2.82310633396981e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0228761233136368,0.00411997671830084,-0.0309512776815065,-0.0148009689457672,2.87053233623678e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42087,-0.0394967493988738,0.00711549106976,-0.0534431118956034,-0.0255503869021442,2.89713060789228e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0441429468108941,0.0079622859048865,-0.0597490271844716,-0.0285368664373166,3.02354953600502e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0270627568126082,0.0048846055782963,-0.036636583746069,-0.0174889298791475,3.07414325142443e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0397632689130104,0.00717798507734567,-0.053832119664608,-0.0256944181614129,3.0990281164858e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0363813267243341,0.00657463824007767,-0.0492676176748863,-0.0234950357737819,3.20950333602706e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42113,-0.0174918302396774,0.00316234168648735,-0.0236900199451926,-0.0112936405341622,3.23789293246562e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0529972797899205,0.00958662167409159,-0.07178705827114,-0.034207501308701,3.2941877745314e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42119,-0.040488355486771,0.0073438214247213,-0.0548822454792247,-0.0260944654943172,3.58716975233493e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,39979,0.0138401572548907,0.00251014778859502,0.00892026758924451,0.018760046920537,3.59070524672389e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0450649151227167,0.00817627835687537,-0.0610904207021924,-0.0290394095432409,3.63477662344873e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0130715021661345,0.0023725830710523,0.00842123934687194,0.017721764985397,3.67906761836151e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0352781845163467,0.00640502013539416,-0.0478320239817192,-0.0227243450509741,3.69884129380795e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0176469392429027,0.0032074667517651,-0.0239335740763623,-0.0113603044094431,3.84015520039256e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0248128658482915,0.00451281794424672,-0.033657989019015,-0.0159677426775679,3.90349351337317e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.022735455826868,0.00413514020360591,0.0146305810278004,0.0308403306259356,3.90937252831128e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0522036281509591,0.0094962066332776,-0.0708161931521832,-0.033591063149735,3.93973244242913e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0353684769593677,0.00643485575098595,-0.0479807942313002,-0.0227561596874352,3.96183698015416e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,39886,-0.0169169005700931,0.00307867816243584,-0.0229511097684673,-0.0108826913717188,3.99512733352356e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,39638,-0.0174391523704056,0.0031738146128553,-0.023659829011602,-0.0112184757292092,4.00067984007256e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0362816422177641,0.00660383817454443,-0.0492251650398711,-0.023338119395657,4.00134952540392e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0737570321933561,0.0134285034950449,-0.100076899043644,-0.0474371653430682,4.04951188702531e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,41638,-0.013942438845543,0.00253967007329027,-0.0189201921891919,-0.00896468550189406,4.09770315542201e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0158539392896923,0.00288934360551968,-0.0215170527565108,-0.0101908258228737,4.17470736349563e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0202610663105392,0.00370338779079417,-0.0275197063804957,-0.0130024262405826,4.55570695780545e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0244382553745252,0.00446865514219269,-0.0331968194532229,-0.0156796912958275,4.61058498430276e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0358790492965416,0.00656397808792772,0.0230136522442033,0.0487444463488799,4.69864018368392e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0660078762470659,0.0121008204074381,0.0422902682484873,0.0897254842456445,4.98894338808959e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0140603429936575,0.00258063536925447,-0.0191183883173962,-0.00900229766991872,5.17136277583489e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0499472268590663,0.00917038274398957,-0.0679211770372859,-0.0319732766808468,5.22639347174086e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0308511284350756,0.0056708011892368,-0.0419658987659797,-0.0197363581041715,5.43121609648467e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0422679943421566,0.00777043450592698,-0.0574980459737735,-0.0270379427105397,5.43514281135107e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,41913,-0.0666377077027975,0.0122591736411172,-0.0906656880393871,-0.0426097273662078,5.55301642856603e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0265877320387573,0.00489108986940163,-0.0361742681827845,-0.0170011958947301,5.56344897099569e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,39575,-0.0343216947269964,0.0063259259859216,-0.0467205096594028,-0.0219228797945901,5.90004439135736e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0267365888664096,0.0049289044566643,-0.0363972416014717,-0.0170759361313476,5.91320732850302e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0280753300689628,0.00517884279957783,-0.0382258619561353,-0.0179247981817902,6.04279571915001e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0258171723867442,0.00476623030129935,-0.0351589837772909,-0.0164753609961975,6.17524178160852e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0361500799265882,0.00668979001556525,-0.0492620683570961,-0.0230380914960803,6.63495128590566e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0278063726897317,0.00515345664088349,-0.0379071477058633,-0.0177055976736001,6.94351787415108e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0399236125749078,0.00742652431414952,-0.0544796002306409,-0.0253676249191748,7.75039816212551e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.027291768992693,0.00508297099616093,-0.0372543921451685,-0.0173291458402176,8.06243292427376e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,39575,-0.0227530945861327,0.00423961754756197,-0.0310627449793542,-0.0144434441929112,8.17867735713486e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0396925609204899,0.00740098139554022,-0.0541984844557487,-0.025186637385231,8.34333912000424e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.029023445969082,0.00541415910885531,-0.0396351978224384,-0.0184116941157256,8.43115676371391e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0415529341080928,0.00775604381563442,-0.0567547799867362,-0.0263510882294493,8.57983562492779e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0693279513942201,0.0129623568386494,-0.0947341707979728,-0.0439217319904673,9.04584066152948e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.042881034752576,0.00802533988263318,-0.058610700922537,-0.027151368582615,9.31150344196218e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0353304505806626,0.00663598051356281,-0.0483369723872457,-0.0223239287740795,1.03125924015617e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0200469161358355,0.00376867293380493,-0.0274335150860931,-0.0126603171855778,1.06182747329143e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,39638,-0.0295665370859982,0.00555909499512473,-0.0404623632764427,-0.0186707108955538,1.06619231370511e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.026117216292517,0.00491772050379725,-0.0357559484799596,-0.0164784841050744,1.10847823528364e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0638127045152111,0.012026040477569,-0.0873837438512465,-0.0402416651791758,1.13724086764726e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0350253701663418,0.00661075812320565,-0.0479824560878249,-0.0220682842448588,1.19174332344879e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0233588827799841,0.00441065960373713,-0.0320037756033089,-0.0147139899566594,1.20220945028734e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42216,-0.0333229883814804,0.00629333686541837,-0.0456579286377004,-0.0209880481252604,1.20890919976839e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0433549657458339,0.00819298163947695,-0.0594132097592087,-0.0272967217324591,1.23103821461607e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0384201169158298,0.0072600579950504,-0.0526498305861286,-0.024190403245531,1.23331322688177e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0327426342156368,0.00619072215476831,-0.0448764496389827,-0.0206088187922909,1.25349150469229e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,41960,0.0388835683427921,0.00735984932424255,0.0244582636672766,0.0533088730183075,1.28939778230563e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0540632782987058,0.0102359805590107,-0.0741258001943668,-0.0340007564030448,1.30370986017893e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0284178309368364,0.00538117062922963,-0.0389649253701265,-0.0178707365035463,1.30473106027687e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42185,-0.0205847058870998,0.00390276734611687,-0.0282341298854889,-0.0129352818887107,1.35244779752044e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,41654,0.0178495038792531,0.00338600100407715,0.0112129419112618,0.0244860658472443,1.37426397299798e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.03215318562394,0.00610791388087794,-0.0441246968304608,-0.0201816744174193,1.4297632163081e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0407461234635246,0.00774476143764016,-0.0559258558812993,-0.0255663910457499,1.45833294512005e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0277630452601691,0.00527995109007275,-0.0381117493967117,-0.0174143411236265,1.48131066717002e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,41839,-0.0166128759184779,0.00316602163702182,-0.0228182783270406,-0.0104074735099151,1.56778098497655e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0198148348590886,0.0037779457852467,-0.0272196085981721,-0.0124100611200051,1.58791484531927e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0446480635066273,0.00851362875892685,-0.0613347758741239,-0.0279613511391306,1.59774762135117e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.031573513956189,0.00602351246017071,-0.0433795983781236,-0.0197674295342544,1.62052558790113e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0277965243866822,0.00530730559441882,0.0173942054216213,0.0381988433517431,1.65824235289723e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0227674585907718,0.00435004023048727,-0.0312935374425269,-0.0142413797390168,1.68988328982499e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0273789038169984,0.0052362322721988,-0.0376419190705081,-0.0171158885634888,1.73212616887701e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,41984,-0.0197270824211832,0.00377487715830168,-0.0271258416514545,-0.0123283231909119,1.75926825102268e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0469940932828975,0.00899379171021818,-0.0646219250349252,-0.0293662615308699,1.76570345191679e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0235943486590019,0.00452568746893283,-0.0324646960981102,-0.0147240012198935,1.88749199487464e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0414135977673727,0.0079458979486706,-0.0569875577467671,-0.0258396377879783,1.90243595701098e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0227769063884947,0.00437492160021662,-0.0313517527249193,-0.0142020600520701,1.95497498383606e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.045299896890452,0.00871894189833992,-0.0623890230111982,-0.0282107707697058,2.07105218984876e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0297211320341666,0.0057229059520942,-0.0409380277002713,-0.018504236368062,2.10110653636437e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42083,-0.0196278518535102,0.00378147024930582,-0.0270395335421496,-0.0122161701648708,2.12737878968497e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.024192852923362,0.00466993799779028,-0.033345931399031,-0.0150397744476931,2.25031980515707e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0133306121329482,0.00257497822746058,-0.018377569458771,-0.00828365480712552,2.28734305102797e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0313981066335498,0.00606495921366424,-0.0432854266923317,-0.0195107865747679,2.29509443500137e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42070,-0.0251864935920289,0.00486723378724356,-0.0347262718150263,-0.0156467153690315,2.31553333150754e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0292650755024644,0.00565823867923236,-0.0403552233137599,-0.018174927691169,2.35411084134751e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0142990494168943,0.00276473109621363,-0.019717922365473,-0.00888017646831559,2.3572400599157e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0602728232100946,0.0116657788627954,-0.0831377497811736,-0.0374078966390156,2.42401993721304e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0417382244430998,0.00808128148485266,-0.057577536153411,-0.0258989127327886,2.44126108299716e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.035207314292738,0.00681761485016725,-0.0485698393990658,-0.0218447891864102,2.45013494504385e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42310,-0.0486927235926264,0.00945643807774004,-0.0672273422249969,-0.0301581049602559,2.65277759588469e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.0229997807154425,0.00446660278822675,-0.0317543221803669,-0.014245239250518,2.65987565162946e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0204425624390479,0.00397217388956004,-0.0282280232625856,-0.0126571016155102,2.69273933698019e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0387396095268896,0.00752763101810459,0.0239854527314046,0.0534937663223746,2.69469714186024e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,39929,-0.0211618772463534,0.00411433333616448,-0.0292259705852358,-0.013097783907471,2.74241807507657e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,39636,-0.0248453369400395,0.00483391348758052,-0.0343198073756973,-0.0153708665043817,2.79739555956565e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42113,-0.0132466853211206,0.00258018776358447,-0.0183038533377462,-0.00818951730449508,2.87587832178395e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,39713,0.0160659508139126,0.00312976322902349,0.00993161488502655,0.0222002867427986,2.89549041431635e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42137,-0.040202245797293,0.0078343741036767,-0.0555576190404993,-0.0248468725540867,2.91390215398768e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0411342290645206,0.00803017437952408,-0.0568733708483878,-0.0253950872806534,3.06614747517305e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0244419741460511,0.0047727023745079,-0.0337964708000866,-0.0150874774920156,3.0874327669064e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.052174935224747,0.0102047769390871,-0.0721762980253578,-0.0321735724241362,3.21779639244497e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0128071328229717,0.00250508152794892,-0.0177170926177516,-0.00789717302819183,3.22275777200017e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,41756,-0.0403896379176024,0.00790416034243746,-0.0558817921887799,-0.024897483646425,3.26809229535849e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,41966,-0.0308198473492618,0.00604135199148579,-0.042660897252574,-0.0189787974459497,3.41622519235749e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0212630558224677,0.00416847723059967,-0.0294332711944431,-0.0130928404504923,3.43657424571785e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0196720193217712,0.00386351291327838,-0.0272445046317968,-0.0120995340117456,3.6058319250909e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.0175452480157131,0.00344807343950976,-0.0243034719571522,-0.010787024074274,3.66996586232223e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0328555531434867,0.00645889426728438,-0.0455149859073641,-0.0201961203796093,3.68847498105641e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.039855965440583,0.00786617101633085,-0.0552736606325915,-0.0244382702485746,4.10115894834942e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0260003836644999,0.00514281902035688,-0.0360803089443994,-0.0159204583846004,4.34617371029164e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0239026374342723,0.00472830995229709,-0.0331701249407746,-0.01463514992777,4.35539185489813e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0224691309588945,0.00445314875254851,-0.0311973025138896,-0.0137409594038994,4.57919819566778e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.0139373107538593,0.00276412376210772,-0.0193549933275905,-0.0085196281801282,4.66184406831726e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0278569236997129,0.00552779715928258,-0.0386914061319068,-0.0170224412675191,4.73062647256416e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0147027051275832,0.00292073962772792,-0.0204273547979299,-0.00897805545723648,4.87950894844589e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0338693537428025,0.00674128273403301,-0.0470822679015072,-0.0206564395840978,5.13520867157728e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0444329869410173,0.00888897347095699,-0.061855374944093,-0.0270105989379416,5.84517237988376e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0332650948948381,0.006697962720389,-0.0463931018268005,-0.0201370879628756,6.90207420788761e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.0233557459035312,0.00470220161861715,-0.0325720610760208,-0.0141394307310416,6.90216239115997e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42262,-0.0150042755754594,0.00302255206710801,-0.0209284776269911,-0.00908007352392773,6.98496661797814e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,41843,-0.0304566991794563,0.00614345782991892,-0.0424978765260974,-0.0184155218328153,7.22592291446424e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0237618053430594,0.0047968741272041,-0.0331636786323794,-0.0143599320537393,7.3747238729672e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0262320300155252,0.00529621192459802,-0.0366126053877374,-0.0158514546433131,7.41401026080923e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,39657,-0.0172708022460775,0.00348816026429916,-0.0241075963641038,-0.0104340081280511,7.48217974400042e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0379473090798661,0.00766968476352038,-0.0529798912163661,-0.0229147269433662,7.61908787028259e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0351700811975565,0.00711581602353803,-0.049117080603691,-0.021223081791422,7.82213809235526e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42310,-0.0134820327160376,0.00272817037279901,-0.0188292466467237,-0.00813481878535155,7.83244013295877e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0394777545789392,0.00801165649287165,-0.0551806013049677,-0.0237749078529108,8.42666893500864e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0569439488378515,0.0115614585962701,-0.0796044076865408,-0.0342834899891621,8.54091192366328e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0348165210518589,0.00707385264764343,0.0209517698624778,0.04868127224124,8.67324224015611e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.02470529293528,0.00503365872661444,0.0148393218311157,0.0345712640394443,9.33239057681775e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.0101417617412154,0.00206749744596088,0.00608946674713205,0.0141940567352987,9.43458434093513e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.021924874605548,0.00447257500797818,-0.0306911216211852,-0.0131586275899108,9.59562561747613e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0549348917830675,0.0112104973123802,-0.0769074665153327,-0.0329623170508023,9.67995729386779e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0144404471856224,0.00294685045163381,0.00866462030042016,0.0202162740708247,9.70205321190328e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0587919442694087,0.0120024513601247,-0.0823167489352531,-0.0352671396035644,9.77978982445303e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0451354579912103,0.0092324915848069,-0.0632311414974319,-0.0270397744849888,1.02865071308871e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,41913,-0.0371911446648497,0.00761162742183652,-0.0521099344116493,-0.0222723549180501,1.04052072088794e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42224,-0.0365053564901049,0.00747243105919416,-0.0511513213661254,-0.0218593916140844,1.04424739596422e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0378409631959259,0.0077499153663133,-0.0530307973138999,-0.0226511290779518,1.06041600440117e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.0227353188980316,0.00466724528260785,-0.031883119651943,-0.0135875181441202,1.12395946620249e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42016,-0.0171487620353417,0.00352521178065214,-0.0240581771254199,-0.0102393469452635,1.15987932599764e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0664132056905454,0.0136525139464485,-0.0931721330255845,-0.0396542783555062,1.16293744761803e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0594089835370012,0.0122198089768107,-0.0833598091315502,-0.0354581579424521,1.17685199902426e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.037796745245156,0.00777655234047542,-0.0530387878324879,-0.0225547026578242,1.18747539000291e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0211004548678589,0.00434440076426861,0.0125854293698924,0.0296154803658254,1.20574974052253e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0382246772954363,0.00787387426348756,-0.0536574708518719,-0.0227918837390007,1.21965250366379e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0409320073318575,0.00843498897264422,-0.0574645857182402,-0.0243994289454748,1.23448796361982e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0161964913220571,0.00334028156504216,-0.0227434431895397,-0.00964953945457443,1.25547918893372e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0174999238104463,0.00361453972687426,-0.0245844216751198,-0.0104154259457727,1.30541611660698e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0133651778849479,0.00276092852939491,-0.0187765978025619,-0.00795375796733388,1.30726671268891e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0429805569136173,0.00887909998678637,-0.0603835928877186,-0.0255775209395161,1.30855296705736e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.016898780129577,0.0034968348871631,-0.0237525765084167,-0.0100449837507373,1.36529343560715e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0319425191363282,0.00661883615238105,-0.0449154379949951,-0.0189696002776614,1.40819861602428e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0244528821143695,0.00506910632505205,-0.0343883305114715,-0.0145174337172675,1.42608241864207e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0200619145716053,0.00415929499024232,-0.0282141327524802,-0.0119096963907303,1.42675255163841e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.030488425981067,0.00633825224973343,-0.0429114003905445,-0.0180654515715894,1.52398826262446e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0390848864279911,0.00812690731230178,-0.0550136247601026,-0.0231561480958796,1.53116809961691e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.0140537448359287,0.00292352402554777,0.00832363774585513,0.0197838519260024,1.54764182839718e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0357754185789496,0.00745558036787007,-0.0503883560999749,-0.0211624810579242,1.61918532563948e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,39990,-0.0479265515812619,0.0099913812113239,-0.0675096587554568,-0.0283434444070671,1.63272885868276e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0354509134113842,0.00739583212752783,-0.0499467443813388,-0.0209550824414297,1.65745418417655e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0186350141486367,0.0039121376280606,-0.0263028038996354,-0.0109672243976379,1.92796699785678e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0222756872410711,0.00468127827272248,-0.0314509926556072,-0.013100381826535,1.97133742180331e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0475771009170633,0.0100024855774067,-0.0671819726487804,-0.0279722291853462,1.98986051404948e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0233184002828168,0.00490247591719914,0.0137095474851065,0.0329272530805271,1.99104774552342e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0320673642379618,0.00674657899357067,-0.0452906590653604,-0.0188440694105633,2.02755921122339e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0609090353699348,0.0128363564591923,-0.0860682940299516,-0.035749776709918,2.10590450618509e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42249,0.0153491534562685,0.00323479427948551,0.00900895666847688,0.0216893502440601,2.10602335551831e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0329810381486139,0.00695242079570567,-0.046607782908197,-0.0193542933890308,2.12348581242502e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42148,-0.0480899589632231,0.0101503929311899,-0.0679847291083552,-0.028195188818091,2.18305040094029e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0308768885713202,0.00651964814131969,-0.0436553989283067,-0.0180983782143336,2.20200055021221e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),39775,0.0930826967096304,0.0196635108880743,0.0545422153690047,0.131623178050256,2.23084654063561e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00885705162727065,0.00187229795625838,0.00518734763300421,0.0125267556215371,2.2614916336656e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,39990,-0.0111253325172279,0.00235416405811939,-0.0157394940711419,-0.00651117096331391,2.31942666698461e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0362411351529194,0.00767089553407617,-0.0512760903997087,-0.0212061799061301,2.33449435171076e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0294140239748904,0.00622650051967346,-0.0416179649934504,-0.0172100829563304,2.33588360566458e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.0101238794444734,0.00214376506826707,-0.0143256589782768,-0.00592209991066989,2.35340096863925e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0208334867190789,0.00441217772072987,-0.0294813550517095,-0.0121856183864484,2.36537655330811e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0311295852541025,0.0066141346213985,-0.0440932891120435,-0.0181658813961614,2.54950641601963e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.0162831907801873,0.00346237733837309,-0.0230694503633986,-0.00949693119697607,2.59018719861505e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0140095202710086,0.00300110113789508,0.00812736204073429,0.019891678501283,3.06917011505683e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0291450366396846,0.00624532304517015,-0.0413858698082181,-0.0169042034711511,3.09078007355927e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0124588684365771,0.00267110614908781,-0.0176942364887892,-0.00722350038436498,3.13289654617089e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0268811055903949,0.00576610905784188,-0.038182679343765,-0.0155795318370248,3.1685822547677e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.014749521480193,0.00316525574271829,-0.0209534227359209,-0.00854562022446518,3.20091726471502e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0286476869972627,0.0061510273437848,0.0165916734034445,0.0407037005910809,3.23337538727e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0293830684503571,0.00630924136675669,-0.0417491815292002,-0.017016955371514,3.23697106416899e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,41814,-0.0182577465787659,0.00393400842505279,-0.0259684030918694,-0.0105470900656625,3.50054812866114e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0172029938867604,0.00370857174560915,-0.0244717945081543,-0.00993419326536642,3.53912340528172e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0483355476496454,0.0104222284022958,-0.0687631153181452,-0.0279079799811456,3.56187097799912e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0156103965493966,0.00336637779871159,0.00901229606392187,0.0222084970348713,3.57326263819792e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,39638,-0.014914051778669,0.00321951274953485,-0.0212242967677573,-0.00860380678958067,3.65594888099513e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0128330183877416,0.00277667768079235,0.00739073013338858,0.0182753066420946,3.84777534344223e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0379107585439771,0.00821591241722711,-0.0540139468817422,-0.021807570206212,3.98879931819464e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0504877763169326,0.0109663652548164,-0.0719818522163728,-0.0289937004174925,4.1851150180363e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.0313963986555258,0.00682046117400726,-0.04476450255658,-0.0180282947544716,4.20584895394223e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0135443043073137,0.00294654663558705,-0.0193195357130643,-0.00776907290156308,4.33935618981969e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0161410173916378,0.00351711261464058,-0.0230345581163334,-0.00924747666694231,4.48764762841869e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0422416169487861,0.00922173078278949,-0.0603162092830535,-0.0241670246145187,4.68577454255189e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.0383883030704181,0.00838406312307188,-0.054821066791639,-0.0219555393491972,4.71996310720509e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0130442463671997,0.00285145617441658,0.00745539226534324,0.0186331004690562,4.82188391439733e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0265541937261986,0.0058065599805709,-0.0379350512881176,-0.0151733361642797,4.84740686438253e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0148112013770849,0.00324128533936948,-0.0211641206422491,-0.0084582821119207,4.93142632896134e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.019827483500005,0.00434167219635203,-0.028337161004855,-0.011317805995155,5.00483781645156e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0310089250702137,0.00679273131206732,-0.0443226784418657,-0.0176951716985618,5.04855329066331e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.042972373246592,0.00945520560794066,-0.0615045762381557,-0.0244401702550283,5.55566662892651e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0390559023345771,0.00859886591017092,-0.0559096795185121,-0.0222021251506421,5.62195824055247e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0234164835130423,0.00515911855638128,-0.0335283558835497,-0.013304611142535,5.71434517656612e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0259164523145338,0.00571270439886871,0.0147195516927511,0.0371133529363164,5.76459534837552e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42119,0.0215122919273322,0.00475259579065764,0.0121972041776432,0.0308273796770212,6.05004833838085e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0259890093090174,0.00574516174547647,-0.0372495263301513,-0.0147284922878835,6.13062738397326e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0159161469430009,0.00351861013224433,0.00901967108380204,0.0228126228021998,6.13629809064457e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0191360699131463,0.00423635329675913,-0.0274393223747942,-0.0108328174514984,6.33231980985265e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.0239412448810652,0.00530323176184584,0.0135469106278473,0.034335579134283,6.40181325989659e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0343400916041612,0.00760661102216644,-0.0492490492076074,-0.0194311340007149,6.41255155504472e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0590762870526935,0.0130954149081381,-0.0847433002726442,-0.0334092738327429,6.49984244328916e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.0111030250723144,0.00246109267354523,-0.0159267667124631,-0.0062792834321658,6.50427352118627e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0143792203541152,0.0031927078081928,0.00812151305005733,0.0206369276581731,6.7314942598105e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00395901858282116,0.00087960377041212,0.0022349951928134,0.00568304197282891,6.83456002948628e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42144,-0.014332035753159,0.00318635008023566,-0.0205772819104209,-0.00808678959589705,6.91831327078936e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0178814906387993,0.00397595105106453,-0.0256743546988858,-0.0100886265787128,6.93557128166682e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0170992432166056,0.00380594807068198,-0.0245589014351423,-0.0096395849980689,7.08881903589705e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.031734273322545,0.007069022275663,-0.0455895569828444,-0.0178789896622455,7.22140658103875e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,38503,-0.0518298257525949,0.0115467087071783,-0.0744613748186644,-0.0291982766865254,7.24652376920217e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.0406616295254841,0.00906244421234847,-0.0584240201816871,-0.0228992388692811,7.30013179267579e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0181214404488654,0.00403945864802518,-0.0260387793989947,-0.0102041014987361,7.32489148310808e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0217409111287739,0.00485032170185138,-0.0312475416644026,-0.0122342805931452,7.45456516038678e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0191750937655206,0.00427789651092147,-0.0275597709269267,-0.0107904166041145,7.4556128326216e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,39759,-0.0118343200045034,0.00264108866069432,-0.0170108537794643,-0.00665778622954251,7.5086581845078e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0176469577425463,0.00394015415586165,-0.0253696598880351,-0.00992425559705745,7.58416104983823e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0256989113866865,0.00573867509121367,-0.0369467145654653,-0.0144511082079077,7.59059977588986e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.016264553706403,0.00363270832038152,-0.0233846620143508,-0.0091444453984552,7.62416423532194e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.0258077845740412,0.00576454793040134,-0.0371062985176278,-0.0145092706304546,7.64644264324638e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42137,0.0113048622747034,0.00252633230515392,0.00635325095660172,0.0162564735928051,7.71023573269105e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0319707262995212,0.00714426333297848,-0.045973482432159,-0.0179679701668834,7.71472396128741e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,41910,-0.0353455601770097,0.00790334726618902,-0.0508361208187401,-0.0198549995352792,7.80500984561401e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0191038527720153,0.00427195026852027,-0.027476875298315,-0.0107308302457156,7.81528715367373e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0167435032404127,0.00374474024502225,0.0094038123601691,0.0240831941206563,7.85605713968715e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0277708283211349,0.00621622606379574,-0.0399546314061745,-0.0155870252360952,7.98044454390483e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0208770011061031,0.00467992269792358,-0.0300496495940333,-0.0117043526181729,8.22612674718418e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,39930,-0.0210795305086754,0.00472586714929722,-0.0303422301212979,-0.0118168308960528,8.2572534661389e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,39657,-0.0201537149774411,0.00452175406389488,-0.029016352942675,-0.0112910770122071,8.39103345708785e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,39742,-0.0104918252201636,0.0023577373534942,-0.0151129904330123,-0.00587066000731502,8.67219573185137e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0179525141745289,0.00403436036188107,-0.0258598604838158,-0.010045167865242,8.67285699107758e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0614940175686859,0.0138237653810506,-0.088588597715545,-0.0343994374218267,8.73255287736643e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.0143715559951265,0.003234131370433,-0.0207104534811752,-0.00803265850907781,8.91153612332222e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0480923891948085,0.0108269927439201,-0.069313294972892,-0.0268714834167251,9.00140685081621e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,39897,-0.0443354205113552,0.00999819269833894,-0.0639318782000995,-0.0247389628226109,9.32255477506683e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42145,-0.0193065886015432,0.00435674464450893,-0.0278458081047807,-0.0107673690983057,9.43473436652958e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,39794,-0.0156302156271578,0.00353316512178307,-0.0225552192658527,-0.00870521198846301,9.78702294173147e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0216481482237663,0.00489561061743279,-0.0312435450339345,-0.012052751413598,9.85933267001421e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0226747915690091,0.00513906702273002,-0.03274736293356,-0.0126022202044583,1.03249273290839e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42119,-0.0151110826976337,0.00342612065253434,-0.021826279176601,-0.00839588621866638,1.03904218698253e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0576539837591802,0.0130733645736217,-0.0832777783234788,-0.0320301891948816,1.04152577967469e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0456555236796054,0.010357680476848,-0.0659565774142276,-0.0253544699449832,1.0535966560993e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0527053105955841,0.0119573967092269,0.0292688130454994,0.0761418081456688,1.05465947870214e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0214069570299779,0.00485806652781926,-0.0309287674245037,-0.0118851466354522,1.0603232697683e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,41900,-0.0543335772643299,0.0123442368741466,-0.0785282815376572,-0.0301388729910026,1.08325926835076e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.0101269772943321,0.00230623525597715,-0.0146471983960473,-0.00560675619261688,1.13623257313984e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.0100602543860032,0.00229782722988224,0.005556513015434,0.0145639957565724,1.20777774683903e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.0118550745779728,0.00271023466416029,0.00654301463621861,0.0171671345197269,1.22790131640996e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0432105167195247,0.00988073381122368,-0.0625767549895231,-0.0238442784495263,1.23370161685092e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0139396375292538,0.00319116568637983,-0.0201943222745583,-0.00768495278394936,1.26418278980837e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0250121689265859,0.00574292211437001,-0.0362682962707511,-0.0137560415824207,1.33881483747984e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.00941721405444119,0.00216542027959975,-0.0136614378024567,-0.00517299030642569,1.38013657233896e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0235757841291791,0.0054318831629787,0.0129292931297408,0.0342222751286173,1.43548822338516e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,39736,-0.018459513671593,0.00425387664521829,-0.0267971118962209,-0.0101219154469652,1.44095128454446e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0262712403302751,0.00605478515759772,-0.0381386192391666,-0.0144038614213835,1.44437994269132e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0214999899441607,0.00496393516507865,-0.0312293028677148,-0.0117706770206065,1.49333659596413e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0108679618631785,0.00251243400975419,-0.0157923325222967,-0.00594359120406032,1.5340528790526e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42119,-0.0231200457515024,0.00534586186997072,-0.033597935016645,-0.0126421564863598,1.53730377623044e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0384514940991316,0.00889819993739906,-0.0558919659764338,-0.0210110222218294,1.56244550351744e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0145810692107994,0.00337519338842062,-0.0211964482521038,-0.00796569016949496,1.57110809161166e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,39736,0.0452195934754176,0.0104862389003004,0.0246665652308288,0.0657726217200064,1.62971176109372e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.015155210654553,0.00351876312695861,-0.0220519863833919,-0.00825843492571417,1.66683628290919e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,39934,-0.0118600239778538,0.00275755669736138,-0.0172648351046822,-0.00645521285102553,1.71516741719233e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,39854,-0.0199937909041548,0.00465288788926529,-0.0291134511671148,-0.0108741306411948,1.74524231897551e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0335396997217833,0.00781090126176649,0.0182303332487209,0.0488490661948456,1.76975133930152e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0153115157123874,0.00356824737379188,-0.0223052805650195,-0.00831775085975534,1.79335516523662e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0145790843599979,0.00341127812697452,-0.021265189488868,-0.00789297923112786,1.93499697987312e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0140455362043832,0.00330137491114471,-0.0205162310302268,-0.00757484137853953,2.10967314217957e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.013628465750646,0.0032047763696933,-0.0199098274352448,-0.00734710406604709,2.13047404833617e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.0161648434551324,0.00380141531102079,-0.0236156174647332,-0.00871406944553165,2.13263640783239e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0227085676074974,0.00534030229746978,-0.0331755601105382,-0.0122415751044566,2.13326551683957e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0356892502553684,0.00840154390377136,-0.0521562763067602,-0.0192222242039765,2.17469356073598e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0137385743964808,0.00323432871291233,0.00739929011917269,0.020077858673789,2.1769679378747e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0220518803904532,0.0051957237755403,-0.0322354989905122,-0.0118682617903942,2.20832623244998e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0427247594044972,0.0100888097301197,-0.0624988264755318,-0.0229506923334626,2.30205987941448e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0324902082114249,0.00767721099521094,0.0174428746608115,0.0475375417620384,2.33412845099855e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.136204656475877,0.0321967057104377,-0.199310199668334,-0.0730991132834186,2.34821777772871e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0252712598165821,0.00598512576662723,-0.0370021063191714,-0.0135404133139927,2.43709107413687e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.0233208034119194,0.00553369632258957,0.0124747586196438,0.0341668482041949,2.52460211448976e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0290911733812537,0.00690334644884778,-0.0426217324209954,-0.0155606143415121,2.52806526582422e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0165302673362834,0.00392331055344354,-0.0242199560210328,-0.00884057865153408,2.53566771104021e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0198582566669057,0.00472997091382988,-0.0291289996580123,-0.0105875136757992,2.70874569876931e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.0115885249279992,0.0027626655728736,-0.0170033494508315,-0.00617370040516696,2.75326767097114e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0266750551425863,0.00637178912876642,-0.0391637618349685,-0.0141863484502042,2.85571190376461e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0396535212065687,0.00948334624989359,-0.0582408798563602,-0.0210661625567773,2.91555764894715e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0189576104038736,0.00453490790174997,0.0100691909164437,0.0278460298913035,2.93216668105811e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0180843573877605,0.00433305140262119,0.009591576638623,0.0265771381368981,3.02078003415993e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0149367603255627,0.00358514440291601,-0.0219636433552781,-0.00790987729584728,3.11517892939249e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0212641820883801,0.0051048173681011,-0.0312696241298583,-0.011258740046902,3.12992509785535e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0154164565534883,0.00370148539920923,-0.0226713679359384,-0.00816154517103821,3.13370703193939e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,41839,-0.0328910334403285,0.00789968155835761,-0.0483744092947094,-0.0174076575859476,3.1526626311043e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00544467043947562,0.00130838802271687,0.00288022991495056,0.00800911096400068,3.18333728590252e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0274935896617206,0.00661007634641441,-0.0404493393006929,-0.0145378400227484,3.21576540923411e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0551343677743772,0.0132826165782075,-0.0811682962676639,-0.0291004392810904,3.33701896073437e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,39649,-0.0215427830796647,0.00520239571422739,-0.0317394786795504,-0.011346087479779,3.48464039158268e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0533927079110989,0.0129096459040742,-0.0786956138830844,-0.0280898019391134,3.55738786483692e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,41839,-0.0306558186683605,0.00742021710573832,-0.0451994441956076,-0.0161121931411134,3.62790982430868e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,39657,-0.0227723255470515,0.0055158363734067,-0.0335833648389287,-0.0119612862551744,3.67762392841437e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0440203111981232,0.0106799445095313,-0.0649530024368045,-0.0230876199594419,3.78210014657844e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,41900,-0.0348666295903842,0.00845978745488036,-0.0514478130019497,-0.0182854461788187,3.78770327699589e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0424739073578505,0.0103059250552294,-0.0626735204661002,-0.0222742942496008,3.78965499518505e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.017651027784232,0.00429735870865944,-0.0260738508532045,-0.00922820471525949,4.02968209102828e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.0166116216759015,0.00404443682815513,-0.0245387178590855,-0.0086845254927174,4.03167286523094e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0204532334683059,0.00499229780118108,-0.0302381371586208,-0.010668329777991,4.21623217666135e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0194000638352214,0.00474374448843814,-0.0286978030325602,-0.0101023246378827,4.35089392155228e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,41913,-0.0337546858254245,0.0082601422650921,-0.049944564665005,-0.017564806985844,4.40585904608263e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0172903173642524,0.00424123271501234,0.00897750124282819,0.0256031334856766,4.59408842299887e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0167309017008508,0.00410845514289356,0.00867832962077938,0.0247834737809221,4.68132745516654e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0259237525579144,0.00637229850506468,-0.0384134576278411,-0.0134340474879876,4.77101850158004e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0307909330062013,0.00757327324767355,-0.0456345485716414,-0.0159473174407611,4.82103732036708e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42249,-0.0122478387368574,0.00301497390404883,-0.0181571875887931,-0.00633848988492165,4.88556286581229e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0128232738544289,0.00315856498789798,-0.019014061230709,-0.00663248647814889,4.94419143470534e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0265521434461895,0.00655210685701366,-0.0393942728859363,-0.0137100140064427,5.0970313747937e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0216681105841683,0.00534700872698745,0.0111879734792729,0.0321482476890637,5.09828272101287e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0290292530838873,0.00718147974806018,-0.0431049533900852,-0.0149535527776893,5.32433335687802e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00936895907533475,0.00232381352426522,-0.0139236335828946,-0.00481428456777491,5.57333466206807e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0125150993336337,0.00310506695165983,-0.018601030558887,-0.00642916810838046,5.60117294582639e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0212916510700217,0.00528791086012117,-0.0316559563558592,-0.0109273457841842,5.69974878358214e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,41843,-0.0284259960831505,0.00706395351748832,-0.0422713449774276,-0.0145806471888734,5.75136663997662e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.038415557102227,0.00955250465655904,-0.0571384662290827,-0.0196926479753712,5.81996152195189e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0442241135080156,0.0109990094501556,-0.0657821720303206,-0.0226660549857107,5.84049345912874e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.014146983051847,0.00351882628474705,-0.0210438825699512,-0.00725008353374277,5.84178091664256e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0249411653027921,0.00621487800369573,-0.0371223261900358,-0.0127600044155485,6.03125778195604e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0300838687218371,0.00750623769279099,-0.0447960945997074,-0.0153716428439667,6.16792209199164e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42070,-0.0183077771327396,0.00458236505436777,-0.0272892126393005,-0.0093263416261788,6.49648012156498e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0315777916916521,0.00792394600471967,-0.0471087258609027,-0.0160468575224016,6.7810580587849e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0171335862602147,0.00430702868433049,-0.0255753624815025,-0.00869181003892698,6.99148588887424e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0419705235394648,0.0105621109739657,-0.0626722610484375,-0.0212687860304921,7.12213383399262e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0210985558406705,0.00531084733101578,-0.0315078166094614,-0.0106892950718796,7.14218228791008e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0436731154208583,0.0110173891072324,-0.0652671980710338,-0.0220790327706828,7.41636090450542e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0491053700232035,0.0123912692237397,-0.0733922577017334,-0.0248184823446736,7.4498753617048e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0227784995527692,0.00576306556810057,-0.0340741080662463,-0.0114828910392921,7.77320553087678e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42062,-0.0136473255577026,0.00346735849254307,-0.0204433482030871,-0.00685130291231822,8.32873796527722e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.0124652642428212,0.0031687849276333,0.00625444578465998,0.0186760827009825,8.40366198498483e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0172759251132247,0.00439241284163478,-0.0258850542828288,-0.0086667959436205,8.42755438391431e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0463177301446665,0.0117877924786296,-0.0694218034027804,-0.0232136568865525,8.56190764308482e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0508101395989966,0.0129453086340188,-0.0761829445216735,-0.0254373346763197,8.71629099018146e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.0237121689560894,0.00604596706553975,-0.0355622644045473,-0.0118620735076315,8.83546032943122e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0227498004578762,0.00580140365576912,-0.0341205516231837,-0.0113790492925688,8.84686464285931e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0313279889130323,0.00799293286882429,-0.0469941373359279,-0.0156618404901367,8.91937587502872e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0316745345690058,0.00808434080883608,-0.0475198425543245,-0.0158292265836871,8.98059303362279e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0145776487274505,0.00372231924131694,0.00728190301446928,0.0218733944404317,9.04639722299405e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0189421300048506,0.00484089725308452,-0.0284302886208963,-0.009453971388805,9.17135763058997e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0168916680850993,0.00431713159966016,-0.0253532460204332,-0.00843009014976535,9.18014581541234e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0138691911562213,0.00354577735839485,-0.0208189147786752,-0.00691946753376734,9.22869236122229e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0197127780141228,0.00505729682754923,-0.0296250797961193,-0.00980047623212634,9.75141586307066e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0242906341550806,0.00625201889321485,-0.0365445911857817,-0.0120366771243795,0.000102725693337225
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.014834316740106,0.00383426726439149,-0.0223494805783134,-0.00731915290189873,0.000109858335192939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.0120736813412216,0.00312477951373265,-0.0181982491881376,-0.00594911349430562,0.0001122452159972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,41839,0.0310427649998551,0.0080462791968127,0.0152720577741022,0.046813472225608,0.000114847835466588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0362603600044972,0.0094070985516147,-0.054698273165662,-0.0178224468433324,0.000116466606754266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0352171423786132,0.00915949325846744,-0.0531697491652093,-0.017264535592017,0.000121166826192743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0304897677313259,0.00793892957819792,-0.0460500697045938,-0.014929465758058,0.000123451000868781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0177466994610921,0.0046231519523828,-0.0268080772877624,-0.00868532163442186,0.000124280869121797
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0302980217518593,0.00791615212822564,-0.0458136799231815,-0.014782363580537,0.000130097136587625
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0191472753797138,0.00502432149412194,-0.0289949455081928,-0.00929960525123476,0.000139059157103743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42107,-0.0164660331507947,0.00432520791046582,-0.0249434406553077,-0.0079886256462817,0.000141288777868526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42200,0.0163808028485396,0.00430692793021656,0.00793922410531516,0.0248223815917641,0.000143370214419671
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.00832889376521437,0.00219117481042997,0.00403419113677164,0.0126235963936571,0.000144679306626485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0193330318470632,0.00508907329686857,-0.0293076155089256,-0.00935844818520084,0.000145961140858359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42296,-0.0322958490869464,0.00852130945703722,-0.0489976156227393,-0.0155940825511534,0.000151286694507305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.0165634355228777,0.00437995571405763,-0.0251481487224306,-0.00797872232332472,0.000156616138445812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.0166643940683562,0.0044077963665797,-0.0253036749468524,-0.00802511318985995,0.00015708629292281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,39657,-0.0145358267583452,0.0038486573902585,-0.0220791952432518,-0.00699245827343854,0.00015965250744325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0099857861907401,0.00265369582286317,-0.0151870300035519,-0.00478454237792827,0.000168605595272966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0343475511207855,0.00915520511043095,-0.0522917531372302,-0.0164033491043408,0.000176375910650691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.020568041213352,0.00548383116966136,-0.0313163503058883,-0.00981973212081575,0.000177269766444072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0216050677125953,0.00577660591854804,0.0102829201122411,0.0329272153129494,0.000184851047156607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0149984447758123,0.00401952576796905,0.00712017427059294,0.0228767152810316,0.000191381758759607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0120704065763682,0.00323727384035758,0.00572534984926729,0.018415463303469,0.000193357357403996
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,39934,-0.0244080803414378,0.00656012314978457,-0.0372659217150156,-0.0115502389678601,0.000199651761243393
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0283339062213971,0.00762499198373555,-0.0432788905095188,-0.0133889219332755,0.000203449857400084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42145,-0.0118180747579194,0.00318180055972576,-0.0180544038549819,-0.00558174566085693,0.000204607411256536
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.0116842258918723,0.00314984340172864,-0.0178579189592604,-0.00551053282448415,0.000208691989450581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.0195487080317498,0.00528217809808425,-0.0299017771039949,-0.00919563895950462,0.000215723856428757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0197021516966918,0.00533056255749073,-0.0301500543093736,-0.00925424908400995,0.0002200180679723
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.00982908825524682,0.0026610365203218,0.00461345667541609,0.0150447198350775,0.000221875683428557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.0096807286008557,0.0026218381970705,-0.0148195314671139,-0.00454192573459751,0.000223074172940624
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0224176387181109,0.00608159121571145,-0.0343375575009054,-0.0104977199353165,0.000228771938973854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,39649,-0.0181877845679038,0.00493615295796261,-0.0278626443655106,-0.00851292477029712,0.000230150158433731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42137,0.0176801947315393,0.00480851011215008,0.0082555149117251,0.0271048745513534,0.000237040525386649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0192359518851227,0.00523250736212135,-0.0294916663148805,-0.00898023745536484,0.000237791649563968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0228367712438673,0.00621879500843016,-0.0350256094603904,-0.0106479330273442,0.000241380681970467
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.00908625720569836,0.00247951555651153,-0.013946107696461,-0.00422640671493576,0.000248923238174956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.023778972461533,0.00649064468063171,-0.0365006360355712,-0.0110573088874949,0.000249889056524737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42016,0.0164392276807101,0.00449866411074518,0.00762184602364952,0.0252566093377706,0.000258922087605861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.027375491056558,0.00749200460986378,-0.042059820091891,-0.012691162021225,0.000259391397640757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.011894592541792,0.00326515645011203,-0.0182942991840116,-0.00549488589957241,0.000270801536880414
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.0108451290479029,0.00297908328075186,-0.0166841322781766,-0.00500612581762927,0.000273400698453415
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0426781415122127,0.0117307395193792,-0.065670390970196,-0.0196858920542295,0.000275633019334404
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0174450789467238,0.00479533659813334,0.00804621921438249,0.0268439386790652,0.000275865413466641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0218434742327482,0.00600832604018012,-0.0336197932715012,-0.0100671551939951,0.000278634544587255
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.0119643055809816,0.00329113523782758,-0.0184149306471237,-0.00551368051483959,0.000278665154438733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.0113153561564204,0.00312993873832077,-0.0174500360835291,-0.00518067622931167,0.000301418586453966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0124000224728305,0.00343128320653276,-0.0191253375576347,-0.00567470738802631,0.000303072648669174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42262,-0.0123004527900989,0.00341523697009323,-0.0189943172514816,-0.00560658832871615,0.000317338092289822
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,41749,0.0261106243748444,0.00725285483308376,0.0118950289020003,0.0403262198476886,0.000319329242104369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0101024527165418,0.00282202846438707,0.00457127692634315,0.0156336285067405,0.000345258086907157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0200381027999188,0.0056014323716217,-0.0310169102482974,-0.00905929535154028,0.000348336973220771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.0119639835008401,0.0033543876337684,0.00538938373865409,0.0185385832630262,0.00036306782724841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42264,-0.00788072160011449,0.00221515774231527,-0.0122224307750524,-0.00353901242517656,0.000375476883988264
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0226919899349014,0.0063981808802808,-0.0352324244602518,-0.010151555409551,0.000391493153175803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0190874522325205,0.00539280341984217,-0.0296573469354112,-0.00851755752962986,0.000402366615553549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42138,-0.0155533583314241,0.00439926250932999,-0.0241759128497108,-0.00693080381313727,0.00040844567043877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42261,-0.0131335923865527,0.00372097529838252,-0.0204267039713824,-0.00584048080172296,0.000417541054318773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,-0.00509644538279449,0.00144430922942912,-0.00792729147247557,-0.00226559929311341,0.000419379428139201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.0134479594438088,0.00382377294769286,-0.0209425544212868,-0.00595336446633075,0.000438296243407337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0375431224410138,0.0106939479859582,-0.0585032604934918,-0.0165829843885358,0.000448684929937425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0292529963149095,0.00835533328963762,-0.0456294495625993,-0.0128765430672198,0.000465143083837642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,39959,-0.00545785709910418,0.0015603985910542,-0.0085162383375704,-0.00239947586063795,0.000471025742258274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.027441124774946,0.00784712146991364,-0.0428214828559767,-0.0120607666939153,0.000472441223682398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0244216767187318,0.00699296847134241,-0.0381278949225629,-0.0107154585149006,0.000480399180638732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.0243703865578999,0.00698738145380491,0.0106751189084423,0.0380656542073575,0.000488972531880452
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42137,0.00746017154580126,0.00214300380677222,0.0032598840845277,0.0116604590070748,0.000500792547187965
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0131806867319615,0.00378717492774441,-0.0206035495903405,-0.00575782387358247,0.000502321570374534
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42249,-0.0275044198386072,0.00791516816140594,-0.0430181494349628,-0.0119906902422515,0.000512630236962107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0327231464256049,0.00942666921285077,-0.0511994180827924,-0.0142468747684173,0.000519833665844025
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0112542640981807,0.00324317164824079,0.0048976476676287,0.0176108805287326,0.000522168725396874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0243898024288923,0.00702938053596891,0.0106122165783932,0.0381673882793914,0.000522674881509634
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,39657,-0.0238903491836726,0.00690255283112805,-0.0374193527326836,-0.0103613456346616,0.000540027326046672
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.022791659804667,0.00660941394046277,-0.035746111127974,-0.00983720848135998,0.000565726647041094
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0200965793746993,0.00583082097490005,-0.0315249884855034,-0.00866817026389523,0.000569724715363368
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42119,-0.0205074298191544,0.00595326136672398,-0.0321758220979334,-0.00883903754037541,0.000573346432583658
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0102370445699695,0.002972165525979,0.0044116001390507,0.0160624890008884,0.000574258249270029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.017146105345451,0.00498156778168911,-0.0269099781975617,-0.00738223249334038,0.000579407612538232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00805101185387637,0.00233986801694088,0.00346487054067224,0.0126371531670805,0.000581765361575907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.030457590411166,0.00886632813709107,-0.0478355935598645,-0.0130795872624675,0.000594310652388347
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42015,-0.0186670718421905,0.00543681592089481,-0.0293232310471443,-0.00801091263723667,0.00059773793708214
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0168899050178613,0.00491930173447873,0.00724807361828295,0.0265317364174396,0.00059785218629943
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0147305947736702,0.00429100616990752,-0.0231409668666889,-0.00632022268065146,0.000599299805177306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.0197772406502903,0.00576391644053085,-0.0310745168737308,-0.00847996442684983,0.00060302193143039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0219232190617424,0.00640487211443444,0.00936966971745088,0.0344767684060339,0.000621766610419621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0323774432911398,0.00947064160949099,-0.0509399008457421,-0.0138149857365374,0.000631028132826901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42070,-0.0274592831756504,0.00803729535776678,-0.0432123820768732,-0.0117061842744275,0.000636229997046957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0262524877451065,0.00770461600225051,-0.0413535351095175,-0.0111514403806955,0.000657869500717358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0251211703320744,0.00737333762370932,-0.0395729120745446,-0.0106694285896041,0.000658641367038413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,39575,-0.0279003858652081,0.00820276959568018,-0.0439778142727412,-0.0118229574576749,0.000672962137736685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0304751972460714,0.00899774272550625,-0.0481107729880636,-0.0128396215040791,0.000708658951582446
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.0115067169217913,0.00340468225720004,0.00483353969767923,0.0181798941459034,0.000728228590572118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.0412055399582092,0.0122145540692295,-0.065146065933899,-0.0172650139825195,0.000744777925836555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0196234054597039,0.00583263883433532,-0.0310553775750011,-0.00819143334440666,0.000769676332650448
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0272326237429223,0.00810057546923815,-0.0431097516626291,-0.0113554958232155,0.000776930179125501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42070,0.00547430672870966,0.00162883132762324,0.00228179732656811,0.0086668161308512,0.000779104754315535
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,39649,-0.013587578754369,0.0040449757781991,-0.0215157312796392,-0.00565942622909872,0.000784541696487195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,39699,-0.0160648086471697,0.00480429406645225,-0.0254812250174161,-0.00664839227692326,0.000828997796318162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0243426166476271,0.00733038175016607,-0.0387101648779526,-0.00997506841730159,0.000900021573188556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,39958,-0.00975675223348193,0.00293858236296842,-0.0155163736649,-0.00399713080206382,0.000902285845038816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.00946953089032496,0.00285559414932844,0.00387256635764122,0.0150664954230087,0.000915102297775202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.0083534781439347,0.00252038638097289,-0.0132934354506416,-0.00341352083722783,0.000920942156275737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0308094755194863,0.00933233676095967,-0.0491008555709673,-0.0125180954680054,0.000965228833684081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.0098786967240696,0.00299705119074955,0.00400447639020048,0.0157529170579387,0.000982770269230448
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,41960,-0.0143108650721409,0.00434576168942856,-0.0228285579834209,-0.00579317216086091,0.000993598886362523
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.0141700921519261,0.00430618211535214,0.00572997520583587,0.0226102090980162,0.00100212618978699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0137596248701343,0.00419100641359207,-0.0219739974407748,-0.00554525229949385,0.00102980067763336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.034915411872235,0.0106786783733047,-0.0558456214839121,-0.0139852022605578,0.00108005757181941
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.0149367972368168,0.00457808841705088,-0.0239098505342366,-0.0059637439393971,0.00110645524852062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00651328630308255,0.00199651357344786,0.00260011969912474,0.0104264529070404,0.00110826566840147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0311057497215081,0.00956340703667385,-0.0498500275133888,-0.0123614719296273,0.00114647359643804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0373665367800628,0.0114885065461253,-0.0598840096104684,-0.0148490639496571,0.00114731704372338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,41913,-0.011895108738635,0.00366212175340981,-0.0190728673753182,-0.00471735010195176,0.00116447199877891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.0109285538855924,0.00336968731460911,0.00432396674895853,0.0175331410222262,0.00118551008117238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0111669927191378,0.00345397466474656,-0.0179367830620411,-0.00439720237623453,0.00122754589634508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00953286804726904,0.00295450194655945,-0.0153236918625256,-0.00374204423201252,0.00125583538167754
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.0161501951386316,0.00500767836623163,0.00633514554081758,0.0259652447364455,0.00126303443531843
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.0148417121152091,0.0046032879075277,-0.0238641564139634,-0.00581926781645476,0.00126714719566289
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.0202889842012647,0.00630468219341506,0.00793180710217114,0.0326461613003582,0.00129353009935254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0219461822605566,0.00682426895647531,-0.0353217494152482,-0.00857061510586498,0.00130405723572455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.0102218329455415,0.00318779611604432,-0.0164699133329883,-0.00397375255809458,0.00134652094777266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42181,-0.0115903116927039,0.00361683530457413,-0.0186793088896692,-0.00450131449573862,0.00135588713693545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0135934706511747,0.00424575086370086,-0.0219151423440283,-0.00527179895832097,0.00137022810938718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0328144445827503,0.0102555755230915,-0.0529153726080095,-0.012713516557491,0.00137902983834008
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0247776745793056,0.0077464094070066,-0.0399606370170386,-0.00959471214157269,0.00138417337671084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,39575,0.0241655725850663,0.00756051367082825,0.00934696579024291,0.0389841793798897,0.0013960286157521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0511637621794747,0.0160235627347803,-0.0825699451396441,-0.0197575792193053,0.00141116271670765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.0253155489967296,0.00792911337048431,-0.0408566112028788,-0.00977448679058033,0.0014131586941343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0201662790509862,0.00632285545884782,-0.0325590757503279,-0.00777348235164445,0.00142876889896405
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,41830,-0.0294165722861919,0.00923436022507602,-0.0475159183273409,-0.0113172262450429,0.00144811395422199
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.0161237353274577,0.00506531460710644,-0.0260517519573863,-0.00619571869752906,0.0014601106862866
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0254245835126177,0.00799569335155157,-0.0410961424816588,-0.00975302454357661,0.00147723933414581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,39966,-0.0289025120566103,0.00909196523993175,-0.0467227639268765,-0.0110822601863441,0.00148227830964852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0195506743868531,0.00615378674510443,-0.0316120964072578,-0.00748925236644844,0.00149199435277637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0151114271226542,0.00477122747130701,-0.024463032966416,-0.0057598212788925,0.00154256663987301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0102568623241693,0.00324694704161757,-0.0166208785257397,-0.00389284612259881,0.00158768166218039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42119,-0.0219269077321726,0.0069456934642045,-0.0355404669220134,-0.00831334854233175,0.00159802519113922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.0116604755734949,0.00369529953228839,0.00441768849020967,0.0189032626567802,0.00160647544954884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.0082124389612124,0.00261150223076244,0.00309389458891802,0.0133309833335068,0.00166674196863759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42027,-0.015661499385215,0.00498282889858565,-0.0254278440264429,-0.00589515474398716,0.00167536011807343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0105566070430369,0.00336405060652191,-0.0171501462318199,-0.00396306785425396,0.00170514474294281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0491277939102328,0.0156813023657682,0.0183924412733271,0.0798631465471385,0.00173533226144616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.0112658291942642,0.00359751923711981,-0.018316966899019,-0.00421469148950936,0.0017425405909733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0301999670593209,0.00965185187968183,-0.0491175967434973,-0.0112823373751445,0.00175897084997654
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.030816705589298,0.00985001874235828,-0.0501227423243202,-0.0115106688542758,0.00176018335074262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0311318352134439,0.00995405661157482,-0.0506417861721305,-0.0116218842547572,0.0017672660123303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0449070399737739,0.0143941205193092,-0.07311951619162,-0.0166945637559278,0.00181344669019032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0161480194506884,0.00520630607935001,-0.0263523793662144,-0.00594365953516237,0.00192933115270431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0194189335333522,0.00628261431489061,0.00710500947616662,0.0317328575905378,0.00200050429260334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0177802662377323,0.0057529949995641,-0.0290561364368779,-0.00650439603858662,0.00200157683721216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0208423310097381,0.00674359816193073,-0.0340597834071224,-0.00762487861235392,0.00200180762206573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.0160619785350033,0.00520842032868906,-0.0262704823792339,-0.00585347469077278,0.00204762925673571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0162272528685595,0.00527780831959173,-0.0265717571749592,-0.00588274856215968,0.00211272688455075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0104290010717392,0.0033983465337157,-0.017089760277822,-0.00376824186565641,0.00215395111526893
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0156557138437328,0.00510279948720035,-0.0256572008386454,-0.00565422684882008,0.00215887283724305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.0112747194798952,0.00367600506136616,0.00406974955961749,0.0184796894001729,0.00216564049745676
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.0232476330759898,0.00758926499946369,-0.0381225924749386,-0.00837267367704093,0.00219479461389288
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.0125750029812627,0.0041141984515096,-0.0206388319462215,-0.00451117401630387,0.00224479821392383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.0237520257225884,0.00779398933109559,-0.0390282448115357,-0.00847580663364102,0.00231215962309073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.00808352094369458,0.00265855777168013,-0.0132942941761876,-0.00287274771120152,0.00236682490028723
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0100444815975367,0.00330558333693882,0.00356553825713657,0.0165234249379368,0.0023818931154083
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0202447567314565,0.00670419462101529,0.00710453527426654,0.0333849781886465,0.00253593853734512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0215739658012705,0.00715745620142151,-0.0356025799560566,-0.00754535164648434,0.00258141915331045
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.00852432095238195,0.00283656149192905,0.00296466042820101,0.0140839814765629,0.00266032203299459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0207862415787391,0.00694296828279068,-0.0343944594130088,-0.00717802374446936,0.00276069344235854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0212271143521863,0.00709656040890226,-0.0351363727536347,-0.00731785595073787,0.00278496292508863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0203723871968912,0.0068135314018025,-0.0337269087444241,-0.00701786564935831,0.00279605762463877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42123,-0.00751027987909835,0.00251792652946404,-0.0124454158768479,-0.00257514388134883,0.00286205106930652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0115428883882652,0.0038797522809778,-0.0191472028589817,-0.00393857391754871,0.00293360325939412
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00656054164136804,0.00220581965787056,-0.0108839481707943,-0.00223713511194174,0.00294390910663371
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0104557854066469,0.00352468906904062,-0.0173641759819665,-0.00354739483132728,0.00301793781117123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.00773243577443997,0.00260817015658444,0.00262042226753446,0.0128444492813455,0.00303502009332311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,39586,-0.0339965704098162,0.0114666695632719,-0.0564712427538292,-0.0115218980658032,0.00303514189296412
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,41668,-0.0116484927734388,0.00394282808519472,-0.0193764358204204,-0.00392054972645711,0.00313887339885806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0120861050135333,0.00409523445558065,-0.0201127645464714,-0.00405944548059523,0.00317022090338572
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42249,-0.0206654186077398,0.00700281818624747,-0.0343909422527849,-0.0069398949626948,0.00317270316279021
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0127112807569335,0.00431634232414364,0.00425124980161199,0.021171311712255,0.00323712614930338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0142012680244082,0.00482948003691324,-0.0236670488967581,-0.00473548715205821,0.00328192886313329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.029409244195512,0.0100249505683415,-0.0490581473094613,-0.00976034108156275,0.00335721661487475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.00901146874115825,0.00307403274778002,-0.0150365729268071,-0.0029863645555094,0.00338020719494722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.0105988203158197,0.00363051250454392,-0.0177146248247258,-0.00348301580691363,0.00351444413132754
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0246904731467389,0.00846123882092188,-0.0412745012357458,-0.00810644505773206,0.00352799463008492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.00954071318486916,0.00327121336077688,-0.0159522913719919,-0.00312913499774647,0.00354618189724193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.0125653440281717,0.00431787215678515,-0.0210283734554706,-0.00410231460087276,0.00362059942914206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42310,-0.00615197522644993,0.00211608860731338,-0.0102995088967842,-0.0020044415561157,0.00365218914430806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0124278003258135,0.00427851724525381,0.00404190652511607,0.020813694126511,0.00368203044135319
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00868066802255679,0.00299003372839471,0.00282020191490317,0.0145411341302104,0.00369964413918322
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.0130897056786039,0.00451673810023793,0.00423689900213753,0.0219425123550702,0.00376241146443421
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00848558919209525,0.00293055246475217,-0.0142294720230095,-0.00274170636118099,0.00379085050619115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0127609840247402,0.00441458163773253,0.0041084040147844,0.0214135640346959,0.00385184318202022
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0141413321757555,0.0048972053430344,0.00454280970340811,0.023739854648103,0.0038890503129433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.0143541154452392,0.00497795221292144,-0.0241109017825653,-0.00459732910791321,0.00393860094523566
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0126228559775825,0.00437893442405233,-0.021205567448725,-0.00404014450643992,0.00394993099861442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00882725178363151,0.0030703205338774,-0.0148450800300312,-0.0028094235372318,0.00404744132681981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.020934042455813,0.00728263781343842,-0.0352080125701523,-0.00666007234147367,0.00405408450674077
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0125604444454729,0.00437429199625874,0.00398683213280576,0.02113405675814,0.00409265015242772
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.0122265744888764,0.00426999344540407,0.00385738733588438,0.0205957616418683,0.00419953930264157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.0104070223904907,0.00364647359546586,-0.0175541106376038,-0.00325993414337764,0.0043253398479124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.0117973809500336,0.00413636213445522,-0.0199046507335659,-0.00369011116650138,0.00435081153958065
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0148559240241345,0.00521513244534698,0.00463426443125443,0.0250775836170146,0.00439757522604074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0173788132950229,0.0061384024717805,-0.0294100821397127,-0.00534754445033315,0.00464636539271942
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,41881,-0.0172995844263893,0.00611099924670989,-0.0292771429499407,-0.00532202590283791,0.00464879931713401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,39966,-0.0132121174624976,0.00466727115561024,-0.0223599689274937,-0.00406426599750155,0.00465130504744828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.0130825434556875,0.00462169933509167,-0.0221410741524672,-0.00402401275890783,0.00465187379835881
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42016,-0.0129113530676801,0.00456997714923539,-0.0218685082801815,-0.00395419785517874,0.00473126812072531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.0154802015736877,0.00550344308233956,0.00469345313230218,0.0262669500150733,0.00491794641817128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0180084607914039,0.00640251350059056,-0.0305573872525614,-0.00545953433024637,0.00492120682175798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.00837847679592148,0.0029827678057212,-0.014224701695135,-0.00253225189670793,0.00497726501174492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0291620699546332,0.0104073651755607,-0.0495605056987322,-0.00876363421053421,0.00508657593284062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.0121397363102112,0.00433786203270616,-0.0206419458943153,-0.00363752672610718,0.00514053973272561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.0171111834514246,0.00612189137646427,0.00511227635355463,0.0291100905492946,0.00519598154490613
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0168237907407637,0.00604356047041825,-0.0286691692627835,-0.00497841221874393,0.00538227001111273
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0142298532062528,0.00511986354202724,-0.0242647857486262,-0.00419492066387946,0.00545612381480401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.010105151757151,0.00365227268130284,0.00294669730179744,0.0172636062125046,0.00567021470918953
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0113211181921393,0.00409646260683767,0.00329205148273747,0.0193501849015411,0.00572407973824691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.0141115426318157,0.00511035948179114,-0.0241278472161263,-0.00409523804750501,0.00576404536318491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.0166063173136175,0.00604702146552388,-0.0284584793860443,-0.00475415524119064,0.00603714517054039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0254289170801603,0.00925958545658883,-0.0435777045750744,-0.00728012958524622,0.00603827380738648
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,39726,0.00621383897599233,0.0022667221800388,0.00177106350311628,0.0106566144488684,0.00612882916341329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0193975902055842,0.00711298048950584,-0.0333390319650156,-0.00545614844615272,0.00639837963525715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0104688884694108,0.00384739844979319,-0.0180097894310055,-0.00292798750781619,0.00651619253628287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00806177828574309,0.00296534388867781,-0.0138738523075516,-0.00224970426393459,0.00656308352268074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.0113590714991107,0.00418243764504376,-0.0195566492833965,-0.00316149371482493,0.00661821836062906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.0107467501050822,0.00395775453412862,-0.0185039489919743,-0.0029895512181901,0.00663062425982807
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0256269999884011,0.00944522063473684,0.00711436754431688,0.0441396324324853,0.00667352202544956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0127987103860467,0.00471793347377129,0.00355156077745493,0.0220458599946384,0.00668223828238155
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0120745076959594,0.00446718658084105,-0.0208301933944078,-0.00331882199751089,0.00688154907588101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,39560,0.0116479771600807,0.00431771648102488,0.00318525285727189,0.0201107014628894,0.00699236198649682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.0145300574329313,0.0053960014165396,-0.0251062202093489,-0.00395389465651371,0.00709555508877098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,41976,-0.0161646121689227,0.00600480021790477,-0.027934020596016,-0.00439520374182935,0.00711243382708979
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0171089388507104,0.00635933911570059,-0.0295732435174836,-0.00464463418393728,0.00714616353946542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.00921675668032574,0.00343139036757073,0.00249123155988712,0.0159422818007644,0.00724192415580795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.0107689224321094,0.00403410225586203,-0.018675762853599,-0.00286208201061982,0.00760608701141195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.0180449325593348,0.0068038038376197,-0.0313803880810695,-0.00470947703760023,0.00800842435591239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,41913,-0.0141140718666379,0.00532420472046736,-0.024549513118754,-0.0036786306145219,0.00803664609848148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,41780,-0.00861523188876687,0.00327485129664027,-0.0150339404301818,-0.00219652334735194,0.00853021533833881
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.0122255803445108,0.00465528926330227,-0.0213499473005833,-0.00310121338843835,0.00864715983327739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0165813375718106,0.00633132338672075,-0.0289907314097833,-0.00417194373383796,0.00883047315367013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0162110690763308,0.00620185013411207,-0.0283666953391905,-0.00405544281347118,0.00896332151170743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,39575,0.00997715608599835,0.00381721057207692,0.00249542336472759,0.0174588888072691,0.008968214829339
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0128895962206728,0.00494952032225797,-0.0225906560522984,-0.00318853638904716,0.00922061384289645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.0122513467978958,0.00471759985795118,0.00300485107631145,0.0214978425194801,0.00941785710349091
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.0213226750278058,0.00821514436822107,-0.0374243579895191,-0.00522099206609255,0.0094546327884009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,39934,-0.0102611067730108,0.00395653220719196,-0.018015909899107,-0.00250630364691456,0.00951378324161836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.012713801328814,0.00491157426018627,-0.0223404868787791,-0.00308711577884895,0.00965075801218483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.0102419190158704,0.00395747003127785,-0.0179985602771749,-0.00248527775456576,0.00966613033508073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.02336723748912,0.00902948801627619,-0.0410650340010213,-0.00566944097721864,0.00966734152973949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.0111485992554978,0.00431074322735599,-0.0195976559811155,-0.00269954252988002,0.00971541500116806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.0108871255875245,0.00420997599171707,-0.01913867853129,-0.00263557264375905,0.00972159821353926
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00771369404668011,0.00299288245932018,-0.0135797436669477,-0.00184764442641255,0.00996693704993339
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00840844799152622,0.00327468109555119,-0.0148268229388065,-0.0019900730442459,0.0102479021684107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0327374847174391,0.0127572786367056,-0.057741750845382,-0.00773321858949614,0.010295250533477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,39934,0.00956738934934103,0.0037539467471199,0.00220965372498604,0.016925124973696,0.0108280297175958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00726482076858798,0.00285746590160439,0.00166418760144338,0.0128654539357326,0.0110230363220697
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.00735570919366576,0.00289323401984993,-0.0130264478725716,-0.0016849705147599,0.0110234629732695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,39721,-0.015949187015022,0.00627429267247521,-0.0282468006530734,-0.00365157337697055,0.0110357934765279
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,39875,0.0200150839688933,0.00787920683550089,0.00457183857131156,0.0354583293664751,0.0110909117603916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.00751160543295726,0.00295944941686572,-0.0133121262900141,-0.00171108457590045,0.0111564485308391
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00571361116300063,0.00225239732862402,0.00129891239889756,0.0101283099271037,0.0112046557562178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0101112208026279,0.00398649742905732,-0.0179247557635803,-0.0022976858416756,0.0112141941805872
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0296637787740909,0.0117315038486436,-0.0526575263174325,-0.00667003123074941,0.0114673335107257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0137492709401526,0.00545098474880313,-0.0244332010478067,-0.00306534083249849,0.0116714192199447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.00923268504075116,0.00367167110939217,-0.0164291604151598,-0.00203620966634251,0.0119291785413955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.0127764149567722,0.00508508282253716,0.00280965262459937,0.022743177288945,0.0119986007602884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0397533849256984,0.0158552602631544,-0.070829695041481,-0.00867707480991577,0.0121811947048091
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00842967671376613,0.00337800032371951,-0.0150505573482564,-0.00180879607927588,0.0125913415391651
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0129731149780026,0.00520548367576414,-0.0231758629825003,-0.00277036697350485,0.0127095855684868
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00853716518023609,0.00342625613530078,0.00182170315504656,0.0152526272054256,0.0127258638547839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.0100764144095932,0.00404804922386203,-0.0180105908883628,-0.00214223793082364,0.0128149755393109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0193943329863574,0.00782278769790804,-0.0347269968742571,-0.00406166909845763,0.0131793496420362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42070,-0.0148394834680343,0.00599122366573337,-0.0265822818528717,-0.00309668508319689,0.0132661902645686
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42137,-0.0143571871162661,0.00580239595043956,-0.0257298831791277,-0.0029844910534046,0.0133598644607501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0172438914140884,0.00697193795539533,-0.0309088898066633,-0.0035788930215136,0.013401024271075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0174285937174135,0.00705342497159552,-0.0312533066617407,-0.00360388077308623,0.0134904378425839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.0128464200376555,0.00520879677159898,-0.0230556617099896,-0.00263717836532154,0.0136671082778061
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.039782380760107,0.0161379109202112,-0.0714126861637211,-0.00815207535649295,0.0137079014531281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,39649,-0.0159813183349928,0.00649420021911204,-0.0287099507644524,-0.00325268590553315,0.0138756193328583
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0303517291757067,0.0123634435357448,0.00611937984564686,0.0545840785057665,0.0141049970296337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0110905164222682,0.00452417434943868,0.00222313469736841,0.019957898147168,0.0142458168251687
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.00712409318993298,0.00291136128419419,0.00141782507291237,0.0128303613069536,0.0144176557934612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42119,0.0176858535729737,0.00723339680699924,0.00350839583125515,0.0318633113146922,0.0144967859831502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.014012626566743,0.00573279687737466,-0.0252489084463973,-0.00277634468708863,0.0145288470752863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0127972975948764,0.00523967616726768,0.00252753230703177,0.0230670628827211,0.0146033076463983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.025112708962434,0.0102847321555815,-0.0452707839873737,-0.00495463393749439,0.0146321065633816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,39966,0.00846162924655984,0.00346922447602246,0.00166194927355581,0.0152613092195639,0.014740922112678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00742391411758831,0.00304687096196188,-0.0133957812030336,-0.00145204703214303,0.0148403177258556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.010462274642701,0.00429537590932255,-0.0188812114249732,-0.00204333786042881,0.0148758447205856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.00677471617196764,0.00278235467111226,-0.0122281313273477,-0.00132130101658762,0.0149093063687406
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.0154054240889681,0.00633527488287844,-0.0278225628594098,-0.00298828531852635,0.0150443390700023
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00954367887070083,0.00392693455124866,-0.0172404705911482,-0.00184688715025346,0.0151016021830545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00791197376653601,0.00325741176805393,0.00152744670115032,0.0142965008319217,0.0151573312115102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.0148493356876688,0.00614232812601815,-0.0268882988146644,-0.00281037256067324,0.0156390777309813
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00812038004524114,0.00336824615594093,-0.0147221425108854,-0.0015186175795969,0.0159310587042073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0125728194910505,0.00522817794776096,0.00232559071343903,0.022820048268662,0.0161969724236448
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,41839,-0.0116160872401628,0.00483194277166602,-0.0210866950726282,-0.00214547940769741,0.0162295381458755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42210,-0.0109213129785104,0.00454607278162535,-0.0198316156304961,-0.00201101032652476,0.0163028843897339
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0290952947232794,0.0121189962635281,-0.0528485273997945,-0.00534206204676429,0.0163757822203886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.062218118066916,0.0260551087319818,-0.1132861311816,-0.0111501049522316,0.0169592474836292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,39586,-0.011116006193827,0.00465911332348134,-0.0202478683078504,-0.00198414407980353,0.0170559330629395
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0166373188890263,0.0070133632671358,0.00289112688544018,0.0303835108926125,0.0176975421571636
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00966797873554202,0.00408127845364378,-0.0176672845046838,-0.00166867296640021,0.0178602256949068
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00447109488253172,0.00188995749709447,-0.00817541157683688,-0.000766778188226558,0.0180094442611292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,41839,-0.00978082313526875,0.00414455358414826,-0.0179041481601993,-0.00165749811033817,0.0182932046010643
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42181,0.00972927211045747,0.00413478212407551,0.00162509914726947,0.0178334450736455,0.018635243098468
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.0101598561296991,0.00432610611484964,-0.0186390241148044,-0.0016806881445938,0.0188638693426611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.0151397495305016,0.00647098560001158,-0.0278228813065243,-0.0024566177544789,0.0193168454339936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.0080991004531342,0.00347116694917449,0.00129561323275219,0.0149025876735162,0.0196495837550509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42310,0.010478781827527,0.00449125936700265,0.00167591346820183,0.0192816501868522,0.0196546583728575
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00943728310790556,0.00405651729873307,-0.0173880570134224,-0.00148650920238875,0.0200126220880258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.00613934275520196,0.00264016345978641,0.000964622374020591,0.0113140631363833,0.0200671729967303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.0160557793506604,0.0069129073493645,-0.0296050777554148,-0.00250648094590597,0.0202196650080986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,39575,0.0101077454364721,0.00435459785795767,0.00157273363487508,0.0186427572380691,0.0202960988198041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.0111199619457676,0.0047911826710292,-0.0205106799809849,-0.0017292439105504,0.0203091403801544
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00932431964460229,0.0040220432796854,-0.0172075244727857,-0.0014411148164189,0.0204507832556654
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.0102598598299096,0.00443839321524558,-0.0189591105317909,-0.00156060912802823,0.0208140342810938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00746351610757408,0.00322945708952525,0.00113378021210459,0.0137932520030436,0.0208470383708143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.00766454204254025,0.00332267987722945,-0.01417699460191,-0.00115208948317053,0.0210844295219225
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0153523787508374,0.00665826792409996,-0.0284025838820734,-0.00230217361960153,0.0211423811503211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.013336019225545,0.00580015748900638,-0.0247043279039975,-0.00196771054709246,0.0215061990284323
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,39966,-0.0230294726429941,0.010016423603807,-0.0426616629064558,-0.0033972823795325,0.0215132669153028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0226469378497527,0.00986454056332223,-0.0419814373538642,-0.0033124383456411,0.0217063866128068
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,41883,-0.0217996217418371,0.00953326400059845,-0.0404848191830101,-0.00311442430066415,0.022229570074384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.00706451349607566,0.00309165567465419,-0.0131241586183979,-0.00100486837375345,0.0223269509661196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42158,-0.00759211161831805,0.0033236884180402,-0.0141065409176769,-0.00107768231895925,0.0223726449845276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,39934,-0.00811087646828045,0.00355140409546894,-0.0150716284953996,-0.00115012444116132,0.0223987227993481
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0151928900887119,0.0066607925767464,-0.0282480435391349,-0.00213773663828899,0.0225709047288563
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00906087758797552,0.00397762033630913,-0.0168570134471414,-0.00126474172880963,0.0227444746329492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.0100435589382085,0.00440948873895513,0.00140096100985648,0.0186861568665606,0.0227620443135061
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,39575,0.0124916653035596,0.00550941361304404,0.00169321462199329,0.0232901159851259,0.0233893640784117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,41877,-0.0104215200075503,0.00461308430841586,-0.0194631652520454,-0.00137987476305526,0.0238919479505451
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0132911578755117,0.00588692843382251,-0.0248295376058038,-0.00175277814521958,0.0239807817227959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0088587412285142,0.00392795264859395,-0.0165575284197583,-0.00115995403727006,0.0241300775612563
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0204795939119813,0.0091385250790712,0.0025680847570017,0.0383911030669608,0.0250448412498767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.0109258157284193,0.00488512261322092,-0.0205006560503323,-0.00135097540650631,0.0253355179104177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0205850319824712,0.00922265644690285,-0.0386614386184008,-0.00250862534654166,0.0256344073093732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.0122262887829141,0.00547823456223981,-0.0229636285249042,-0.00148894904092412,0.0256449313369761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0285056181688517,0.0127759228528735,-0.0535464269604838,-0.00346480937721964,0.0256843038381659
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00825180469232122,0.00369929525022511,0.00100118600188,0.0155024233827624,0.0257249872771761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00675944014462138,0.00303153099193395,-0.0127012408888119,-0.00081763940043083,0.0257861091159169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,39657,0.0245444795765408,0.0110158864480066,0.00295334213844786,0.0461356170146337,0.0258939848911446
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.0143503185360778,0.00644326826404278,-0.0269791243336017,-0.00172151273855399,0.025954806299084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0138312470279313,0.00621625745255012,0.00164738242093306,0.0260151116349295,0.026100665161938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.00704122513013866,0.00316660112521184,-0.0132477633355539,-0.000834686924723456,0.026192445073238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42016,-0.0134353578441884,0.00605308152368896,-0.0252993976306187,-0.00157131805775802,0.02646328340282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.00976583870307192,0.00440018496803034,-0.0183902012404114,-0.00114147616573246,0.026478684205014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.025185413369517,0.0113546576016839,-0.0474405422688174,-0.0029302844702166,0.0265668753371144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00889835339792552,0.00401935768819249,0.00102041232906824,0.0167762944667828,0.0268575606153909
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0066322494401342,0.00299935835386507,0.000753507066558667,0.0125109918137097,0.0270368701288759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.0110667482321098,0.00501778078427779,-0.0209015985692943,-0.00123189789492531,0.0274356863564905
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.0125956792328277,0.00572519646543225,-0.023817064305075,-0.00137429416058053,0.0278207529856026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00606373334002277,0.00275629120624045,0.000661402575791485,0.0114660641042541,0.027829710178893
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.020761942520495,0.00944488696012846,-0.0392739209623468,-0.00224996407864321,0.0279542116778517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,41839,0.00764137813945405,0.00347686499569567,0.000826722747890543,0.0144560335310176,0.0279821674461125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.0159418225183337,0.00727923826395119,-0.0302091295156781,-0.00167451552098939,0.0285382051785146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0123409472243361,0.00563819311788919,-0.0233918057353989,-0.00129008871327331,0.0286308333333768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,39475,-0.00936245421458387,0.00429267202028881,-0.0177760913743499,-0.000948817054817809,0.0292024137469807
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0138479139732037,0.00636486754140052,-0.0263230543543487,-0.00137277359205863,0.0296004519217649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,-0.00954352669517274,0.00438826082326663,-0.0181445179087753,-0.000942535481570146,0.0296636444346394
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00736683460360834,0.00338875532114712,0.000724874174159991,0.0140087950330567,0.0297335161567743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0192177649223936,0.00887755202846749,-0.0366177668981898,-0.00181776294659729,0.0304274511790197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.017643322952057,0.00815723820476328,-0.033631509833393,-0.00165513607072099,0.0305700676002097
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,39757,0.0388303148278551,0.0179673488768676,0.00361431102919463,0.0740463186265156,0.0307041926312082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00805636304735825,0.0037290448344049,-0.0153652909227919,-0.000747435171924644,0.0307567102167352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,39657,0.012772272472122,0.00591244730485384,0.0011838757546085,0.0243606691896356,0.0307759400831006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00803322869008877,0.00372064251202302,-0.0153256880136539,-0.000740769366523643,0.0308599991320771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,39979,-0.0060154039386113,0.00278659572387752,-0.0114771315574112,-0.000553676319811369,0.0308948539604501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,39575,0.0106419358645379,0.00495762531299351,0.000924990251070618,0.0203588814780052,0.0318486408456598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00934515526414652,0.00435432000175064,-0.0178796224675778,-0.000810688060715254,0.0318801093504303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.0061199537958542,0.00285587375136079,-0.0117174663485214,-0.00052244124318705,0.0321393876742321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,41843,-0.0168798057595924,0.00790313047068197,-0.0323699414821291,-0.00138967003705577,0.0327109131321815
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.017313102254257,0.00812046231625867,-0.033229208394124,-0.00139699611438998,0.0330262175169585
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.00479047861431058,0.00224737593471881,-0.00919533544635945,-0.000385621782261712,0.0330588128332666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00904739665901177,0.00426168638752902,-0.0174003019785686,-0.000694491339454898,0.0337793873181108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.00994865167865701,0.00469072955966524,-0.0191424816156009,-0.000754821741713147,0.0339471737252504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0182377049254152,0.00862483455348296,0.00133302920058863,0.0351423806502418,0.0344902304750767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,39919,-0.016094398930415,0.00761446156043366,-0.031018743588865,-0.00117005427196504,0.0345659542579527
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,39959,-0.00512578475028976,0.0024251113227114,-0.00987900294280411,-0.000372566557775416,0.0345687392296092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0116979934199566,0.00553571927987877,-0.022548003208519,-0.000847983631394223,0.0346073823608268
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00718104441164918,0.00340089795739474,-0.0138468044081429,-0.000515284415155494,0.03475052924152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42018,0.0108862415094012,0.00515986820580373,0.000772899826025891,0.0209995831927765,0.0348948616296411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.00915959770375183,0.00434735877987036,-0.0176804209122977,-0.000638774495205921,0.0351459399783697
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00440038169146185,0.00208948192098149,0.00030499712633813,0.00849576625658557,0.0352289946374091
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.00741433925848814,0.00352365467438032,-0.0143207024202736,-0.000507976096702723,0.0353828270403462
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,39979,0.00513266643100482,0.00243987302684441,0.000350515298389782,0.00991481756361986,0.0354298939439902
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,39929,0.00866581327015084,0.00412485649611877,0.00058109453775804,0.0167505320025436,0.0356738649933037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0226601629454583,0.0107968961427682,-0.0438220793852841,-0.00149824650563257,0.0358602879002504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,39586,0.0106151157232247,0.00505824899799199,0.00070094768716039,0.020529283759289,0.035877139004983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,39575,0.00985354557028954,0.00471506851756088,0.000612011275870215,0.0190950798647089,0.0366588200476189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,39657,0.00860972913304749,0.00412222346856216,0.000530171134665658,0.0166892871314293,0.036765397429923
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.0148341337594092,0.00710356105533493,-0.0287571134278657,-0.000911154090952774,0.0367921597225101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.0146939033401495,0.00705102055707854,-0.0285139036320234,-0.000873903048275547,0.0371846528291145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0101920489312886,0.00492456672084387,-0.0198441997041426,-0.00053989815843462,0.0385096725081496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00804911840507748,0.00389290127389639,-0.0156792049019144,-0.000419031908240557,0.0386932645630745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,41913,-0.0106968163226391,0.00517752121746616,-0.0208447579088728,-0.000548874736405419,0.0388467315362188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.0074859475939719,0.00362447423702912,-0.014589917098549,-0.000381978089394822,0.0389088847846748
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.0153587174417551,0.00743869627221405,0.000778872748215559,0.0299385621352946,0.0389741491112379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00658664921221683,0.00319528570139098,-0.0128494091869432,-0.000323889237490517,0.0392874139345932
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,39958,-0.00855722177558297,0.00415416248020179,-0.0166993802367785,-0.000415063314387471,0.039429395770616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,41913,0.0103004667098236,0.00501335254517033,0.00047429572128972,0.0201266376983574,0.0399365024720309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.0123705823641821,0.00602201862173639,-0.0241737388627854,-0.000567425865578754,0.0399733817747392
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,39586,0.0205154432979172,0.0100247274265191,0.000866977541939654,0.0401639090538947,0.0407325337974778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0221401045213994,0.0108444393269699,-0.0433952056022603,-0.0008850034405384,0.04121347206311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0139553508153275,0.00685420235035303,-0.0273895874220194,-0.000521114208635516,0.0417668058205376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0171680644073925,0.0084398356280105,-0.0337101422382931,-0.000625986576491936,0.0419542972774763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00938421187089371,0.00461779899196823,-0.0184350978951514,-0.000333325846635982,0.0421546589253013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0182416717400912,0.00904974435310011,-0.0359791706721674,-0.000504172808014947,0.0438545339657553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0100169950513843,0.004974230202115,0.000267503855238887,0.0197664862475297,0.0440564400190371
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.0114896258550997,0.0057245258365283,0.000269555215504201,0.0227096964946951,0.0447644346039499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00565296792412388,0.00281833318124051,0.000129034888892486,0.0111769009593553,0.0449038181141525
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00962656099072818,0.00481396820824704,-0.0190619386788924,-0.000191183302563989,0.0455557034312176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0151505764988163,0.00759350796442547,-0.0300338521090902,-0.000267300888542375,0.0460454513084961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0248281348519012,0.0124453898034089,-0.0492210988665827,-0.000435170837219709,0.0460668908830797
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00710983718725332,0.00356463701128651,-0.0140965257293749,-0.000123148645131757,0.0461169661975838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0180802747950582,0.00906504664390821,0.000312783372998084,0.0358477662171183,0.0461216596436978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0054136213395168,0.00271513528874188,9.19561735827183e-05,0.0107352865054509,0.0461864990600331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0128207487767103,0.00643034397978873,-0.0254242229770962,-0.00021727457632437,0.046199862143276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0108853392555727,0.00545989050499861,-0.02158672464537,-0.000183953865775454,0.0462102804455006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.0095052046573681,0.0047907190545395,0.000115395310470678,0.0188950140042655,0.0472660365461904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00831138661463182,0.00420541076072213,6.87815236164423e-05,0.0165539917056472,0.048139528037442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.0063228119794533,0.00320068485060939,-0.0125961542866477,-4.94696722588978e-05,0.0482414745808421
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.00821050782808674,0.00416498274169272,4.71416543690005e-05,0.0163738740018045,0.0487116842434204
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42070,-0.00609856518592004,0.00309570592814462,-0.0121661488050835,-3.09815667565898e-05,0.0488579165327067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42079,0.00607897766254655,0.00308630369015241,2.98224298478375e-05,0.0121281328952453,0.0488974697896947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,39930,-0.0132745905575582,0.00674291680499044,-0.0264907074953395,-5.84736197769553e-05,0.0490151227675757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,0.00831616231058544,0.00422923474553061,2.68622093454515e-05,0.0166054624118254,0.0492784041453313
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.01105606798697,0.0056240706754537,-0.0220792465108592,-3.28894630807243e-05,0.0493405796860534
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.00722702049379527,0.00367950417655545,-0.014438848679844,-1.51923077465798e-05,0.0495355032470922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.0106865996737434,0.005459334774053,-1.36964834004938e-05,0.0213868958308872,0.050314690847086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00585720846898204,0.00299494424484657,-0.0117272991888813,1.28822509172389e-05,0.050525852855664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.00659631661833123,0.00338119725287201,-0.0132234632339604,3.08299972979044e-05,0.0510920629045161
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00919617334403727,0.00471547289414194,-0.0184385002165555,4.61535284809328e-05,0.0511762757909628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0131011423337865,0.00672299219414603,-0.0262782070343128,7.59223667396933e-05,0.0513556952837696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42262,-0.00514463308603956,0.00264473521528804,-0.0103283141080041,3.90479359249985e-05,0.0517671155934532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00880280672826518,0.00453239242097329,-8.06824168424758e-05,0.0176862958733728,0.0521384090780739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,39934,-0.00473449500196602,0.00244470408204195,-0.00952611500276824,5.7124998836206e-05,0.0528150254442575
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.0047525478366871,0.00245703585505742,-0.00956833811259964,6.32424392254371e-05,0.0531016369564784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0113878951633369,0.00594109818615207,-0.023032447608195,0.000256657281521166,0.0552892964753825
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,39930,-0.023954727454022,0.0125118682959148,-0.048477989314015,0.000568534405971061,0.055573748220347
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00968746223953716,0.00506083368383921,-0.000231771780787685,0.019606696259862,0.0556202545813928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00461768277958117,0.00241686534063536,-0.00935473884722647,0.000119373288064134,0.0560808030895626
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.0118008501720023,0.00620302311514982,-0.000357075133691364,0.0239587754776959,0.0571404182018125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0135573365367094,0.00713803966326027,-0.000433221203280725,0.0275478942766995,0.0575501728674494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.00375876797273897,0.00198076572396581,-0.00764106879171195,0.000123532846234012,0.0577696269216239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0158812923417003,0.00837138585155327,-0.0322892086107447,0.000526623927344101,0.057841796423897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0162187423361835,0.00855117650166388,-0.000541563607077692,0.0329790482794447,0.0578975813132521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00704551450036483,0.00373228281271195,-0.000269759812550588,0.0143607888132802,0.059089539147114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00728177308643603,0.00385816912539358,-0.000280238399335381,0.0148437845722074,0.0591325073778924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00985635542321927,0.00524147243926531,-0.000416930557740728,0.0201296414041793,0.0600724648421076
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.00699227944019706,0.00372130029890733,-0.0142860280260554,0.000301469145661304,0.0602717755750641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.00937440588935426,0.00499153371040712,-0.0191578119617522,0.000409000183043696,0.0603984773843232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0103973061554665,0.00555297623789291,-0.00048652727080362,0.0212811395817366,0.0611790947104261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00673640659268594,0.00359788107279663,-0.000315440309995445,0.0137882534953673,0.0611880467819859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0108534299262011,0.00579965134627929,-0.000513886712506332,0.0222207465649085,0.0613167383619704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00593765510917013,0.00318268274807124,-0.000300403077049504,0.0121757132953898,0.0621221269410631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0280458155457685,0.0150847027900514,-0.0576118330142691,0.00152020192273218,0.0630177058436061
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,39649,0.0134958594447253,0.00726213725823132,-0.000737929581408035,0.0277296484708587,0.0631406915908109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.01373684490831,0.00739727548945465,-0.0282355048676411,0.000761815051021136,0.0633313412125939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00603472433896429,0.00325276354460763,-0.0124101408863952,0.000340692208466666,0.0635848997662897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0179041986510901,0.00966017052898932,-0.0368381328879092,0.00102973558572894,0.0638462468070408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.0105021256420345,0.00567715449905208,-0.0216293484601766,0.000625097176107542,0.0643549995386776
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.00595823694063256,0.00322903451984174,-0.000370670718257254,0.0122871445995224,0.0650289912686547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,39657,0.0110485548199392,0.00601098002981009,-0.000732966038488549,0.022830075678367,0.066080059686778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.00390819868524376,0.00212775764747871,-0.00807860367430203,0.000262206303814514,0.0662701611920674
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0164214182496454,0.0089451409096414,-0.0339538944325425,0.00111105793325178,0.0664103312788837
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42249,-0.00446669244222248,0.00243513967890463,-0.00923956621287555,0.000306181328430594,0.0666363647782489
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00765786221644034,0.00419471434154679,-0.015879502325872,0.00056377789299136,0.0679379945291653
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42119,-0.0133039645384226,0.00729798890307375,-0.0276080227884472,0.00100009371160193,0.0683310534533938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,39979,0.00591277080235106,0.00324783246960104,-0.00045298083806698,0.0122785224427691,0.0687048502523949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0159033812196045,0.00875236049740558,-0.0330580077945194,0.00125124535531047,0.0692382051124445
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0152190708734736,0.0084004164456781,-0.0316838871070027,0.00124574536005543,0.0700590323140995
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00994972417873952,0.00549470457465696,-0.00081989678758811,0.0207193451450672,0.0702015963013784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,39560,0.00599337951136869,0.00331310905027071,-0.0005003142271619,0.0124870732498993,0.0704800228412601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00519834948528416,0.00287405465845901,-0.000434797645295505,0.0108314966158638,0.0705225306938956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0123000278775686,0.00680461320391009,-0.0256370697572324,0.00103701400209519,0.0706904790759661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0191269198781365,0.010588683008379,-0.0398807385745594,0.00162689881828636,0.0708894407794508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,39757,-0.0136836876780048,0.00760718236454876,-0.0285937651125204,0.00122638975651075,0.0720796685906168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,39757,0.00650076580096713,0.00361506916013687,-0.000584769752901134,0.0135863013548354,0.0721658373488014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,41913,-0.00987309756023641,0.00549631829988771,-0.0206458814280163,0.0008996863075435,0.07246771679952
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00567860294287715,0.00316730758356906,-0.000529319920918201,0.0118865258066725,0.073014802844528
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.00791299199298598,0.00441727425703792,-0.0165708495367803,0.000744865550808339,0.0732554247129333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0180241790886429,0.0100631120779411,-0.0377478787614074,0.00169952058412168,0.073297384771083
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.0133754221273174,0.0074903242866677,-0.0280564577291861,0.00130561347455126,0.0741760778750824
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,39649,-0.0142022197700779,0.00797079844952922,-0.0298249847311552,0.00142054519099937,0.0748123571336139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.0129018975273315,0.00724252970014116,-0.0270972557396082,0.00129346068494515,0.0748682864607436
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,41900,-0.00931352483009926,0.00523692076991836,-0.0195778895391392,0.000950839878940724,0.0753552251365046
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.00424548427179764,0.00239111879981476,-0.00893207711943457,0.000441108575839295,0.0758341997344088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.00992950843614653,0.00559441037755423,-0.00103553590385976,0.0208945527761528,0.0759375784875653
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.0119000485898822,0.00670905021390787,-0.0250497870091416,0.00124968982937726,0.0761354601168894
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.0109289559030565,0.00616616024896356,-0.0230146299910251,0.00115671818491208,0.0763544510755809
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.0102772957361317,0.00581081685352845,-0.00111190529678407,0.0216664967690475,0.0769803224864455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.00661595671908337,0.00374600462695749,-0.0139581257879201,0.000726212349753312,0.0773998480307989
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00724030886236949,0.00409959999726812,-0.000794907132276038,0.015275524857015,0.0774064666445095
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,39919,0.0199479875785834,0.0113297877516509,-0.00225839641465234,0.0421543715718192,0.0783217202233275
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.00544264758727787,0.00311531147017424,-0.0115486580688194,0.000663362894263649,0.0806488854459771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0119908484950177,0.00686671642655062,-0.0014679157010215,0.0254496126910569,0.0807945064689733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00727930032736769,0.00417545256108162,-0.000904586692352284,0.0154631873470877,0.081298992368016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.00582736251832907,0.00334578015710801,-0.000730366589602634,0.0123850916262608,0.0815871232037381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42016,0.00637972451578983,0.00366299796239424,-0.00079975149050287,0.0135592005220825,0.0815895611497037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0086114524539589,0.00495767408199677,-0.0183284936546726,0.00110558874675477,0.0824108801011385
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.0145290061511902,0.00839984064691509,-0.00193468151676335,0.0309926938191438,0.083716261305903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,39929,-0.00564472976573242,0.00326789461905911,-0.0120498032190883,0.000760343687623438,0.0841358150025043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42224,-0.0113542729900139,0.00657974669262288,-0.0242505765075547,0.00154203052752698,0.0844349031748179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00784119879950247,0.00454456152637083,-0.00106614179218436,0.0167485393911893,0.0844826126563014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00475954200061273,0.00276027601922622,-0.0101696829982961,0.000650598997070664,0.0846810228090383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0312640318235487,0.0181512106747488,-0.00431234109895892,0.0668404047460564,0.0850164136439051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.0062566609405476,0.00363280716033936,-0.000863641093717547,0.0133769629748127,0.0850490240765129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0130348892356839,0.00757447476131398,-0.0278808597678593,0.00181108129649154,0.085296847513172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42286,-0.00558907283635735,0.00325281915833712,-0.0119645983866981,0.000786452713983401,0.0857783333655906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0113634181471466,0.00661831987326188,-0.00160848880444672,0.0243353250987399,0.0860083822577933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.00914140487297661,0.00533221933898053,-0.0195925547773784,0.00130974503142522,0.0864878581311839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.005240470945274,0.00306916692418892,-0.000775096226136281,0.0112560381166843,0.0877600364295886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00822871367102235,0.0048327069317755,-0.0177008192573023,0.00124339191525762,0.0886498678381764
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.0105391632034089,0.00620559723062059,-0.0227021337754253,0.00162380736860742,0.0894735379405629
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,39757,0.00761287182459002,0.00448621223834444,-0.00118010416256509,0.0164058478117451,0.089734260560561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.00789722056135336,0.00465609256143955,-0.00122872085906816,0.0170231619817749,0.0898942004733376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,39575,0.0102102277199873,0.00603082774745324,-0.00161019466502107,0.0220306501049956,0.0904827007568287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.00434104853108585,0.00258203114163596,-0.00940182956869234,0.000719732506520641,0.0927371288536939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,39958,0.00544494243148809,0.00325058118044923,-0.000926196682192406,0.0118160815451686,0.0939485445991557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,39657,-0.00717351188835353,0.00430075527633061,-0.0156029922299615,0.00125596845325447,0.0953508703865053
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.0119920857887547,0.0072033291924979,-0.0261106110060506,0.00212643942854115,0.0959767882459812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00660208144329908,0.00396786446880904,-0.0143790958021648,0.00117493291556663,0.0961632031483461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00440842759522176,0.00265755585666956,-0.000800381883850583,0.0096172370742941,0.0971782079396649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0165083571912878,0.00999032317363327,-0.036089390611609,0.00307267622903344,0.0984745609244542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00935374937635758,0.00568499776579834,-0.0204963449973223,0.00178884624460716,0.0999280603337449
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.00494640407458265,0.00300693296234743,-0.000947184531618316,0.0108399926807836,0.0999928829386903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,39919,-0.0199798293709766,0.0121570409641726,-0.0438076296607548,0.00384797091880168,0.100311847246267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.00644286714308168,0.00392489056635749,-0.0141356526531424,0.001249918366979,0.10071369014776
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,41825,-0.0099311510244997,0.00606055737136709,-0.0218098434723792,0.0019475414233798,0.1013093176284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0110893472283268,0.00677183774177855,-0.0243621492022127,0.0021834547455592,0.101535153749932
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0193351308769281,0.0118135395550276,-0.00381940665092603,0.0424896684047823,0.101717919558265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00821862127665108,0.0050280966344372,-0.018073690680148,0.00163644812684583,0.102174140145901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00766127357151944,0.00469999438817742,-0.0015507154293083,0.0168732625723472,0.103111967620891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.00482639347237942,0.00296193718271652,-0.00097900340574496,0.0106317903505038,0.10323634610601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00870510366783866,0.00534782133785893,-0.00177662615436484,0.0191868334900422,0.103598265291359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,39757,-0.0076223437000916,0.00468349763929971,-0.016801999073119,0.00155731167293584,0.103661393005435
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,39586,0.00924626906273273,0.00568564444135438,-0.00189759404232185,0.0203901321677873,0.10392554659267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,39757,-0.015188173611322,0.00935409874776452,-0.0335222071569405,0.00314585993429644,0.104469847932727
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.00546963803957724,0.00340337371595157,-0.0121402505228423,0.00120097444368783,0.108056129039271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.0069486815360379,0.00432732441109469,-0.0154302373817835,0.0015328743097077,0.108353069330333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00527812087238235,0.00329127693900004,-0.00117278192805773,0.0117290236728224,0.108815708013007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00758982023633303,0.00473830569235485,-0.0168768993933485,0.00169725892068247,0.109228307414078
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00908980764496598,0.00567645224894008,-0.0202156540528885,0.00203603876295658,0.109334276374954
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,41864,-0.00853844491431976,0.00534647271521518,-0.0190175314361415,0.00194064160750199,0.110284192692266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.0102870029570851,0.00644375682017271,-0.00234276041045344,0.0229167663246236,0.110421550447941
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42123,-0.00616803626698241,0.00386407839973054,-0.0137416299304543,0.00140555739648944,0.110456290203817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,41714,-0.00450788739663689,0.00284195270184613,-0.0100781146922553,0.00106233989898153,0.112719492694084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.00924112056885907,0.00583368328142472,-0.00219289866273339,0.0206751398004515,0.113195510005636
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.0115510452032254,0.00729254833852586,-0.0258444399467361,0.00274234954028528,0.113232583847789
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.00945066581908914,0.00597348461364119,-0.0211586956618259,0.00225736402364759,0.113654954573531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0132739422767937,0.00839481778939473,-0.0297277851440074,0.00317990059041995,0.113858720588603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00617660985415628,0.00391057595088037,-0.00148811900956924,0.0138413387178818,0.114253664233729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00686595448963103,0.00434970557732912,-0.0153913774211961,0.00165946844193405,0.114482386268102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.0106087799924715,0.00674465032899143,-0.0238282946372948,0.00261073465235167,0.115766737244313
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,39722,-0.00560064293082068,0.00359631048183791,-0.012649411475223,0.00144812561358163,0.119420561005379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00965039694023963,0.00622060996219755,-0.0218427924661468,0.00254199858566758,0.120839068590959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0136773568320037,0.00886039471363833,-0.0310437304707348,0.00368901680672741,0.122696236953195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00608622750072458,0.00394330012803691,-0.00164264075022777,0.0138150957516769,0.122754094550427
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00576050424118721,0.00373525620832718,-0.00156059792713407,0.0130816064095085,0.123054314892775
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00525125492480603,0.00341128956549697,-0.00143487262356804,0.0119373824731801,0.12374149891599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00393043242307025,0.00255355592343739,-0.00107453718686704,0.00893540203300753,0.123784223819556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.00669778572417519,0.00435924135508536,-0.0152418987801425,0.00184632733179212,0.124450026330601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00458819606458605,0.00299005817189323,-0.0104487100814968,0.00127231795232468,0.124934284242763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,39979,-0.00248182379853056,0.00162147493045906,-0.00565991466223032,0.000696267065169199,0.125896953686208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00461555438310912,0.00302614715831803,-0.0105468028134125,0.00131569404719422,0.127231663488435
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.00927364921488264,0.00609116835709922,-0.00266504076503184,0.0212123391947971,0.127913674921353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.00430428814103937,0.00282895017992504,-0.00984903049369244,0.0012404542116137,0.128158733125829
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00300675453203594,0.00198030660706996,-0.00688815548189306,0.000874646417821185,0.128959569555033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00563662475669774,0.00371340598424862,-0.00164165097242955,0.012914900485825,0.129065089104571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00744156850033395,0.00490301464450348,-0.0170514772035608,0.00216834020289287,0.129105281272786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42088,-0.0118295346763514,0.00779971056962725,-0.0271169673928208,0.00345789804011805,0.1293751529351
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,41913,0.00445160709380968,0.00293987076343726,-0.00131053960252736,0.0102137537901467,0.129994136424938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.0042950258567984,0.0028444949648845,-0.00128018427437522,0.00987023598797202,0.131086703867327
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.00787711081954885,0.00522852515334684,-0.0181250201201087,0.00237079848101096,0.131950207250944
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,39929,0.0146424674811638,0.00972841088792934,-0.00442521785917766,0.0337101528215053,0.132320004690146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,39586,-0.00797081457752596,0.00529890122841927,-0.0183566609852277,0.00241503183017582,0.132548552062291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00884659862058389,0.00590702665996895,-0.020424370874123,0.00273117363295525,0.134255408890803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.00839264990528751,0.00560854330623549,-0.0193853947855091,0.00260009497493405,0.134577050620806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42016,0.0205493887292968,0.0137569761471646,-0.00641428451914579,0.0475130619777394,0.135266285792295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,41913,0.00761187927901236,0.00509774875124786,-0.00237970827343344,0.0176034668314582,0.13541260334638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00797731224806284,0.00537041169650564,-0.0185033191732139,0.0025486946770882,0.137461341304665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,41843,0.00866369130508651,0.0058542113871672,-0.0028105630137612,0.0201379456239342,0.138921722942029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00472267343544637,0.00319485832877155,-0.0109845957598386,0.00153924888894587,0.139379902805151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,39560,0.00747027415726711,0.0050555462484624,-0.00243859648971919,0.0173791448042534,0.139533065751525
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.0057359323239843,0.0038959140608441,-0.0133719238832387,0.00190005923527013,0.140969170441466
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00576312053684744,0.00392128197158558,-0.00192259212746029,0.0134488332011552,0.141669920840438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00452129218939668,0.00308386732072325,-0.0105656721380143,0.00152308775922089,0.142645698753993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.00591479104080259,0.0040385369666935,-0.0138303234955219,0.00200074141391667,0.143061704471728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00419865733357995,0.00287075479169907,-0.00982533672531013,0.00142802205815023,0.143610534936995
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.00827359769096303,0.00566172242590715,-0.0193705736457411,0.00282337826381499,0.143950910633766
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00562984738393353,0.00386932463251312,-0.00195402889579218,0.0132137236636592,0.145699289185266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00535529774926525,0.00368132100995697,-0.0018600914302504,0.0125706869287809,0.145774906712661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.0114206245125321,0.00787771613293921,-0.0268609481330929,0.00401969910802878,0.147160137455438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.00936902442424082,0.00649560682528493,-0.0221004138017993,0.00336236495331764,0.149227600772006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,42060,0.0056437474580279,0.00391461607571979,-0.00202890005038288,0.0133163949664387,0.14940701102352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,41538,-0.00437869142911828,0.00305379110652758,-0.0103641219979123,0.00160673913967577,0.151638019565741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,39919,-0.00661832577401777,0.00461731078402896,-0.0156682549107145,0.00243160336267899,0.151779065981651
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.00719221685427664,0.00502704660643939,-0.0170452282028978,0.00266079449434457,0.152543470312132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.00785190853123046,0.00551272969604124,-0.00295304167301037,0.0186568587354713,0.154376207637509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0127780726612425,0.00900769521164092,-0.00487700995357366,0.0304331552760587,0.156051927128312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00376590602346752,0.00266021096769733,-0.00897991952015429,0.00144810747321925,0.156907873530172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00798700136529561,0.00565408630049978,-0.0190690105142752,0.00309500778368395,0.157794843629564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00449652928870075,0.00320642517460169,-0.0107811226309201,0.00178806405351858,0.160838928807707
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,39649,-0.00544645207372033,0.00388814383585552,-0.0130672139919971,0.00217430984455648,0.161306573320291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,39930,-0.00467907087180909,0.00334241662134978,-0.0112302074496547,0.00187206570603649,0.161568689283335
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,41800,-0.00722558269235531,0.00516923436768145,-0.017357282053011,0.00290611666830033,0.162195060380781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0104172983655595,0.00748483047387715,-0.00425296936323972,0.0250875660943587,0.164009632261112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00727652484786797,0.00524834990079206,-0.0175632906534204,0.00301024095768447,0.165640572211475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42187,0.00406119954120309,0.00293533827829839,-0.00169206348426174,0.00981446256666793,0.16651773695106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00328010957234048,0.00237699198724887,-0.00793901386734827,0.00137879472266731,0.167632599838232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00406718747869184,0.00296092154026882,-0.00173621874023505,0.00987059369761873,0.169586608635549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,39750,-0.0146846712455329,0.0107295837426709,-0.035714655381168,0.00634531289010209,0.171147167932945
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00615632932534246,0.00450090140683319,-0.0026654374320506,0.0149780960827355,0.171402917163543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.00237226352298568,0.00173505538895664,-0.00577297208534068,0.00102844503936933,0.171567740144684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.0067464933259962,0.00496018463133796,-0.0029754685514262,0.0164684552034186,0.17381668400147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0154874109226372,0.0114107907196978,-0.0378525607332448,0.00687773888797041,0.17472630421576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.00526327798140065,0.00387920192831166,-0.0128665137608915,0.0023399577980902,0.174873699076783
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00434942381826144,0.00322224961571312,-0.00196618542853627,0.0106650330650592,0.177100747415943
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0109754216187746,0.0081768121732884,-0.00505113024087069,0.0270019734784198,0.179538085496407
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.004537176546164,0.00338555034587037,-0.00209850213174192,0.0111728552240699,0.180221140693528
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.0100191015498037,0.00747778769774189,-0.00463736233777045,0.0246755654373777,0.180322185697757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0111732489028353,0.0083396472532437,-0.0275189575191929,0.00517245971352238,0.180346137365386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.0069901989094082,0.00522645228583238,-0.0172340453896397,0.00325364757082325,0.181098582957886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42189,-0.0065336037171159,0.00488817571615747,-0.0161144281207845,0.00304722068655273,0.181371069745798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00483686203500491,0.00362463498497807,-0.0119411466055619,0.0022674225355521,0.182082013831968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.00416664706058006,0.0031319410540922,-0.0103052515266008,0.00197195740544066,0.183418483593912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,39560,0.00765476756974751,0.0057684543185514,-0.00365140289461324,0.0189609380341083,0.184534681769861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,39560,-0.0101912848115434,0.00769429343321084,-0.0252720999406367,0.00488953031754981,0.185356328838065
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00505395614670858,0.00381584538900627,-0.00242510081574371,0.0125330131091609,0.185370803241896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00611277565042365,0.00461907547783416,-0.00294061228613131,0.0151661635869786,0.185737790917499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00880564210749298,0.00665803844160632,-0.0042441132380554,0.0218553974530414,0.186009935011242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,-0.00385386304488655,0.00291698856528279,-0.00957116063284083,0.00186343454306772,0.186468395780769
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00500747766794191,0.00379073341264039,-0.0124373151567171,0.00242235982083326,0.186536017653341
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.0095687883196103,0.00725285419040156,-0.00464680589357675,0.0237843825327974,0.187091892774746
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.010095800598563,0.00765493700122329,-0.00490787592383464,0.0250994771209606,0.187242957524685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.0122887779605978,0.00934337880970177,-0.0306018004276132,0.0060242445064177,0.188456802249816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.00905486604566102,0.00688503799432283,-0.00443980842321173,0.0225495405145338,0.188481740125915
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.00347632441974147,0.0026522347588595,-0.00867470454710609,0.00172205570762315,0.189976508773921
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42070,-0.0049257303077751,0.00375944423099549,-0.0122942410005263,0.00244278038497605,0.190140948863262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0153632743059591,0.0117569381832294,-0.0384068731450888,0.00768032453317062,0.191328008867808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42262,-0.00415700841834839,0.00318152587056798,-0.0103927991246616,0.00207878228796486,0.191367737470255
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00600727399248805,0.00460581379036806,-0.00302012103663336,0.0150346690216095,0.192165285590795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00983910951963715,0.00755341571623851,-0.0246438043234646,0.00496558528419034,0.192736469757538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.0146347246899702,0.0112473255079805,-0.036679482685612,0.00741003330567152,0.193225448136318
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00741708350689939,0.00570453822958294,-0.00376381142308318,0.018597978436882,0.193557194832107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00525239289121847,0.00404989859694891,-0.0131901941412383,0.0026854083588014,0.194685250715059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00926629400903659,0.00716146026727717,-0.00477016811482666,0.0233027561328998,0.19572286181359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00792605240674016,0.00612764094722673,-0.0199362286633046,0.00408412384982423,0.195863511888097
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0114544840708884,0.00886508867891465,-0.00592108973978431,0.0288300578815611,0.196353067077653
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42070,-0.0264688934993003,0.0205532454813906,-0.0667532546428259,0.0138154676442252,0.197830533714658
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00365601319850375,0.0028464486444109,-0.00192302614454162,0.00923505254154913,0.199024934590693
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,39649,-0.00554487868991123,0.0043413551969,-0.0140539348758352,0.00296417749601278,0.201550368738256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42310,-0.0077018444189627,0.00603259923438531,-0.0195257389183579,0.00412205008043251,0.201728342988609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00766323973788988,0.00603981926728196,-0.00417480602598276,0.0195012855017625,0.204544186624125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00559590966545952,0.00441062378407129,-0.00304891295132021,0.0142407322822392,0.204562573767499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00613495983818986,0.00483841802057264,-0.00334833948213252,0.0156182591585122,0.204836230904209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,39560,-0.00998774704905401,0.00790052473425705,-0.0254727755281978,0.00549728143008981,0.206189510023957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00653387376809227,0.00518199356625525,-0.0166905811579526,0.00362283362176802,0.207378768346383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00891908032225863,0.0070795428062163,-0.0227949842224426,0.00495682357792532,0.207754430536174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00665701710650622,0.00528463261565138,-0.0170148970331829,0.00370086282017049,0.207802174291571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0164242015105845,0.0130432104579511,-0.0419888940081687,0.00914049098699969,0.207978757706738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.0102663764564615,0.00815336340940628,-0.0262469687388978,0.00571421582597481,0.207995304984299
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00524348740957302,0.00416795007396962,-0.00292569473540744,0.0134126695545535,0.208399814515863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00910237286624924,0.007262080233981,-0.023336050124852,0.00513130439235353,0.210082789809056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.00481225353300214,0.00384443113507793,-0.0027228314917506,0.0123473385577549,0.210687998278354
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.0105867108354353,0.00847585150644693,-0.00602595811720073,0.0271993797880712,0.211674804235386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42310,0.0099351032516072,0.00796279491089188,-0.00567197477374088,0.0255421812769553,0.212165746140073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.0100741423490726,0.00808584849155219,-0.00577412069436967,0.0259224053925149,0.212828444862011
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.00647006625983178,0.00521698638797223,-0.00375522706059379,0.0166953595802573,0.214925806393459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00645018072090858,0.0052036188749587,-0.00374891227401047,0.0166492737158276,0.215165903394553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.0093360020833905,0.00753654022192493,-0.0241076209183634,0.00543561675158237,0.215453755223797
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,39657,-0.00440673440062389,0.00356851870274222,-0.0114010310579986,0.00258756225675087,0.216897025032308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,41900,0.0051604476857293,0.00419252273731053,-0.00305689687939935,0.0133777922508579,0.218393503754321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00484408065622928,0.00393626658638123,-0.00287100185307794,0.0125591631655365,0.218483336475806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,39649,-0.00768447282907173,0.00625476724497604,-0.0199438166292248,0.00457487097108131,0.219256031627804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00518320885188491,0.00422157538428099,-0.00309107890130583,0.0134574966050757,0.219552106352565
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00430243922351816,0.0035085400081453,-0.00257429919244663,0.0111791776394829,0.220121025116254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.0076124948230556,0.00621142607429421,-0.00456190028256106,0.0197868899286723,0.220389220729266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,39560,0.00402836443121666,0.0032905020485596,-0.00242101958396015,0.0104777484463935,0.220887995131203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.0136231349102024,0.011215502524032,-0.0356055198573052,0.00835925003690037,0.224517921272184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00540720597517106,0.00445309239439886,-0.0033208551178507,0.0141352670681928,0.224675181619562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.0109771010971231,0.00904456851167848,-0.0287044553800129,0.00675025318576674,0.22490036490252
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00461756718458112,0.00380500340630948,-0.00284023949178546,0.0120753738609477,0.224940721059432
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00576052224457044,0.00476705771695216,-0.00358291088065579,0.0151039553697967,0.226917901875644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00469120473133539,0.00391391963392505,-0.0029800777511577,0.0123624872138285,0.230711147516322
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.0093528488377977,0.00782642360268012,-0.00598694142345533,0.0246926390990507,0.232098821848922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.00654999603481972,0.00549302556167107,-0.017316326135695,0.00421633406605559,0.233122031808298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00599706898820999,0.00506078253652312,-0.00392206478337533,0.0159162027597953,0.236039884377591
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00434757328389211,0.00368586315490286,-0.0115718650675017,0.0028767184997175,0.238209420945974
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00494881253430083,0.00420823145938854,-0.0131969461947024,0.00329932112610071,0.239622440804866
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.0052530477197463,0.00447298355406919,-0.00351400004622931,0.0140200954857219,0.240262300546019
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00566243479591359,0.00483012334835975,-0.0151294765586987,0.00380460696687151,0.241094915953871
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00496134327378316,0.0042355649012407,-0.00334036393264861,0.0132630504802149,0.241477481662086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.00367586320781647,0.00313927429759933,-0.00982884083111115,0.00247711441547821,0.241648977049582
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00607468987463581,0.00518911568812524,-0.00409597687408967,0.0162453566233613,0.241756557301507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00554026770359718,0.00473362685450518,-0.00373764093123298,0.0148181763384273,0.241862032827406
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0196609270156539,0.0168333787900688,-0.0526543494441887,0.013332495412881,0.242838237898541
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,41843,0.011134959099884,0.00953440696290881,-0.00755247854741724,0.0298223967471853,0.242879756488747
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42196,-0.0044039995730344,0.00377966021446636,-0.0118121335933885,0.00300413444731966,0.243964966432777
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00471262543359581,0.00405257318664918,-0.00323041801223658,0.0126556688794282,0.244906542882635
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.00843609651885325,0.00726200607650897,-0.0226696284288108,0.00579743539110434,0.245392341202428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00478688775692422,0.00413507171032344,-0.0128916283091582,0.00331785279530973,0.247039790286577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.00656549703140279,0.00567414092117447,-0.0176868132369048,0.00455581917409918,0.247260028219396
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00801896950508186,0.00693864836987664,-0.0216187203100401,0.00558078129987636,0.247830638839499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.00959856374393742,0.0083303498323499,-0.0259260494153432,0.00672892192746838,0.249246644363514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42145,-0.0142178782754397,0.0123454502269701,-0.0384149607203011,0.00997920416942165,0.24947724463577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00477635302337695,0.00414867040244452,-0.0129077470121682,0.00335504096541431,0.249634245571897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00351835178848201,0.00306038549344341,-0.00248000377866707,0.00951670735563109,0.250310945059064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00367929362196632,0.00320283830681837,-0.00259826945939768,0.00995685670333032,0.250679667179919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00490407487797156,0.00427314070907225,-0.00347128091181004,0.0132794306677532,0.25113761798321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,39575,-0.00859959402645234,0.00749369669171401,-0.0232872395422118,0.00608805148930712,0.251168240443217
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,39649,0.00423775613927107,0.00370518228083311,-0.00302440113116181,0.011499913409704,0.252757270411349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00771798959410433,0.00676994296728938,-0.0209870778099915,0.00555109862178286,0.254295327231548
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.0035277216699518,0.00309737748961349,-0.00254313820969065,0.00959858154959425,0.254753748135915
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00755577564558405,0.00664531079406446,-0.00546903351078228,0.0205805848019504,0.255558752120302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00838729617526454,0.00737666095994087,-0.00607095930621957,0.0228455516567486,0.255561292224814
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.00264365574156217,0.00232722803082289,-0.00720502268197504,0.0019177111988507,0.255990145629787
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.00738328697366652,0.00651763262884025,-0.0201578469261934,0.00539127297886038,0.257311387493302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0049305787199382,0.0043845494606413,-0.00366313822291874,0.0135242956627951,0.260805877556832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00366181511411211,0.00325704850002747,-0.010045630174166,0.00272199994594173,0.260921207082518
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00727658337377012,0.00647774418079347,-0.0199729619681253,0.00541979522058509,0.261321640756024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,39586,-0.00473917724752841,0.00422507620233393,-0.0130203266041029,0.0035419721090461,0.262023665932576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.0126353725857898,0.0113151386998667,-0.0348130444375286,0.00954229926594893,0.264156060936433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00290853866321372,0.00261401225013944,-0.00803200267348702,0.00221492534705958,0.265872853940561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00544857108050165,0.00491203008600795,-0.0150761500490772,0.00417900788807394,0.267355120410009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0089356716887488,0.00808956809160911,-0.00691988177080506,0.0247912251483027,0.269360637860236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.014968103076475,0.0136079994469888,-0.041639781992573,0.0117035758396229,0.271374411512845
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.0072955013659673,0.00666002607834411,-0.00575814974758714,0.0203491524795218,0.273358318007112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.00361003337540436,0.00329692909767802,-0.0100720144068533,0.00285194765604457,0.273549778891056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00558172228826628,0.005098230911104,-0.0155742548740301,0.00441081029749757,0.273612170147044
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42144,0.00391275571605209,0.00358118549806442,-0.00310636786015419,0.0109318792922584,0.274594729556526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00470135825433844,0.0043105781864657,-0.00374737499113434,0.0131500914998112,0.275448225558201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,39657,-0.00551892116270296,0.00507209166245252,-0.0154602208211099,0.00442237849570399,0.276576575300804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00679444956970957,0.00628790593863349,-0.00552984607001207,0.0191187452094312,0.279917316572349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,41913,0.00562076643812829,0.00522260131513822,-0.00461553213954261,0.0158570650157992,0.281839951220151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00405025129764755,0.00376487702206529,-0.00332890766560042,0.0114294102608955,0.282040379221262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.0056573705341727,0.00528658040207035,-0.00470432705388518,0.0160190681222306,0.284580710955902
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00778514729563681,0.00728153992921497,-0.00648667096562452,0.0220569655568982,0.285019942074411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00347373872569216,0.00325441967369246,-0.00985240128612938,0.00290492383474506,0.285814710879245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00558042986892167,0.00523434296506845,-0.0158397420804558,0.00467888234261249,0.286393530098497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.00256566926703304,0.00240776936375877,-0.00728489722000023,0.00215355868593416,0.286632721994204
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.00436010183884515,0.00411163337845063,-0.0124189032606084,0.0036986995829181,0.288968420566794
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,41839,-0.00671490439689505,0.0063445732210009,-0.0191502679100568,0.00572045911626671,0.289906213296842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00941320853491041,0.00890471099465274,-0.0268664420844298,0.00804002501460895,0.290487219994645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00295232261816911,0.00279426088191143,-0.0025244287103773,0.00842907394671552,0.29072839565502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.00669357793340054,0.0063372973598249,-0.0191146807586573,0.00572752489185626,0.290886749936381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00976810682019618,0.00925491966609196,-0.0279077493657364,0.00837153572534406,0.29123873383715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00329454075350805,0.00312906098027296,-0.00942750027484305,0.00283841876782696,0.292413007953195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00613233305367346,0.00582741697602506,-0.00528940421933566,0.0175540703266826,0.292669948509122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00647927700804293,0.00618381091283075,-0.00564099238110535,0.0185995463971912,0.294762760610937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,39510,0.00385523407829539,0.00371318637250217,-0.00342261121180885,0.0111330793683996,0.299174392487977
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00387947321627559,0.00373686485378841,-0.00344478189714971,0.0112037283297009,0.2992126847285
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00246271246686284,0.00237236300785108,-0.00218711902852527,0.00711254396225096,0.299253574101961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42249,-0.00324484960964253,0.00312604477547602,-0.00937189736957553,0.00288219815029048,0.299286189438133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,41865,-0.0083273470639218,0.00802842715339126,-0.0240630642845687,0.00740837015672508,0.299646335036118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.00534222216858363,0.00515043996394317,-0.0154370844979122,0.00475264016074498,0.299648697946903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00521336585145495,0.0050412893068984,-0.00466756119006592,0.0150942928929758,0.30109654854704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00410621909395028,0.00397816087705699,-0.00369097622508141,0.011903414412982,0.302005391183861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00395935178678493,0.00384816692136719,-0.0115017589526646,0.00358305537909475,0.303551970448958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00383391790218848,0.00373914260037471,-0.00349480159454594,0.0111626373989229,0.305222156295839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0085384937287704,0.00834737961768871,-0.00782237032189948,0.0248993577794403,0.306379840155071
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.0108743280652442,0.0106651183455268,-0.0317779600224768,0.0100293038919883,0.307929117098269
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00450203602146792,0.00444621571734203,-0.0132166188274583,0.00421254678452247,0.311294929062392
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00332891499270142,0.0032942709141783,-0.00978568598449088,0.00312785599908804,0.312269830133743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00830727715891992,0.00825680378145333,-0.00787605825272861,0.0244906125705685,0.314383062380512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00650498685464071,0.0065071656727524,-0.00624905786395399,0.0192590315732354,0.317490845527871
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.00306923464242206,0.00307477756529575,-0.00295732938555761,0.00909579867040173,0.318201483200739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00313437117293756,0.00314417318117559,-0.00302820826216659,0.00929695060804171,0.318843369575833
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.0114068371622953,0.0114651718643413,-0.0110648996918137,0.0338785740164042,0.319800996572526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,39966,-0.00912989463605159,0.00918277822308753,-0.0271281399533032,0.00886835068119997,0.320126715686536
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.00385191964796145,0.00387522961324872,-0.00374353039400603,0.0114473696899289,0.320251995038519
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00631730351735874,0.00635740637205974,-0.0187778200065958,0.00614321297187836,0.320394749872257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,41843,-0.00405295728257451,0.00408065655435854,-0.0120510441291172,0.00394512956396822,0.32062477156077
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,39560,-0.0035543989204674,0.00362683372712221,-0.0106629930256269,0.00355419518469212,0.327093886348821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,41913,-0.00475015391459094,0.00485796055127052,-0.0142717565950812,0.00477144876589929,0.328186936473825
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42262,0.00658868000155269,0.0067391421498178,-0.0066200386120902,0.0197973986151956,0.328253194266479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00487591512998479,0.0049891268988325,-0.0146546038516965,0.00490277359172691,0.328434397122481
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,39575,-0.0069058498019135,0.00706920589998135,-0.0207614933658769,0.00694979376204995,0.328644216749938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.00246454250906836,0.00253015577240344,-0.0074236478229791,0.00249456280484238,0.330040448042352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.00278051407839344,0.00286041392774456,-0.00838692537677277,0.00282589721998589,0.331037844080048
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00510727704494163,0.00525990370911147,-0.00520213422491686,0.0154166883148001,0.331578002774397
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00582106027359367,0.00600273922752522,-0.0175864291595431,0.00594430861235576,0.332200123768775
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00481853339735695,0.00499940186081846,-0.00498029424984722,0.0146173610445611,0.335152789356261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00602982818679261,0.00626231488644038,-0.00624430899063054,0.0183039653642157,0.335630985411709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00668446008983595,0.00696544684440402,-0.0203367359048678,0.00696781572519593,0.337247405492956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00378907191698002,0.00399008291318708,-0.00403149059286665,0.0116096344268267,0.342324325644355
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,39575,0.00598218882062979,0.00630808598992289,-0.00638165971961908,0.0183460373608787,0.342979004576758
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.00394038210690016,0.00415997677689797,-0.0120939365896202,0.00421317237581987,0.343551052952534
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,39970,0.00363477074033885,0.00383919680676446,-0.00389005500091949,0.0111595964815972,0.343784823352292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.00394863299641075,0.0041866535117447,-0.0121544738794304,0.00425720788660885,0.345625957670536
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,41913,0.00954827098946831,0.0101433927538592,-0.0103327788080956,0.0294293207870323,0.346553303613694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00700934543028585,0.00747317943503195,-0.0216567771229485,0.00763808626237676,0.348299081444708
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.0048187261080676,0.0051396133899264,-0.0148923683523233,0.00525491613618815,0.348488188135095
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42016,0.0105352504359298,0.0112562802708453,-0.0115270588949271,0.0325975597667866,0.349318755523609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,39908,-0.00616477588211184,0.00660546645065623,-0.019111490125398,0.00678193836117436,0.350693301785468
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00508066097959473,0.00548842660297555,-0.00567665516223734,0.0158379771214268,0.354616463424411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,39919,0.00463546505667797,0.00500924823413812,-0.00518266148223273,0.0144535915955887,0.354787287777269
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.00883716481023969,0.00957915821167917,-0.00993798528465149,0.0276123149051309,0.35626333683048
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,39979,-0.00200491304532781,0.00218480375698363,-0.00628712840901573,0.00227730231836011,0.358814899162133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,39979,-0.00146626432001324,0.00160480644116307,-0.00461168494469285,0.00167915630466637,0.360909362480224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00250355413124725,0.00274657339110517,-0.00287972971531888,0.00788683797781338,0.362041969235158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00494625736977012,0.00544538843749083,-0.00572670396771191,0.0156192187072522,0.363719243475811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,41774,0.00619947201362479,0.00684302602066067,-0.00721285898687013,0.0196118030141197,0.364976365576384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00465356478148483,0.00514406467131292,-0.0147359315372582,0.00542880197428849,0.365668596327077
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0038204531138433,0.0042241663964823,-0.00445891302326201,0.0120998192509486,0.36578839791147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00404362705813996,0.00447504958620685,-0.00472747013082547,0.0128147242471054,0.366230642856801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42070,-0.00185526391198484,0.00205867595684019,-0.00589026878739162,0.00217974096342194,0.367501940661919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.00675971825065638,0.00750756931754543,-0.0214745541130454,0.00795511761173266,0.36793036317193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00406026357885507,0.00454292577004306,-0.00484387093042932,0.0129643980881395,0.37147234482418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.0049898005979744,0.00559303299723237,-0.00597254407660106,0.0159521452725499,0.372334377064749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00742658303538294,0.00833996392759633,-0.0237729123334717,0.00891974626270587,0.37322697971098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00477190106989523,0.00541801296466145,-0.0153912064806317,0.00584740434084122,0.37847379835309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00384263168970244,0.00436901124710183,-0.00472063035461715,0.012405893734022,0.37913878482576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00495209553665958,0.00563356312315056,-0.0159938792580347,0.00608968818471551,0.379401919025938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00414041840224257,0.00472876624415571,-0.0134088002407878,0.00512796343630263,0.381276940390504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00385595760595337,0.00443669575425687,-0.00483996607239009,0.0125518812842968,0.384808211858276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00451481240026509,0.00519552435734706,-0.0146980401406653,0.00566841534013513,0.384876168509642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0129247074750593,0.0149709240495751,-0.0422677186122265,0.0164183036621078,0.387979425100355
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,39657,0.0068363087018616,0.00800154320942751,-0.00884671598861633,0.0225193333923395,0.39291643027755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00490395083275135,0.00574219403739367,-0.016158651146043,0.00635074948054025,0.393112023581748
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,0.0101495803069298,0.0119124887919315,-0.0131988977252559,0.0334980583391155,0.394222639535917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,39757,0.00517743331460444,0.00607974450203216,-0.00673886590937859,0.0170937325385875,0.3944614583958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00807045178403489,0.00953754547105681,-0.0267640409073062,0.0106231373392365,0.397472344231863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.00772626045919953,0.00916263007249668,-0.010232494482894,0.025685015401293,0.39911164613158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,39649,-0.00541958675082246,0.0064495729384722,-0.018060749710228,0.00722157620858304,0.400757462038131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.00275347224355596,0.0032772197659476,-0.00917682298481326,0.00366987849770134,0.400819307315443
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42262,0.00415496266221488,0.00496661833168083,-0.00557960926787955,0.0138895345923093,0.402844557762798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,41913,0.00273415982730635,0.0033018908123133,-0.00373754616482772,0.00920586581944043,0.407652029966285
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00493211144990743,0.00599499661472614,-0.0068180819149558,0.0166823048147707,0.410693858114719
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00553804305858807,0.00673629684975555,-0.0187411848841089,0.0076650987669328,0.411026441718712
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.00451877146105715,0.00550077967130655,-0.015300299616818,0.00626275669470369,0.411391689777122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.00496871504791503,0.00611471259527016,-0.0169535517346445,0.00701612163881448,0.416475289553297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,41913,-0.0120451919645792,0.0148462266509088,-0.0411437962003604,0.017053412271202,0.417190578985958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00489088806605227,0.00606982947337079,-0.016787753833859,0.00700597770175448,0.420392811142637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00245737134804507,0.00305004679556146,-0.00352072037125539,0.00843546306734552,0.420442898878702
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0166363096541145,0.0206608361513196,-0.0571315485107008,0.0238589292024719,0.420712716497337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,39757,0.00463034695358676,0.00576100866451546,-0.00666123002886355,0.0159219239360371,0.421564888005923
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00527771807453117,0.00662267210528839,-0.00770271925183408,0.0182581554008964,0.425516362528498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.00240728253162364,0.00302413266043916,-0.0083345825460844,0.00352001748283712,0.426034654145454
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00382977537967313,0.00483572540504448,-0.0133077971735603,0.00564824641421404,0.428389232056262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,39560,0.00567824865695802,0.00717158046700703,-0.00837804905837576,0.0197345463722918,0.428511413490817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00379179168858227,0.0047964745524296,-0.0131928818113443,0.00560929843417974,0.429230631065885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.00204094449442591,0.00259043399198182,-0.00303630612985845,0.00711819511871027,0.430782195392271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,-0.00519176332782599,0.00659744962833037,-0.0181227645993535,0.00773923794370155,0.431333773989831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00616135655975567,0.0078303917764786,-0.00918621132214239,0.0215089244416537,0.431385696872319
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00258681625574263,0.00328883324564051,-0.00903292941719804,0.00385929690571277,0.431562178727948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00484479504134481,0.00618941146485463,-0.00728645142977027,0.0169760415124599,0.433787157806479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,-0.00725827899100985,0.00929374142903182,-0.0254740121919122,0.0109574542098925,0.434824623406749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.00543940668751069,0.00696904117822741,-0.00821991402181503,0.0190987273968364,0.435107569922668
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00420240190726836,0.00540172078853867,-0.00638497083826744,0.0147897746528042,0.436600744020598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00719434948003365,0.00929848523405273,-0.025419380538777,0.0110306815787097,0.43911767154177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00403145954940134,0.00523434578368761,-0.00622785818662638,0.0142907772854291,0.441201645829904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00321252563394289,0.00418310048947363,-0.00498635132542543,0.0114114025933112,0.442514451608538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00675878489291417,0.00882084272001025,-0.0105300668383059,0.0240476366241343,0.443556598540292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00482514304842334,0.00634119651285097,-0.0172538882136112,0.00760360211676455,0.4467181858662
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,39822,-0.0025692196666979,0.00339320845315569,-0.00921990823488306,0.00408146890148726,0.448966738533146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.0026095919380926,0.00346097066200068,-0.00417391055942873,0.00939309443561393,0.450858748842891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00347852327642977,0.00461631291486393,-0.00556945003670354,0.0125264965895631,0.451148445461744
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00481838923822773,0.00643979168069098,-0.0174403809323821,0.0078036024559266,0.454342708187297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00424557878329652,0.00569405748396187,-0.00691477388526874,0.0154059314518618,0.455912820149682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,-0.00489015454365093,0.00657071282950955,-0.0177687516894896,0.00798844260218778,0.456747344523571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,41913,-0.00381949456872187,0.00518855367995004,-0.0139890597814239,0.0063500706439802,0.461659332588261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.00385987992870389,0.00524796027017222,-0.0141458820582414,0.00642612220083367,0.462047146676902
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,41839,0.00357583294017716,0.00489488550572738,-0.00601814265104851,0.0131698085314028,0.465082675555611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.00230989829859036,0.00319115235418412,-0.00856455691279124,0.00394476031561053,0.469173598741921
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00309489488718447,0.00428248762267653,-0.0114885706276305,0.00529878085326152,0.469888069133638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,39919,0.00304868274464226,0.00422004442778134,-0.00522260433380916,0.0113199698230937,0.470045648556285
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00298603034161603,0.00414383655011457,-0.00513588929660854,0.0111079499798406,0.471173282184027
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00242153508733771,0.0033723314528336,-0.00903130473489156,0.00418823456021615,0.472735823684877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00546676714333316,0.00762299224896228,-0.00947429766463292,0.0204078319512992,0.473302056503458
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42246,-0.00337489415223378,0.00471083584721739,-0.0126081324127799,0.00585834410831231,0.473749926013675
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00412222901350559,0.00576685730850712,-0.00718081131116837,0.0154252693381796,0.474738867351858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42310,0.00132829508377669,0.00185831731764837,-0.00231400685881413,0.0049705970263675,0.474754827394593
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00366656843815163,0.00513663447789427,-0.0137343720148244,0.00640123513852114,0.475361271975569
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.0020518636840701,0.00288066112507611,-0.00769795948921927,0.00359423212107908,0.476300766338167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,39966,0.00364813487400089,0.00517294122773855,-0.00649082993236667,0.0137870996803684,0.480678976540185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00311893434084054,0.00443898019001422,-0.00558146683158733,0.0118193355132684,0.482302341339436
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.00159916983727889,0.00227713567217502,-0.00606235575474193,0.00286401608018415,0.482523583566503
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42145,0.00353825664357689,0.0050988729846053,-0.00645553440624949,0.0135320476934033,0.487738536299594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,39929,0.00705151084227821,0.0102601304543642,-0.0130583448482756,0.027161366532832,0.49192476597202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00357209034319639,0.00521075027473955,-0.0137851608816859,0.00664098019529312,0.493028307891667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,41913,-0.00290119734034277,0.00423929090718831,-0.0112102075184319,0.00540781283774632,0.493760344233746
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.0018723577813644,0.00273868478913539,-0.00724017996806976,0.00349546440534095,0.494197288231922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.00455056737780433,0.00671116126229218,-0.00860330869628834,0.017704443451897,0.497747995326793
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,39979,-0.00137353406266846,0.00202928859458687,-0.00535093970805872,0.0026038715827218,0.49851173824174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,-0.00197784666359691,0.00293653539410343,-0.00773345603603964,0.00377776270884582,0.500623474932056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42048,-0.00420784962442197,0.00626098751712906,-0.0164793851579949,0.00806368590915099,0.501547858950325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00320382811822968,0.00477075053724812,-0.012554499171236,0.00614684293477662,0.501879839506479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00447163890972654,0.00669314267433601,-0.0175901985514251,0.00864692073197205,0.504088537723686
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.0031166973039019,0.00466691594879742,-0.00603045795574104,0.0122638525635448,0.504257307977464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,39649,-0.00292055747873674,0.00437483532666787,-0.0114952347190058,0.00565411976153228,0.50441495364669
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00588462675969842,0.00892191693683356,-0.0233715839558922,0.0116023304364954,0.509543821021555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.00260547309514446,0.00397648445998222,-0.00518843644642068,0.0103993826367096,0.512339596898502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.00254983033361568,0.00391400644678654,-0.0102212829693173,0.00512162230208594,0.514761224703436
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00277547622308262,0.00426665395835217,-0.0111381179814529,0.00558716553528764,0.515379999255053
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.0054593526784253,0.00845995768171705,-0.0220408697345907,0.0111221643777401,0.51873542701756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00456898674330029,0.00711432670981287,-0.0185130670945335,0.00937509360793294,0.520741368539504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.0029502188644988,0.00459957748375295,-0.00606495300365699,0.0119653907326546,0.521269085989577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.006249944403637,0.0098933161225534,-0.0256408440038417,0.0131409551965677,0.527573867395471
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00175571352041659,0.00279056497337863,-0.00722522086823872,0.00371379382740553,0.529256921231696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00330574293389509,0.00526262463146658,-0.0136204872115696,0.00700900134377941,0.529913515441836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00383251748328503,0.00613682051872229,-0.00819565073341066,0.0158606856999807,0.532304361088528
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.0023181181542453,0.00372185454203891,-0.00497671674815097,0.00961295305664157,0.533402916178222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,-0.00600695771110394,0.00966820042549904,-0.0249566305450821,0.0129427151228742,0.534405563378869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00276719018153264,0.00450749956551637,-0.0116018893299447,0.00606750896687946,0.539288424301728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00355620767356833,0.00585454650763186,-0.0150311188285268,0.00791870348139011,0.543580269366335
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00262112851734242,0.00432967417981287,-0.0058650328750908,0.0111072899097756,0.544934413265095
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00404183332538446,0.00668891383972929,-0.0171521044512539,0.00906843780048495,0.545682061733957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.00465444237660168,0.00772037573336779,-0.0197863788140025,0.0104774940607992,0.546602437006748
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00221209500118091,0.00367493296032279,-0.00499077360105176,0.00941496360341358,0.547225367639547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00238549325712432,0.00396903350920886,-0.0101647989351737,0.00539381242092504,0.547834843450755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00410428032952383,0.00685638193622276,-0.0175427889245204,0.00933422826547278,0.549446934386894
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.00364211644325248,0.00609640865496787,-0.0155910774069895,0.00830684452048454,0.550238944884539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.00174668065935651,0.00292839806151002,-0.00748634085991614,0.00399297954120313,0.550878014910901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.00651691963709469,0.0109513461614138,-0.0149477188392764,0.0279815581134658,0.551802719564863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,39586,-0.00391552280479991,0.00665419142826004,-0.0169577380041896,0.00912669239458977,0.556256111181494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.00169582021218027,0.00288276791860466,-0.00734604533264541,0.00395440490828487,0.556369176366861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,39929,0.00253974127148614,0.00432671866928812,-0.00594062732031857,0.0110201098632908,0.557222014271156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00354578028164779,0.00604556698771452,-0.00830353101427267,0.0153950915775682,0.557545473270756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,39649,0.0037347357884898,0.00636871796753101,-0.00874795142787098,0.0162174230048506,0.557606110209187
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.00442652383322567,0.00754940578160878,-0.0192233591651789,0.0103703114987275,0.55765628511611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00174297864319576,0.00298801032555084,-0.00759947888127541,0.00411352159488389,0.559687000552214
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00327209585436267,0.00564425587841229,-0.0143348373760508,0.00779064566732543,0.562114433595409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00464118182243954,0.00804960166826444,-0.0111360374473588,0.0204184010922378,0.564239490236413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,39657,-0.00106540993739985,0.00185323394205011,-0.00469774846381806,0.00256692858901837,0.565375829606577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42123,0.00794247306926776,0.0138503733446028,-0.0192042586861538,0.0350892048246893,0.566350729887831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.00764802779264448,0.0133383341972997,-0.0337911628193519,0.018495107234063,0.566392408389634
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00332713356006004,0.00581048949291941,-0.0147156929661821,0.008061425846062,0.566921422653329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,39925,-0.00295635476057014,0.00518027828960509,-0.0131097002081961,0.00719699068705584,0.568218275788969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,39560,0.0037768307906748,0.00661975201588814,-0.00919788316046596,0.0167515447418156,0.568323455093745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00311195455484448,0.0054666673082423,-0.00760271336931044,0.0138266224789994,0.569191416901024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,39806,0.00219571139581619,0.00385741988593997,-0.00536483158062614,0.00975625437225852,0.56921986809778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.0020280712669382,0.00357925101685152,-0.00904340325996717,0.00498726072609078,0.570982440694293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00385367750979289,0.00680219683016936,-0.0171859832969248,0.00947862827733905,0.571042238704576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.00201308302479889,0.00356044149524059,-0.00899154835547044,0.00496538230587266,0.571809466027284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00199504595765092,0.00353186353921842,-0.00891749849451902,0.00492740657921718,0.572173311736916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,39649,0.00292796127193869,0.0051872063222423,-0.00723896311965622,0.0130948856635336,0.57245378118001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42208,-0.00670678110360709,0.0120347584880799,-0.0302949077402436,0.0168813455330294,0.577342415300544
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00281125912080724,0.00512700180264571,-0.0128601826539928,0.00723766441237834,0.583480471789924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00275841694416773,0.00507234707729033,-0.0127002172156568,0.00718338332732132,0.586579683097085
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,41913,0.00428813908535341,0.0078872956655778,-0.0111709604191791,0.0197472385898859,0.58667305464642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.00297218201317068,0.0054847151920394,-0.0137222237895679,0.00777785976322654,0.587896459004871
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.0028620921515342,0.00528408367079826,-0.00749471184323039,0.0132188961462988,0.588074793065063
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00275444410596118,0.00510228745524781,-0.00724603930632453,0.0127549275182469,0.589314837948489
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.0050192689367448,0.00932999960551522,-0.0233060681635546,0.013267530290065,0.590607821356884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00288355182659103,0.00538569042366705,-0.0134395050569785,0.0076724014037964,0.592375839461703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00147551233091322,0.00277035245580241,-0.00690540314428594,0.0039543784824595,0.594315571904705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.00303747676739616,0.00573593810893504,-0.00820496192611651,0.0142799154609088,0.596432991149495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00282873896615607,0.00535527459187253,-0.0076675992339141,0.0133250771662262,0.597360462801536
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00293564649043554,0.00560278316679686,-0.0139171014973574,0.0080458085164863,0.600315660131818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00387069648841369,0.00740994431750577,-0.018394187350725,0.0106527943738976,0.601426504563365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,41900,0.0018178543349932,0.00349516026231057,-0.00503265977913552,0.00866836844912192,0.602998251412709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.00381187438779228,0.00735469468668332,-0.010603327198107,0.0182270759736916,0.604265479220282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.00302256106886848,0.00584907888534545,-0.00844163354640862,0.0144867556841456,0.605335115518631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.0023046058533908,0.00446099403486439,-0.011048154161725,0.0064389424549434,0.605436948258678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00468873051764355,0.00907877579328277,-0.0224831310724778,0.0131056700371907,0.605549024591548
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00329539239251017,0.00641468603530234,-0.00927739223668242,0.0158681770217028,0.607453447213251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00244406416970548,0.0047652009323213,-0.0117838579970552,0.00689572965764427,0.608030868144312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,41913,0.00335588235995639,0.00654729840915433,-0.00947682252198608,0.0161885872418989,0.608267740718698
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.00173343237596779,0.00338734132810791,-0.00837262137905928,0.00490575662712371,0.608842656284049
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00200120623931165,0.00391587123933679,-0.00567390138978844,0.00967631386841175,0.60932621373808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00180699706479989,0.003549521060344,-0.00876405834307413,0.00515006421347436,0.610705025157555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00258902918522991,0.0051041496512412,-0.0125931625016627,0.00741510413120285,0.611994837451747
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00320382010921098,0.00633443947415092,-0.0156193214785468,0.00921168126012483,0.613022654245974
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,39900,-0.00286345020322285,0.00568746747589571,-0.0140108864559784,0.00828398604953274,0.614646035212624
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00166836791418705,0.00332161366263612,-0.00484199486457974,0.00817873069295385,0.615481465496276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.00219364017864984,0.00439454489238851,-0.00641966781043165,0.0108069481677313,0.61766712831346
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,41900,0.00146397034677612,0.00293620682745547,-0.00429099503503661,0.00721893572858884,0.618074820570742
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.00294472511289808,0.00594656056958385,-0.0145999838292824,0.00871053360348627,0.620468555665125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0021698179070617,0.00438668014920272,-0.010767710999499,0.00642807518537563,0.620865701501248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00278094333998798,0.00565432248521474,-0.0138634154110089,0.0083015287310329,0.622852115079749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.00190859848439814,0.00394721898541553,-0.00964514769581257,0.00582795072701629,0.628727351178167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.00127829601890219,0.00264514092787862,-0.0039061801997399,0.00646277223754429,0.62891755416365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00175246956377157,0.00362667047915152,-0.00886074370290855,0.0053558045753654,0.628951174577378
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.00188508531301648,0.0039016277587422,-0.00576210509411822,0.00953227572015118,0.628996381495826
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.00145013272926923,0.00301626547119847,-0.00446174759427978,0.00736201305281824,0.630688831770023
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.0018817600115948,0.00395124477749169,-0.00586267975228891,0.00962619977547851,0.633909437591763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00393929877436137,0.00834651975231722,-0.0124198799401804,0.0202984774889031,0.636958313428517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00272114170774494,0.0057879091942202,-0.00862316031292665,0.0140654437284165,0.638260961188075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.00871908600889532,0.0186105642286939,-0.0451957918971354,0.0277576198793448,0.639434675420196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.00171372611812736,0.00366138796944252,-0.00889004653823469,0.00546259430197997,0.639755427016579
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00212777290762507,0.00456175753529837,-0.00681327186155974,0.0110688176768099,0.640911644948452
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42115,0.00368415844534038,0.00793297099293223,-0.0118644647008068,0.0192327815914876,0.642360840679508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42262,0.00218124421287536,0.00473860853023067,-0.00710642850637676,0.0114689169321275,0.645298730061918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00321237585955418,0.00701186300276983,-0.0105308756258747,0.016955627344983,0.646864874172249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.00272969728443342,0.00599553327844224,-0.0144809425101802,0.00902154794131337,0.648910652918681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,0.00233136583316664,0.00513026747981709,-0.00772395842727485,0.0123866900936081,0.649523999872728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.00178617836593189,0.0039613072304533,-0.00955034053762036,0.00597798380575658,0.652064224821514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.00359168678959323,0.00798712922210736,-0.0192464600649237,0.0120630864857372,0.652946949395465
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,41913,0.00246091644329834,0.00550367551041604,-0.00832628755711709,0.0132481204437138,0.65478086345985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.00924093046877734,0.0206849584848837,-0.0497834490991493,0.0313015881615947,0.655065359375511
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.00233507697389398,0.00528486891914637,-0.0126934200554209,0.00802326610763292,0.658612259983352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42119,0.00373937475630738,0.00846573997347409,-0.0128534755917018,0.0203322251043166,0.658708466647955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.00163589155014701,0.00372082946241871,-0.00565693419619365,0.00892871729648767,0.660192142948031
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,39638,0.00372545687067772,0.00849898295708882,-0.0129325497252164,0.0203834634665718,0.66114733060209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,-0.00172566067510566,0.00396172009705197,-0.00949063206532751,0.00603931071511619,0.663145865312795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00147639236966127,0.00339035652940223,-0.00516870642796709,0.00812149116728964,0.663229694433272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00185708665531293,0.00431996036228167,-0.00661003565475915,0.010324208965385,0.667287665511782
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00288489892507425,0.00672820901814366,-0.0103023907504873,0.0160721886006358,0.66809284378088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,39919,-0.00123141616995432,0.0028722161612994,-0.00686095984610114,0.00439812750619251,0.668125113544901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.00592546908516989,0.0138301926996319,-0.0211817086061086,0.0330326467764483,0.668334341026435
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.00278322804901302,0.00655009275568128,-0.0156214098501483,0.0100549537521223,0.670906026944079
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00313192038652971,0.00746705928123252,-0.0177673565777455,0.011503515804686,0.674908832285694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.00139424339769105,0.00334809805446584,-0.0079565155844441,0.005168028789062,0.677104571806437
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0033731969103384,0.00817384158032419,-0.012647532587097,0.0193939264077738,0.679846300578937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00262269483539647,0.00636763939837559,-0.00985787838541968,0.0151032680562126,0.680436400517985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00733977629287143,0.0179575595425065,-0.0278570404104413,0.0425365929961842,0.682746235857224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.00336263288370832,0.0082800747991897,-0.0195915794901201,0.0128663137227035,0.684668612171923
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,0.00364663317657743,0.00909132552223046,-0.0141723648469943,0.0214656312001491,0.688344741329336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.00222131609988125,0.00558247711835529,-0.0131629712518576,0.00872033905209513,0.690705114821131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.0020039538633572,0.00504462826359364,-0.0118914252600007,0.00788351753328634,0.691194451768344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.00260552272393937,0.00658678288795759,-0.0103045717364575,0.0155156171843362,0.692429840843022
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.00457081789965069,0.0116062314542544,-0.0273190315499894,0.018177395750688,0.693718033137783
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,39560,0.00497979847909785,0.0126456662541384,-0.0198057073790135,0.0297653043372092,0.693740154044249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00290102848377441,0.00738971077735861,-0.0115828046398485,0.0173848616073973,0.694639629700271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,39966,0.00182491431264683,0.00468794680497772,-0.00736346142510951,0.0110132900504032,0.697077840159207
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.0012294563785809,0.00318295542887852,-0.0074680490191828,0.00500913626202099,0.699309689008823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.00199167506241205,0.00515834420454454,-0.00811867957849524,0.0121020297033193,0.699423271850071
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.00152221383876155,0.00395353049478101,-0.00622670593100922,0.00927113360853233,0.700225225124278
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.0012625276822744,0.00327977310396065,-0.00516582760148848,0.00769088296603728,0.700286650304248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,39757,-0.00147101371392272,0.0038417562452112,-0.00900085595453668,0.00605882852669123,0.701800193014269
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.00398612595617612,0.0104283526925843,-0.0164534453212892,0.0244256972336414,0.702291287337666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00187116391289284,0.00490238412530379,-0.0114798367984883,0.00773750897270258,0.702702751234329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00241124235558674,0.00635405340102416,-0.0100427023104206,0.0148651870215941,0.704338084352478
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00166201405924574,0.00441080825163841,-0.010307198232457,0.00698317011396554,0.706325847101275
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00283002023608296,0.00756032225911453,-0.0119882113917815,0.0176482518639474,0.708168245634075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.0015260381014364,0.00408463929509217,-0.00953193111981706,0.00647985491694426,0.708705853259127
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,39575,0.00325314680559163,0.00893007449456166,-0.0142497992037492,0.0207560928149325,0.715647651117361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,39560,0.0036448241385903,0.0100149525428772,-0.0159844828454491,0.0232741311226297,0.715911153451683
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.00461830176416644,0.0127164028388733,-0.0295424513283582,0.0203058478000253,0.716479847206398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00266343015171137,0.00738385363343581,-0.0118089229698228,0.0171357832732456,0.718323159440728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,41843,-0.00301471381651571,0.0084391742179651,-0.0195554952837273,0.0135260676506959,0.720926420049949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.00121781990227369,0.00341145002588642,-0.00790426195301108,0.0054686221484637,0.721112235811883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,39586,0.00349521522137452,0.00986871424901823,-0.0158474647067012,0.0228378951494503,0.723217318026375
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,0.00119617020131765,0.00339253579000396,-0.00545319994709011,0.00784554034972542,0.724403443382032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,41820,0.00134275173773146,0.00382826439676827,-0.00616064647993435,0.00884614995539727,0.725783851485975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.00205123954008085,0.00585554003721912,-0.0135280980130303,0.00942561893286862,0.726114675729647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,39652,0.00268669370506693,0.00768828243190966,-0.012382339861476,0.0177557272716099,0.726755874238074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,39657,0.00125406529508414,0.00358914171953761,-0.00578065247520958,0.00828878306537786,0.726791676342185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00150984851682828,0.00436250077832638,-0.00704065300869144,0.010060350042348,0.729276437537974
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00249030495311567,0.00722006434678958,-0.0166416310728232,0.0116610211665919,0.730165245014447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00374897116826819,0.0108778622796428,-0.0250695812363681,0.0175716388998318,0.730369822406738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.00330873685685605,0.00964741836939004,-0.0222176768608605,0.0156002031471484,0.731630378899656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00113884992640877,0.00332951590303206,-0.00766470109635161,0.00538700124353407,0.73232224896404
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00223994298096658,0.00655609437499876,-0.010610001994031,0.0150898879559641,0.73261471580405
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42145,-0.00141278488659629,0.00419245858578659,-0.00963000371473801,0.00680443394154543,0.736135365309136
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,41913,0.00172759220791183,0.00518243022540022,-0.0084299710338726,0.0118851554496963,0.73887111376861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00235604530880876,0.00707237076842446,-0.0162178920149207,0.0115058013973032,0.73903959311864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,39575,0.00171490176865272,0.00514935749872884,-0.00837783892885581,0.0118076424661612,0.73911635134971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00108434901543019,0.00326795898831313,-0.00748954863252393,0.00532085060166354,0.740037107710798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,41913,0.0011392495859976,0.00343693999601393,-0.00559715280618969,0.0078756519781849,0.740293158408816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,39575,0.00114037758485568,0.00346238375948255,-0.00564589458373012,0.00792664975344147,0.741888383635801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00193567116092552,0.00595606699342825,-0.00973822014619385,0.0136095624680449,0.745193691372317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,39560,0.00210609853236373,0.00648702600249225,-0.0106084724325211,0.0148206694972485,0.745442195788292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00148807907762867,0.00461310206827647,-0.0105297591314506,0.00755360097619322,0.747021967950646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,41843,0.00549283249068962,0.017468687317561,-0.0287457946517299,0.0397314596331092,0.753192770176883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00217983860464941,0.00703416690404047,-0.0116071285272699,0.0159668057365687,0.756648255844661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.00142424705572532,0.00459660591439949,-0.0104335946479483,0.00758510053649769,0.756681743955688
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.00193621770319234,0.0062742127246877,-0.0142336746435802,0.0103612392371956,0.757631180876071
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.00187369875779504,0.0061307900831473,-0.0101426498051737,0.0138900473207637,0.759897963243619
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00165018123162625,0.00540930148792477,-0.00895204968470631,0.0122524121479588,0.760323458041965
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.00094069006963847,0.00308529226865501,-0.00510648277692536,0.0069878629162023,0.760451723612093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00207122347541967,0.00686386816557125,-0.0155244050799393,0.0113819581291,0.76284268149092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.00109752706750209,0.00365968537711776,-0.00607545627164873,0.0082705104066529,0.764261729670604
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.00294172157501936,0.00990580906655975,-0.0223571073454765,0.0164736641954377,0.766495495655199
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.00121796849091784,0.00411265782067087,-0.00684284083759707,0.00927877781943274,0.767120051388912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00133680988705642,0.00456713459352296,-0.0102883936903614,0.00761477391624857,0.769755307635411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00168850909085922,0.00582257657526703,-0.0131007591783826,0.00972374099666416,0.771826634843348
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,41900,0.000716386173221988,0.0024744687033275,-0.00413357248529991,0.00556634483174389,0.772194794376266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00192301535006008,0.00667067841409305,-0.0149975450416825,0.0111515143415623,0.773138716446653
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.00106545828364367,0.00375288851086549,-0.00842111976494003,0.00629020319765269,0.776489499641274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,39560,0.00199334060060664,0.00706452445779082,-0.0118531273366634,0.0158398085378766,0.77782459508538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00108493419896877,0.0039669772029448,-0.00669034111880304,0.00886020951674057,0.784480604448538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.00125105449768153,0.00459224426600705,-0.00774974426369229,0.0102518532590553,0.785298309002598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,39990,-0.000668488524623532,0.0024677505470515,-0.00550527959684447,0.0041683025475974,0.786480676320106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.00102818589873376,0.00380663778820266,-0.00848919596361097,0.00643282416614344,0.787084898453958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00203552336593498,0.00755453241647978,-0.0168424069022354,0.0127713601703654,0.787593068793482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.0024172365173501,0.00901791133511803,-0.0200923427341814,0.0152578696994812,0.788666184019448
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.00218789114805279,0.00821474758139157,-0.0182887964075803,0.0139130141114747,0.78998468565894
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.00764995037504654,0.028831634233795,-0.0488600527231916,0.0641599534732847,0.790758798319859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,39657,-0.000813376033469884,0.00306974490723843,-0.00683007605165721,0.00520332398471744,0.791041093924626
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.00118064099984259,0.00449202872385718,-0.00762373529891749,0.00998501729860266,0.792685424261413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.000912205546677508,0.00351296839466555,-0.00597321250686697,0.00779762360022199,0.79512390084026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.00246269405945493,0.00951640938781367,-0.0211148564595697,0.0161894683406599,0.795806763658806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.000983851868292015,0.00382850289374764,-0.00652001380345337,0.0084877175400374,0.797198385556763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.000933650352832069,0.00367729536781582,-0.00627384856808693,0.00814114927375107,0.799580559351263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,41843,-0.00363949901622683,0.0143767222733548,-0.0318178746720022,0.0245388766395485,0.800154524173254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.000944197727819312,0.00380586098507336,-0.00651528980292448,0.0084036852585631,0.804068192736556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.000658174382548801,0.00265518645600188,-0.00586233983631248,0.00454599107121488,0.804229886692875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00124123011280137,0.00501624344346914,-0.00859060703639813,0.0110730672620009,0.804570678081856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,-0.000949384833317909,0.00391273755375943,-0.00861835043868639,0.00671958077205057,0.808289045535725
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.00113053367951113,0.00477712090302041,-0.0104936906494311,0.00823262329040888,0.812928168417995
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,39757,0.000590262819708392,0.00250619796051099,-0.00432188518289316,0.00550241082230994,0.813808527843198
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00105985312619414,0.00461113732063702,-0.00797797602225441,0.0100976822746427,0.818215442751073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.00380979804656838,0.0169043185723903,-0.0293226663553166,0.0369422624484533,0.821692208618779
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.00117865944073384,0.00525699948811129,-0.011482378437432,0.0091250595559643,0.822599772932494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00151970838377235,0.00678789982878997,-0.0148239920482007,0.011784575280656,0.822850996512753
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,39560,-0.00103429607735094,0.00463605877260909,-0.0101209712716648,0.00805237911696289,0.823463285561041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.000996652471132749,0.00452698757000069,-0.0078762431660686,0.0098695481083341,0.825752215716948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00132675608695765,0.00607437389883212,-0.0132325289286686,0.0105790167547533,0.827107028531778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,39757,-0.000972593655370722,0.00450609655926293,-0.00980454291152607,0.00785935560078463,0.829116798344529
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,39736,0.00121881365022499,0.00565083427462071,-0.00985682152803161,0.0122944488284816,0.829235387692682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,39586,0.00121539490218461,0.00565827861255195,-0.00987483117841721,0.0123056209827864,0.829927700590855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.000802279461185209,0.0038100286900423,-0.00826993569366811,0.00666537677129769,0.833226261998982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.000908607636559045,0.00432851527811103,-0.00939249758165665,0.00757528230853856,0.833740197142172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.0010539273236092,0.00502455629546796,-0.0109020576627264,0.00879420301550799,0.833861791329338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.000918359610914987,0.00438766909185562,-0.00768147180912203,0.009518191030952,0.834214173331741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.00111997123016299,0.00552846486996134,-0.00971581991496123,0.0119557623752872,0.839464340638846
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,39518,-0.000963709432227907,0.0047662228774967,-0.0103055062721214,0.00837808740766563,0.839767557466898
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.000905449037264238,0.00449208378193135,-0.00789903517532122,0.00970993324984969,0.840259528655488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.000974262624612791,0.00488367551483121,-0.010546266633682,0.00859774138445638,0.841880219091811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,0.00130369778734153,0.00664745343088969,-0.0117253109372023,0.0143327065118853,0.844519906087559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00113638406142466,0.00585845250108912,-0.01034618284071,0.0126189509635593,0.846200258473207
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,39657,0.0011678988475066,0.0061804150329639,-0.0109457146171026,0.0132815123121159,0.850121596296622
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.00160426862512969,0.00855160237861197,-0.0183654092872091,0.0151568720369498,0.851194127157895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.000792781311563653,0.0042379889157022,-0.00751367696321265,0.00909923958633996,0.851612773199576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.000680519041780872,0.00366586305382124,-0.00650457254370876,0.0078656106272705,0.852732433349697
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.000701462591890506,0.00379726643330967,-0.00814410480117746,0.00674117961739645,0.85344489364487
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.00120509584131032,0.00667784929699538,-0.0118834887808006,0.0142936804634213,0.856792847614475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,41976,0.00122810016256152,0.00700469886465644,-0.0125011096121651,0.0149573099372881,0.86082677299513
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00101139846543115,0.00582871420858705,-0.0124356783142618,0.0104128813833995,0.862245916333234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.00128537234248285,0.00750113186993837,-0.0134168461225964,0.0159875908075621,0.8639461264615
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,39859,-0.000565927216316139,0.00330997352196792,-0.00705347531937326,0.00592162088674099,0.864245428194271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.000929324412231628,0.00546150944156473,-0.00977523409323524,0.0116338829176985,0.864887777241874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.000617341727416788,0.00363821610619549,-0.00651356184072638,0.00774824529555995,0.865262356733163
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,39586,0.00137527672148325,0.00812501289577157,-0.014549748554229,0.0173003019971955,0.865591668196755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.000978442069701408,0.00598742800461212,-0.0127138009587412,0.0107569168193384,0.870193330082284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,39586,-0.00128720019106604,0.00798521763464951,-0.0169382267549791,0.014363826372847,0.871940511248692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,39586,-0.000805652547125527,0.00503432310136832,-0.0106729258258074,0.00906162073155638,0.87285884756265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,39657,0.000447023536983913,0.00283329866705149,-0.005106241850437,0.00600028892440482,0.874637024595572
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.000994000010912385,0.00651061659094284,-0.0117668085073356,0.0137548085291603,0.87865837722455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.00183110681612474,0.0123380790487072,-0.0223515281193413,0.0260137417515908,0.882021038809156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00113900291922624,0.00772966513978161,-0.0140111407547457,0.0162891465931982,0.882854701914821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.000522148646589663,0.00361295084506176,-0.00655923500973139,0.00760353230291071,0.885091431159488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.000565740260169453,0.00393730946360792,-0.00715138628850206,0.00828286680884097,0.885750225700463
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00123262124092839,0.00866914299603186,-0.0182241415131508,0.015758899031294,0.886936525005689
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.000420349463425286,0.00295951177201996,-0.0062209925365844,0.00538029360973383,0.887055725651425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.000519221261678519,0.00370514935559879,-0.00674287147529511,0.00778131399865215,0.888555778863874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,-0.000917813684781466,0.00662295704632853,-0.0138988094955854,0.0120631821260224,0.889783999232886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.000804311878774874,0.00580593123314235,-0.0105753133381841,0.0121839370957339,0.889821892243269
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,39638,0.000266706423956668,0.00197312668616237,-0.00360062188092158,0.00413403472883491,0.89248037543886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.00101279421612953,0.00751970143261649,-0.0137258205917988,0.0157514090240578,0.892863063684281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.000943080083445178,0.0071445293426447,-0.0130601974281384,0.0149463575950288,0.89498644882663
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00077506501332056,0.00594922028210119,-0.0108854067395978,0.0124355367662389,0.896347214696675
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.000387033106364258,0.00305044871947675,-0.00559184638381017,0.00636591259653869,0.89903929057232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000598313631512725,0.00475563523234417,-0.0099193586869073,0.00872273142388185,0.899883441160925
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,0.000661781743739041,0.00530242240944533,-0.00973096617877381,0.0110545296662519,0.900678286431328
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,39929,0.000288170908993739,0.002361214943575,-0.00433981038041325,0.00491615219840073,0.902866741404804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.000762064158959169,0.00636183647434876,-0.0132312636486827,0.0117071353307644,0.904654199381819
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.000966792751483497,0.00808692007391366,-0.0168171560963543,0.0148835705933873,0.904841673043234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.000900869036245377,0.00767274900280892,-0.0159394570817509,0.0141377190092601,0.906536110874592
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.00115779744632408,0.00994756006452397,-0.0183394202801429,0.0206550151727911,0.907345513672983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.000716989664584365,0.00642251916003867,-0.0133051272182601,0.0118711478890914,0.911113027621192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,39757,0.000619245958459442,0.00559192229694215,-0.0103409217435472,0.0115794136604661,0.911825016205442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,0.000488590305052139,0.00451903007845032,-0.0083687086487105,0.00934588925881477,0.913903735204641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,39929,0.000307906889724521,0.00289046220913105,-0.00535739904017234,0.00597321281962138,0.915167596670069
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.000612950542395894,0.00582515369500485,-0.0120302517846054,0.0108043506998136,0.916199365699471
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.000485349533219774,0.00463466700504632,-0.00956929686311056,0.00859859779667101,0.916598671656715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.000683855021829988,0.00656308942107541,-0.0121798002434778,0.0135475102871378,0.917014809943858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.000668391908674434,0.00678510565967536,-0.0139671990016381,0.0126304151842893,0.921530168846192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.00063364177638661,0.00665475429459359,-0.01367696019379,0.0124096766410168,0.924144349666201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,39657,0.00102470855322692,0.0108370076599569,-0.0202158264602887,0.0222652435667425,0.92466888678814
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,41913,0.000335374217464952,0.00366399428422665,-0.00684605457961929,0.00751680301454919,0.927070934085812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,39586,0.000453914145369874,0.00518888710944497,-0.00971630458914226,0.010624132879882,0.930293062212184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.00243106636482861,0.0280964708126987,-0.0526380164280609,0.0575001491577181,0.931050068462954
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000239077287507554,0.00281246374555419,-0.00527335165377866,0.00575150622879377,0.932257836780754
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.000449512148213029,0.00538707870490008,-0.0110081864098172,0.0101091621133911,0.93350109501169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,39575,0.000349528119605205,0.00430730495416819,-0.00809278959056444,0.00879184582977485,0.935325928954441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.000375416932028799,0.00480810035767248,-0.00904845976900925,0.00979929363306685,0.937765741028043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.000541791545303177,0.00708613807634579,-0.0133470390843346,0.0144306221749409,0.939055927474118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.00088189224941448,0.0115674819628203,-0.0217903723977134,0.0235541568965424,0.939230171488131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42137,0.000278217599480445,0.00367035477767238,-0.00691567776475741,0.0074721129637183,0.939578315888805
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,39575,0.000410540317255182,0.00544223573370841,-0.0102562417208133,0.0110773223553237,0.93986921781776
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.000334765325679661,0.00454536649275517,-0.00924368365147979,0.00857415300012046,0.941290389365081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.000674296864831248,0.0095877691022178,-0.0181177305755156,0.0194663243051781,0.943933184780521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,39586,-0.000730904761273228,0.0105575232510699,-0.0214236503333702,0.0199618408108237,0.944807243917196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.00027552389269142,0.00410773715703146,-0.00777564093509025,0.00832668872047309,0.94652348582485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.000399992085038649,0.00621926624457305,-0.0117897697543245,0.0125897539244018,0.948720378537135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000279219118847182,0.00437426839225299,-0.00885278516766304,0.00829434692996868,0.949105003547576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,39657,0.000210114436564961,0.0036011736310678,-0.00684818588032792,0.00726841475345785,0.953474001949464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.000458522009134563,0.00819543301766246,-0.0156045267054839,0.016521570723753,0.955383868335321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,41814,0.000343888421964137,0.00656015049158814,-0.0125140065415486,0.0132017833854769,0.958194182957203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.000291215264170632,0.0055875754592503,-0.01066043263596,0.0112428631643012,0.958435170499161
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.000266163532451191,0.00548845347479733,-0.011023532343054,0.0104912052781516,0.961322338228623
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.000236463092390058,0.00537640931903199,-0.0103012991729126,0.0107742253576928,0.964919869648702
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.000187113476006716,0.00435913595793868,-0.0083567930015531,0.00873101995356653,0.965762545359615
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,39736,0.000150516395730026,0.00374546716847452,-0.00719059925448004,0.00749163204594009,0.96794533545256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.000115356916442949,0.00310246333363723,-0.00619618505037192,0.00596547121748602,0.970340154750028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,39757,0.000108445176167351,0.002984744316673,-0.00574165368451173,0.00595854403684643,0.971017363984336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.000258537154875315,0.00926195754538502,-0.0178948996340793,0.0184119739438299,0.977731347771349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.000171209027377622,0.00631708521083556,-0.0125526960406153,0.0122102779858601,0.978378437044296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.000159988836456805,0.00606512914019273,-0.0120476419512346,0.0117276642783209,0.978955854733559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.000142143228928118,0.00617452078258055,-0.012244203962786,0.0119599175049298,0.981633990703256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,9.45262548755027e-05,0.0048047432556241,-0.00932277052614774,0.00951182303589875,0.984304165272339
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,39657,-7.8316151882951e-05,0.00422514196241152,-0.00835959439820954,0.00820296209444364,0.985211796915928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-4.78529838197456e-05,0.00347118582221749,-0.00685137719536602,0.00675567122772653,0.989001099695125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,39934,4.71951422373662e-05,0.00376395248883395,-0.00733015173587718,0.00742454202035191,0.989996032602949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-9.36846260229551e-05,0.00792868677798672,-0.0156339107108769,0.015446541458831,0.990572700826026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,39979,3.52360410630677e-05,0.00358160816070463,-0.00698471595391802,0.00705518803604415,0.992150670683863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-2.24700575034287e-06,0.00246043364300615,-0.0048246969460424,0.00482020293454171,0.999271340685848
